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Endolysosomal inhibition induces the autophagy-dependent secretion  
of autophagosomal cargo 
By Tina Ann Solvik 
 
 
ABSTRACT 
 
Autophagy is traditionally viewed as a degradative pathway in which cytoplasmic material is 
sequestered in double-membrane organelles called autophagosomes and delivered to the 
lysosome for breakdown. However, autophagy-related proteins (ATGs) have also been 
implicated in promoting unconventional secretion of proteins.  We uncovered a role for the ATG 
conjugation system in the loading and secretion of proteins in small extracellular vesicles (EVs) 
separate from the canonical degradative autophagy pathway. To determine the interrelationships 
between degradative and secretory autophagy, I utilized a proteomic strategy to evaluate the 
secretome in response to pharmacologically inhibiting endolysosomal acidification, thereby 
blocking autophagic degradation. In contrast to secretion from cells with baseline autophagic 
activity, the secretome in response to endolysosomal inhibition is significantly enriched with 
autophagy-related proteins and autophagic cargoes. This suggests that impaired autophagic 
degradation in cells results in the redirection of degradative cargo to be secreted outside of the 
cell. To further investigate this pathway, I characterized the secretion of the autophagy regulator 
LC3 and its interacting cargo receptors (p62, NBR1, OPTN, NDP52), which selectively deliver 
cargo to the growing autophagosome but have not previously been implicated in secretory 
autophagy. These autophagy cargo receptors are secreted as unprotected EV-associated protein 
in an autophagosome formation-dependent manner, indicating a distinct mechanism requiring 
classical autophagosome formation for the secretion of these proteins. Furthermore, genetic 
knockdown of two separate SNARE proteins mediating autophagosome-lysosome fusion 
 vii 
increases secretion of LC3 and autophagy cargo receptors. Overall, these findings establish a 
new relationship between degradative autophagy and secretory autophagy, in which the impaired 
degradation of autophagic cargo due to the lack of autophagosome-lysosome fusion results in a 
concomitant increase in EV-associated secretion of cargo receptors. 
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CHAPTER 1: Introduction 
  
 2 
AUTOPHAGY 
Autophagy is traditionally viewed as a catabolic pathway in which cytoplasmic material is 
sequestered in double-membrane organelles called autophagosomes (APs) that are delivered to 
lysosomes for degradation1. Studies in yeast have identified more than 30 autophagy-related 
proteins (ATGs), many of which have identified mammalian orthologues. The canonical process 
of autophagy begins with initiation at the phagophore assembly site, mediated by the UNC51-
like kinase (ULK) complex – composed of the ATG proteins ULK1/2, ATG13, FIP200, and 
ATG101. The ULK complex phosphorylates components of a class III phosphatidylinositol 3-
kinase (PI3K) complex, consisting of Beclin 1 (ATG6), ATG14 and VPS34 to produce 
phosphatidylinositol triphosphate (PI3P), which serves as the initial membrane marker 
recognized by early autophagic effector proteins2. Phagophore membrane expansion is mediated 
by the two ubiquitin-like conjugation systems involving multiple ATGs (ATG3, ATG5, ATG7, 
ATG10, ATG12) that ultimately lead to the lipidation of microtubule-associated protein light 
chain 3 (LC3), the mammalian orthologue of ATG83. LC3 is recognized by autophagy cargo 
receptors that promote the selective capture and engulfment of ubiquitinated proteins, organelles, 
or microbes4. The autophagy cargo receptors p625, NBR16, OPTN7, and NDP528 bind to LC3 via 
their LC3-interacting region (LIR) motifs, ensuring the anchoring of the captured cargo in the 
growing autophagosome membrane9.  In addition to LC3-conjugation-mediated membrane 
expansion, closure of the autophagosome requires ATG2A and ATG2B10. Once closed, the 
autophagosome is then trafficked to and fuses with the lysosome, where the inner membrane is 
susceptible to lysosomal hydrolases, thereby allowing hydrolase access to the autophagosomal 
cargo for degradation. Fusion of the autophagosome and lysosome requires soluble N- 
ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins, which physically 
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drive the fusion of opposing lipid bilayers11. Autophagosome-lysosome fusion is mediated by 
either of two sets of SNARE complexes, STX17-SNAP29-VAMP812 or YKT6-SNAP29-
STX713, in which one SNARE is docked in the autophagosomal or lysosomal membrane and 
SNAP29 bridges the opposing SNAREs, facilitating the membrane fusion.  
 
SECRETORY AUTOPHAGY 
Despite the classical view of autophagy as a degradative process, ATGs have been recently 
implicated in secretion, in a process referred to as “secretory autophagy.” Canonically, protein 
secretion involves the presence of an N-terminal signal, resulting in the transfer of the peptide 
into the ER for subsequent ER-to-Golgi transport. However in unconventional secretion, 
leaderless proteins lacking signal peptides can be secreted without going through the ER-to-
Golgi pathway. One pathway by which these leaderless proteins can be secreted is through 
uptake by membrane-bound organelles, proposed to be autophagosomes or endosomes, diverted 
from their normal trafficking toward lysosomes and instead redirected to the plasma membrane 
and released extracellularly14.  
The field of secretory autophagy emerged in 2010 when parallel studies revealed that two 
species of yeast, Saccharaomyces cervisiae and Pichia pastoris, secrete acyl coenzyme A 
binding protein (Acb1) in an ATG-dependent manner. S. cervisiae secretion of Acb1 requires 
ATGs responsible for elongation of the phagophore membrane (ATG5, ATG7, ATG8, ATG12) 
and P. pastoris secretion requires ATGs responsible for initiation (ATG1, ATG6, ATG9, 
ATG17) and elongation (ATG8). Both studies determined that Acb1 release does not require 
autophagosome fusion with the vacuole (i.e. lysosome), but does require ESCRT machinery 
(VPS23, VPS4), implicating the endosomal pathway, and SNARE-mediated vesicular fusion 
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with plasma membrane, suggesting the secretion of Acb1 within an autophagosome/endosome 
hybrid (amphisome)15,16.  
The first evidence of secretory autophagy in mammalian cells was established in the 
study of IL-1b. The leaderless cytokine had previously been believed to be released via an 
endolyososome17, but the discovery of autophagy-dependent Acb1 secretion initiated interest in 
autophagy regulation of IL-1b release. Not only is IL-1b secretion modulated by induction or 
inhibition of autophagy, but the autophagosome itself has been implicated in its secretion18,19. 
The first study into secretory autophagy of IL-1b revealed the requirement of ATG5, GRASP55, 
and Rab8a18. IL-1B is incorporated into an autophagosome via translocation across the 
phagophore membrane in an HSP-90-dependent manner reminiscent of chaperone-mediated 
autophagy19. The most recent study of IL-1b secretion investigated how despite its incorporation 
into an autophagosome, it evades degradation within the lysosome and is instead directed to 
secretion. They revealed that a specialized cargo receptor regulator, TRIM16, interacts with IL-
1b and delivers it to LC3B+ phagophore in response to lysosomal damage. SNAREs Sec22b, 
SNAP23 or SNAP29, and STX3 or STX4 mediate AP fusion with plasma membrane, and 
STX17, required for fusion with lysosome, is not involved20. Beyond IL-1b, several other 
inflammatory mediators without signal peptides are released in an autophagy-dependent manner. 
HMGB118,21 and IL-622–24. 
ATGs have also been implicated in the secretion of exosomes, small extracellular 
vesicles with a diameter of 50-200 nm. Small extracellular vesicles are derived from inward 
budding of the intermediate endocytic compartment, the MVB, to form intraluminal vesicles 
(ILVs) that, upon fusion of the MVB with the plasma membrane, are liberated into the 
extracellular space25.Our lab first identified this connection when we recognized that cells 
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lacking the ATG12-ATG3 complex have accumulated late endosomes and impaired 
endolysosomal trafficking. We demonstrated that ATG12-ATG3 interacts with and activates 
ALIX, thereby promoting exosome release26. A later study recognized the role of ATGs in 
exosome release independent of canonical autophagy, specifically ATG5. ATG5 disassociates 
the negative regulatory protein ATP6V1E1 from V-ATPase, the proton pump that controls 
endolysosomal acidification. With ATP6V1E1 detached, V-ATPase is more active, resulting in 
increased acidification of the MVB and released exosomes. Intriguingly, this study found ATG5 
and LC3 enclosed in exosomes, potentially a result of ATG5 recruiting ATP6V1E1 into ILVs in 
the MVB27. 
Prior to our lab’s determination of the LC3-dependent secretion pathway, only one study 
had established an ATG-dependent secretome. Loss of ATG5 in macrophages revealed increased 
secretion of 74 proteins relative to WT cells under inflammation-inducing conditions. The 
majority of these proteins were leaderless and cytosolic. However, they only further analyzed 
one protein, ferritin heavy chain, but did not analyze the role of other ATGs, making it unclear if 
the ATG5-dependent release is a canonical or unconventional function of ATG520. 
Ultimately, studies on secretory autophagy have focused on a limited and heterogeneous 
list of protein targets and have not elucidated clear cause-effect relationships between ATGs, 
autophagic vesicular trafficking, and the secretome. Attributing a secretory phenotype to 
canonical autophagy based on the genetic analysis of a single ATG is no longer viable. Future 
secretory autophagy studies need to functionally test multiple ATGs when characterizing a 
phenotype in order to ascertain a general role for autophagy as opposed to a distinct function 
mediated by individual ATG proteins. 
 
 6 
DEFINING THE AUTOPHAGY-DEPENDENT SECRETOME 
Our lab addressed these gaps by producing a rigorously defined autophagy-dependent secretome 
and implicating the ATG conjugation machinery as critical regulators of this pathway. Using a 
proximity-specific biotinylation proteomics approach, we identified approximately 200 targets of 
secretion dependent on the critical ATG, LC3. The secretome had high overlap with previously 
identified LC3 and cumulative ATG8 interactomes28, and furthermore, revealed a novel 
interaction between LC3 and proteins released within small extracellular vesicles, or exosomes. 
Intriguingly, the major targets of secretion were RNA-binding proteins that are not targets of 
canonical degradative autophagy. Further analysis of LC3 and its directed targets of secretion 
confirmed that they were released via extracellular vesicles – a pathway we refer to as LC3-
dependent extracellular vesicle loading and secretion (LDELS). A separate proteomic approach 
identifying the extracellular vesicle proteins secreted in an ATG7 or ATG12-dependent manner 
confirmed a broad LC3-conjugation-dependent secretome29. While our proteomics screen 
established a role for LC3 in secretion, it remains unclear how targets are chosen for secretion 
rather than degradation and the purpose that secretion serves in various cellular states. The 
screen was performed in wild-type cells under serum starvation, a condition that induces 
autophagy and downregulates secretion30–32. In addition, the screen was not enriched in LC3-
interacting cargo receptors that have previously been found in multiple exosome screens33,34.  
Prior to our discovery of LC3-dependent secretion, we and other groups demonstrated the 
molecular crosstalk between extracellular vesicle release and autophagy, implicating them as 
coordinated processes to maintain cellular homeostasis26,35–38. This coordination is likely due to 
connection between the endosomal and autophagy pathways. Both organelles fuse with 
lysosomes for degradation of their cargo and autophagosomes can fuse with the intermediate 
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endocytic compartment, the MVB, to form an amphisome prior to delivery to the lysosome39,40. 
As a result, modulating the autophagy pathway effects the quantity of secreted vesicles. 
Induction of autophagy pharmacologically or by starvation inhibits exosome release, due to the 
increased fusion of MVBs with autophagosomes and their degradation via the autophagy 
pathway40,41. In addition, inhibiting autophagic degradation pharmacologically or by knockdown 
of a protein critical for AP-lysosome fusion42,43 causes an increase in ILV formation in MVBs 
and subsequent secretion of exosomes34,41,44. Exosome release and degradative autophagy are 
negatively correlated, but how these two pathways coordinate targets of secretion versus 
degradation remains unclear. 
It is well documented that the composition of extracellular vesicles is modified by 
changes in the cell’s physiological state or culture conditions, and that secretion can be induced 
as a response to stress33,45–48, suggesting that the level of autophagy in the cell may also impact 
the content of secreted vesicles. There is already some supporting evidence. In addition to 
decreasing the release of EVs overall, the induction of autophagy decreases the secretion of LC3 
and its cargo40. MVBs colocalize with ATG cargo receptors and exosomes contain these 
receptors in addition to autophagic cargo34,41. Furthermore, impaired AP-lysosome fusion results 
in upregulated exosome release and enhanced secretion of ATG cargo receptors34,44, suggesting 
that AP cargo can be diverted into exosomes when they fail to be degraded. A block in 
degradative autophagy is a biologically relevant condition in neurodegenerative diseases 49–52 
and may provide interesting targets of secretion that will further elucidate the mechanism and 
significance of the LC3-dependent secretory pathway. 
In this dissertation, I explore the link between degradative autophagy and secretory 
autophagy. In Chapter 2, I utilize two distinct mechanisms of impairing degradative autophagy to 
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demonstrate that impaired autophagosome-lysosome fusion increases the secretion of LC3 as 
well as autophagy cargo receptors (p62, NBR1, OPTN, NDP52). The secretion of these proteins 
requires ATGs spanning autophagosome initiation, elongation, and closure, implicating the 
autophagosome itself in secretion. Furthermore, these proteins are released in a Rab27a-
dependent manner and are not membrane-protected, suggesting that in the absence of lysosomal 
degradation, autophagosome fuses with the MVB to form amphisomes which are subsequently 
secreted. In Chapter 3, I discuss the biomedical implications for the secretion of undegraded 
autophagic material, focusing on neurodegenerative disease.   
 9 
 
 
 
 
CHAPTER 2: Endolysosomal inhibition induces the autophagy-dependent secretion of 
autophagosomal cargo 
  
 10 
RESULTS 
Inhibition of endolysosomal acidification alters the cargo of autophagy-dependent secretion 
To determine the effects on autophagy-dependent secretion when flux through the endosomal-
autophagy-lysosomal pathway is impaired, we inhibited the acidification of the lysosome, which 
impairs the fusion and degradation of autophagosomes and their cargo. HEK-293T cells were 
subject to serum starvation to induce autophagy and treatment with bafilomycin A1 (bafA1), a 
specific inhibitor of V-ATPase with IC50 value of ~1 nM53, at 20 nM for 16 h, to inhibit 
lysosomal acidification. To assess the effects of bafA1 on autophagic flux, we used mCherry-
GFP-LC3, which reports trafficking of LC3-labeled APs to the lysosome, where the acidic pH 
quenches the GFP signal but not mCherry. Consistent with previous results, bafA1 treatment 
blocked GFP quenching in wild-type cells relative to serum starvation alone, resulting in 
accumulated mCherry+ GFP+ puncta, indicative of reduced autophagic flux. Atg7-/- cells, due to 
their failure to conjugate LC3 to the autophagosome membrane, accumulated cytosolic mCherry-
GFP-LC3 (Figure 2.1a). Measurement of cell viability by trypan blue exclusion54 revealed no 
significant cell death relative to control over the first 8 h of bafA1 treatment; thereafter we 
observed a gradual increase in death compared to controls at 12 h and 16 h or treatment (Figure 
2.1b), although levels of death observed were significantly lower than cells treated with digitonin 
as a positive control. In parallel, we asked whether inhibition of endolysosomal acidification 
modulated EV secretion. Using nanoparticle tracking analysis (NTA), we revealed that bafA1 
does not significantly increase EV production relative to control (Figure 2.1c), inconsistent with 
previous findings44. The EVs were 123.3 +/- 2.6 nm in diameter, which corresponded to the size 
of exosomes (40-150 nm)55, indicating that bafA1 treatment does not significantly impact the 
size of small EVs in comparison to those released from control cells (Figure 2.1d). To scrutinize 
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the effect of bafA1 on EV secretion in this study, we subject conditioned media from cells 
treated for 16 h to differential ultracentrifugation to enrich for large EVs (at 10,000 g) and small 
EVs (at 100,000 g) (Figure 2.1e). To assess the purity of the isolated EVs from these 100,000 g 
fractions, we measured the secretion of intracellular proteins normally absent or 
underrepresented in EVs (i.e. associated with the golgi, mitochondria, and nucleus) as well as 
proteins associated with the endosomal-autophagy-lysosomal pathway that have been previously 
identified in EVs. We observed high secretion of ATG14, LAMP1, Rab7a, and Rab5a, but 
minimal secretion of golgi, mitochondria, and nuclear markers. Furthermore, extracellular 
release of endosomal-autophagy-lysosomal pathway proteins was functionally dependent on 
ATG7, suggesting a requirement for this autophagy regulator on EV secretion (Figure 2.1f). 
Overall, these results indicate that inhibition of endolysosomal acidification upon bafA1 
treatment prevents AP degradation and directs endosomal-autophagy-lysosomal proteins towards 
secretion in small EVs in an ATG7-dependent manner. 
To define the broader ATG7-dependent secretome under endolysosomal inhibition, we 
performed tandem-mass tag-based quantitative proteomics comparing 100,000 g fractions from 
bafA1-treated wild-type and Atg7-/- cells. We identified 182 proteins with statistically significant 
enrichment in 100,000 g fractions from wild-type relative to Atg7-/- cells ((WT:Atg7-/-)>1.5; 
p<0.05). The ATG7-dependent secretome under endolysosomal inhibition included LC3/ATG8 
isoforms (LC3B, GABARAP, GABARAPL2), autophagy cargo receptors (p62/SQSTM1, 
NBR1, OPTN, NDP52/CALCOCO2, etc.), and autophagosome machinery (FIP200, ULK1, 
Beclin-1, etc.). In contrast, none of the RNA-binding proteins recently identified as targets of 
LDELS (HNRNPK, SAFB, LARP1, G3BP1, and SF3A1)29 were significantly enriched in these 
100,000 g fractions (Figure 2.2a, Table 2.1). Five of the six LC3/ATG8 isoforms were amongst 
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the top proteins connected to the secretome, and we identified multiple proteins in common with 
the ATG8 interactome28 (Figures 2.2b-c). Direct comparison of the ATG7-dependent secretome 
under endolysosomal inhibition and under baseline autophagic conditions29 reveals only partial 
overlap, indicating the protein content of the 100,000 g fractions is altered based on the state of 
autophagic flux in the cell (Figure 2.2d). Gene ontology (GO) analyses of this secretome 
highlighted enrichment in proteins related to autophagy and demonstrated that proteins found in 
diverse intracellular and organelle compartments were significantly enriched in these fractions, 
rather than RNA binding proteins, proteins associated with classical secretion, or proteins found 
in the extracellular space (Figures 2.2e-f). Furthermore, 12 proteins in this secretome overlapped 
with previously identified targets of LDELS (Figures 2.3a-b). Remarkably, 27 and 18 proteins 
in the ATG7-dependent secretome overlapped with targets previously identified in the proteomes 
of classifical degradative autophagosomes following chloroquine (CQ) and bafA1 treatment, 
respectively (Figures 2.3c-f) 29,56,57. These results suggest that while at baseline levels of 
autophagy, the autophagy-dependent secretome is enriched in RNA-binding proteins29, blocking 
the degradation of autophagosomes results in the enhanced ATG7-dependent secretion of 
autophagy-related proteins and known autophagic cargoes. In total, these findings indicate that 
proteins normally degraded in the lysosome via autophagy can be secreted extracellularly upon 
endolyososomal inhibition. 
 
Inhibition of endolysosomal acidification induces secretion of autophagic cargo in small 
extracellular vesicles 
To further define the secretion of autophagic cargo under endolysosomal inhibition, we 
measured secreted protein levels relative to untreated cells. BafA1 treatment led to a striking 
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increase in the secretion of LC3 and ATG cargo receptors (p62, NBR1, OPTN, NDP52) in the 
100,000 g fraction, while canonical exosome markers (TSG101, ALIX, CD9) underwent little 
change in secreted levels, indicating that this pathway is regulated separately from exosomes 
(Figure 2.4a-b). A time course analysis of secretion of LC3 and the ATG cargo receptors 
revealed that this release in 100,000 g occurs within several hours of initial intracellular 
accumulation (Figure 2.4c). Notably, the robust EV secretion of these targets was observed as 
early as 4 h, timepoints prior to any significant cell death associated with bafA1 treatment 
(Figure 2.1b). We then used an independent method of blocking lysosome acidification, CQ, a 
lysosomotropic agent that acts as a proton trap in the lysosomal lumen, thereby raising the pH. 
Similar to bafA1, cells treated with 25 µM CQ under serum starvation for 24 h had minimal 
effects on cell death (Figure 2.4d), and secreted increased levels of LC3 and autophagy cargo 
receptors, but not exosome markers, relative to control treated cells (Figure 2.4e-f). Therefore 
two distinct methods of inhibiting endolysosomal acidification increase secretion of autophagic 
cargo relative to untreated cells. To confirm this effect is not unique to HEK293Ts, we repeated 
this experiment in vivo in homozygous transgenic GFP-LC3 mice. We treated mice with 60 
mg/kg CQ for 3 days, before collecting whole blood and isolating the 100,000 g fraction from 
plasma by ultracentrifugation. Again, GFP-LC3 and the cargo receptor p62 was secreted at 
significantly higher levels in CQ-treated mice compared to untreated controls (Figure 2.4g-h). 
We also observed increased levels of EV-associated secretion of NBR1 in the plasma of CQ-
treated mice, although this difference was not significantly different. We conclude that blocking 
autophagosome degradation by inhibiting endolysosomal acidification results in extracellular 
release of autophagy cargo receptors in vitro and in vivo. 
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To further characterize the nature of secretion of LC3 and autophagy cargo receptors, we 
assessed the size, density, and membrane protection of the secreted material. We first compared 
ultracentrifugation fractions of 10,000 g to detect large EVs (150-1,000 nm), 100,000 g to detect 
small EVs (40-150 nm), and TCA-precipitated 100,000 g supernatant to detect soluble protein. 
LC3 and the cargo receptors were significantly enriched in the 100,000 g fraction relative to the 
10,000 g and TCA fractions, indicating they cofractionate with small EVs, consistent with the 
exosome marker CD9 (Figure 2.5a-b). To determine if cargo receptors are secreted within the 
lumen of small EVs or cofractionate with these vesicles, we measured their protection from 
protease in the presence and absence of detergent. In contrast to TSG101, we found that p62, 
NBR1, and OPTN were not membrane-protected from proteases, indicating they do not reside 
within the lumen of small EVs (Figure 2.5c-d). To confirm that the cargo receptors co-
fractionate with EVs, despite their lack of membrane protection, we further purified small EVs 
via linear sucrose density gradient. We demonstrated LC3 and the autophagy cargo receptors 
fractionate in 100,000 g fractions overlapping in density with CD9, a canonical exosome marker 
(Figure 2.5e-f). Overall, we demonstrated that autophagic cargo secreted under endolysosomal 
inhibition are small EV-associated, but not within membrane-protected vesicular compartments. 
 
Autophagosome formation and Rab27a are required for secretion of autophagic cargo 
during endolysosomal inhibition 
To determine the mechanism of packaging of autophagic cargo in vesicles destined for secretion, 
we investigated the requirement for autophagosome formation machinery and nSMase2-
dependent ILV budding. First, we assessed the requirement of autophagy beyond ATG7 using an 
array of Atg CRISPR knock-out cells unable to form mature autophagosomes. We specifically 
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interrogated the autophagosome formation steps of initiation of the phagophore membrane by 
FIP20058 and ATG1459–61, elongation by the LC3 conjugation machinery ATG7 and ATG123, 
and closure by ATG2A/ATG2B10. Since it was previously identified that Atg knockouts exhibit 
differences in EV production29,  we normalized EV lysates by protein concentration in our 
assays. We demonstrated that secretion of autophagic cargo requires ATG7 and ATG12, similar 
to LDELS29, as well as all other autophagosome machinery probed: FIP200, ATG14, and 
ATG2A/ATG2B (Figure 2.6a-b). This indicates that steps from initiation through closure of the 
phagophore, thereby the formation of mature autophagosomes, is essential for the release of 
autophagic cargo. While previous studies have implicated individual ATGs in secretory 
autophagy62, this is the first demonstration of the functional requirement of multiple key steps in 
autophagosome formation (initiation, elongation, and closure) for autophagy-dependent 
secretion, suggesting the mature autophagosome itself is upstream of the secretory event.   
To determine the mechanism of release of packaged autophagic cargo, we interrogated 
the role of Rab27a, which has been identified as necessary for fusion of the MVB63 or 
autophagosome-MVB fusion organelle, the amphisome64, with the plasma membrane to release 
their contents into the extracellular space (Figure 2.6c-d). Depletion of Rab27a resulted in a 
significant, but not complete, decrease in secretion of LC3 and the cargo receptors, suggesting 
the utilization additional factors in plasma membrane fusion. Ultimately, secretion of autophagy 
cargo receptors requires the formation of an autophagosome, as well as Rab27a for fusion of the 
autophagosome, or other downstream organelles, such as an amphisome or autolysosome, with 
the plasma membrane. 
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Genetic inhibition of autophagosome-lysosome fusion promotes secretion of autophagic 
cargo 
While bafA1 is widely used to block autophagosome-lysosome fusion, it has been noted that this 
is secondary to its direct effect, deacidification of the lysosome65. To determine whether secreted 
autophagic cargo are derived from autophagosomes that have not yet fused with lysosomes or 
from de-acidified autolysosomes, we examined secretion by cells genetically impaired in 
autophagosome-lysosome fusion. Specifically, we depleted cells of SNAP29 and VAMP8, two 
N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins which interact 
to mediate autophagosome and lysosome membrane fusion12. First, we confirmed that SNAP29 
and VAMP8 loss would have a similar effect on autophagic flux as bafA1, using mCherry-GFP-
LC3. Consistent with previous studies, knockdown of the genes alone resulted in accumulated 
GFP+ mCherry+ LC3 puncta, indicative of reduced autophagic flux similar to non-targeting cells 
treated with bafA1 (Figure 2.7a). Depletion of SNAP29 and VAMP8 led to a significant 
increase in secreted LC3 and the autophagy cargo receptors (Figures 2.7b-e), similar to the 
effect of bafA1 on wild-type cells. However, knock-down of STX17, another protein in the 
SNARE complex, had a non-significant effect on secretion (data not shown), presumably due to 
its role in autophagosome initiation in addition to autophagosome-lysosome fusion66,67. 
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Figure 2.1. BafA1 prevents autophagosome degradation and modulates EV secretion 
(a) Wild-type (WT) and ATG7-/- HEK293Ts transfected with mCherry-GFP-LC3 were grown in 
full media (FM), treated with vehicle in serum-free media (SS), or treated with 20 nM 
bafilomycin A1 (bafA1) in serum-free media (BafA1) for 16 h. Scale bar, 5 µm. (b) Cell death in 
WT cells treated with 48 µM digitonin in full media (Positive Control), treated with vehicle in 
serum-free media (Vehicle), or treated with 20 nM bafA1 in serum-free media (20 nM BafA1) 
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for indicated time periods quantified using trypan blue staining (mean ± s.e.; n=3). Statistical 
significance calculated by ordinary one-way analysis of variance followed by Sidak multiple 
comparisons test for comparison between pairs (n.s. = not significant, ** = p-value < 0.01, *** = 
p-value < 0.001, **** = p-value < 0.0001). (c) Nanoparticle tracking analysis of CM from equal 
numbers of WT cells treated with vehicle in serum-free media (DMSO) or 20 nm bafA1 in 
serum-free media (BafA1) to determine EV number (mean ± s.e.m.; n=3). Statistical significance 
calculated by unpaired two-tailed t-test (n.s.=not significant). (d) EV size distribution from 
indicated cell treatments in Panel c (mean ± s.e.; n=3). (e) Schematic of 100,000 g EV isolation 
by differential ultracentrifugation. (f) Whole cell lysate (WCL) and 100,000 g EV (100k) 
fractions harvested from WT and ATG7-/- cells treated with vehicle or 20 nM bafA1 in serum-
free media for 16 h were collected, normalized for protein concentration, and immunoblotted to 
detect indicated organelle markers. 
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Figure 2.2. Autophagy-dependent secretome under inhibition of endolysosomal 
acidification is enriched in autophagy-related proteins 
(a) Volcano plot of proteins identified in 100,000 g EV (100k) fractions harvested from wild-
type (WT) and ATG7-/- HEK293T cells treated with 20 nM bafA1 in serum-free media for 16h 
and quantified by tandem mass tag (TMT) mass spectrometry. TMT labeled proteins from 3 
biological replicates were plotted according to their -log10 p-values as determined by two-sample 
t-test and their log2 fold enrichment (WT/ATG7-/-). Red dots: proteins identified that have a p-
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value < 0.05 and fold-change < -1.5 and thus are relatively enriched in 100k from ATG7-/- cells 
treated with bafA1. Grey dots: proteins identified that have a p-value > 0.05 and/or fold-change 
between -1.5 and 1.5 and thus are not relatively enriched in 100k from WT or ATG7-/- cells 
treated with bafA1. Green dots: proteins identified that have a p-value < 0.05 and fold change > 
1.5 and thus are relatively enriched in 100k from WT cells treated with bafA1. (b) Ranked list by 
-log10 adjusted p-value of proteins with the greatest connectivity to the 182 proteins enriched in 
100k from WT cells treated with bafA1 relative to ATG7-/- cells treated with bafA1 as 
determined by the protein-protein interaction (PPI) hub protein tool in the Enrichr gene set 
enrichment analysis web server. LC3/ATG8 family members are highlighted in red. (c) Venn 
diagram showing the overlap of proteins enriched in 100k from WT cells treated with bafA1 
relative to 100k from ATG7-/- cells treated with bafA1 with the ATG8 intracellular interactome 
defined in Behrends et al. 2010. List of enriched proteins is provided in Table 1. (d) Venn 
diagram showing the overlap of proteins enriched in 100k from WT cells treated with bafA1 
relative to 100k from ATG7-/- cells treated with bafA1 with the ATG7-dependent secretome 
defined in Leidal et al. 2020. List of enriched proteins is provided in Table 1. (e) Gene ontology 
(GO) enrichment analysis of the 182 proteins enriched in 100k from WT cells treated with bafA1 
relative to 100k from ATG7-/- cells treated with bafA1 with the top ten terms for biological 
process plotted according to -log10 false discovery rate. (f) GO enrichment analysis of the 182 
proteins enriched in 100k from WT cells treated with bafA1 relative to 100k from ATG7-/- cells 
treated with bafA1 with the top ten terms for cellular component plotted according to -log10 false 
discovery rate. 
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Table 2.1.  Proteins enriched in autophagy-dependent secretome under inhibition of 
endolysosomal acidification 
182 proteins enriched in 100,000 g EV (100k) fractions harvested from wild-type (WT) 
HEK293T cells treated with 20 nM bafA1 relative to 100k fraction harvested from ATG7-/- cells 
treated with 20 nM bafA1. Proteins identified by name, uniprot ID, gene name, p-value, and log2 
fold enrichment (WT/ATG7-/-). 
 
Uniprot 
ID 
Gene Protein P-value Log2(Fold-
Change) 
O95166 GABARAP 
Gamma-aminobutyric acid receptor-
associated protein 0.005661556 2.62129678 
P02792 FTL Ferritin light chain 0.021773366 2.565518083 
P02794 FTH1 Ferritin heavy chain 0.022109262 2.497207754 
Q86VP1 TAX1BP1 Tax1-binding protein 1 0.00210311 2.454087101 
Q13137 CALCOCO2 
Calcium-binding and coiled-coil 
domain-containing protein 2 0.018230688 2.438417275 
P17612 PRKACA 
cAMP-dependent protein kinase 
catalytic subunit alpha 0.011205547 2.434870993 
A3KN83 SBNO1 Protein strawberry notch homolog 1 9.84E-05 2.394471646 
Q13501 SQSTM1 Sequestosome-1 0.022196023 2.342407645 
Q9NQC7 CYLD 
Ubiquitin carboxyl-terminal hydrolase 
CYLD 0.004287523 2.319304451 
Q9NR28 DIABLO Diablo homolog, mitochondrial 0.003478699 2.261795153 
P60520 GABARAPL2 
Gamma-aminobutyric acid receptor-
associated protein-like 2 0.005013484 2.231014392 
Q13772 NCOA4 Nuclear receptor coactivator 4 0.028232656 2.227108801 
P10644 PRKAR1A 
cAMP-dependent protein kinase type I-
alpha regulatory subunit 0.009020855 2.186913661 
P60709 ACTB Actin, cytoplasmic 1 0.003340117 2.182985917 
Q9ULG6 CCPG1 Cell cycle progression protein 1 0.02487707 2.179908892 
Q9P1Z2 CALCOCO1 
Calcium-binding and coiled-coil 
domain-containing protein 1 0.000246982 2.160650872 
A6NKT7 RGPD3 
RanBP2-like and GRIP domain-
containing protein 3 0.00333469 2.1210456 
P21796 VDAC1 
Voltage-dependent anion-selective 
channel protein 1 0.014336043 2.086194684 
P31321 PRKAR1B 
cAMP-dependent protein kinase type I-
beta regulatory subunit 0.030251917 2.055828903 
Q9NQG6 MIEF1 Mitochondrial dynamics protein MID51 0.014814491 2.051987162 
Q9NYA4 MTMR4 Myotubularin-related protein 4 0.004386739 2.042971197 
Q9BWH2 FUNDC2 FUN14 domain-containing protein 2 0.013872062 2.027525856 
Q14596 NBR1 Next to BRCA1 gene 1 protein 0.017299505 2.022793787 
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Uniprot 
ID 
Gene Protein P-value Log2(Fold-
Change) 
P63165 SUMO1 Small ubiquitin-related modifier 1 0.00177225 1.938929413 
Q9GZQ8 MAP1LC3B 
Microtubule-associated proteins 1A/1B 
light chain 3B 0.009191918 1.90610193 
Q9UKA4 AKAP11 A-kinase anchor protein 11 0.015513757 1.893865481 
O00429 DNM1L Dynamin-1-like protein 0.030588659 1.868900651 
Q14145 KEAP1 Kelch-like ECH-associated protein 1 0.036203168 1.853448843 
P45880 VDAC2 
Voltage-dependent anion-selective 
channel protein 2 0.033886228 1.833601867 
Q969H8 MYDGF Myeloid-derived growth factor 0.016250688 1.832601583 
P17152 TMEM11 
Transmembrane protein 11, 
mitochondrial 0.013811064 1.79723727 
Q9BT25 HAUS8 HAUS augmin-like complex subunit 8 0.036396168 1.771108141 
Q9Y6C9 MTCH2 Mitochondrial carrier homolog 2 0.016731908 1.766235931 
Q5T0D9 TPRG1L 
Tumor protein p63-regulated gene 1-
like protein 0.02044599 1.760395846 
P49792 RANBP2 E3 SUMO-protein ligase RanBP2 0.005578968 1.7554435 
Q9H6S1 AZI2 5-azacytidine-induced protein 2 0.001174157 1.738084008 
Q15154 PCM1 Pericentriolar material 1 protein 0.005476891 1.732445559 
Q8TDY2 RB1CC1 RB1-inducible coiled-coil protein 1 0.006752136 1.681121642 
Q15025 TNIP1 TNFAIP3-interacting protein 1 0.045503522 1.670538151 
P54819 AK2 Adenylate kinase 2, mitochondrial 0.017082454 1.666080091 
O75385 ULK1 Serine/threonine-protein kinase ULK1 0.010083791 1.635712774 
Q96NB1 FOPNL 
LisH domain-containing protein 
FOPNL 0.015150176 1.62824819 
Q9NPJ6 MED4 
Mediator of RNA polymerase II 
transcription subunit 4 0.012554917 1.613328095 
O95873 C6orf47 Uncharacterized protein C6orf47 0.017292853 1.608468753 
P27797 CALR Calreticulin 0.034446121 1.55364167 
Q96M27 PRRC1 Protein PRRC1 0.002751053 1.550304861 
Q8TC07 TBC1D15 TBC1 domain family member 15 0.000791322 1.536976035 
O75665 OFD1 Oral-facial-digital syndrome 1 protein 0.006433891 1.524189492 
Q9UKG1 APPL1 DCC-interacting protein 13-alpha 0.000831964 1.505145125 
Q9NS69 TOMM22 
Mitochondrial import receptor subunit 
TOM22 homolog 0.023246768 1.480947144 
Q9BV40 VAMP8 Vesicle-associated membrane protein 8 0.002211841 1.475266717 
O95399 UTS2 Urotensin-2 0.016272289 1.420921727 
Q6ICB0 DESI1 Desumoylating isopeptidase 1 0.033382219 1.420144268 
Q9BSY9 DESI2 Desumoylating isopeptidase 2 0.026646766 1.359091852 
O94830 DDHD2 Phospholipase DDHD2 0.007925354 1.357562741 
O43399 TPD52L2 Tumor protein D54 0.016528018 1.352630477 
 23 
Uniprot 
ID 
Gene Protein P-value Log2(Fold-
Change) 
P10155 TROVE2 60 kDa SS-A/Ro ribonucleoprotein 0.013456403 1.346581062 
Q9Y6I9 TEX264 Testis-expressed sequence 264 protein 0.039637208 1.33544437 
P22694 PRKACB 
cAMP-dependent protein kinase 
catalytic subunit beta 0.027477997 1.306785409 
Q12899 TRIM26 Tripartite motif-containing protein 26 0.041241136 1.301948257 
P63279 UBE2I SUMO-conjugating enzyme UBC9 0.039873512 1.293408119 
P67870 CSNK2B Casein kinase II subunit beta 0.037850784 1.288669564 
Q15084 PDIA6 Protein disulfide-isomerase A6 0.034021405 1.284813804 
Q96CV9 OPTN Optineurin 0.001933402 1.247421152 
P16615 ATP2A2 
Sarcoplasmic/endoplasmic reticulum 
calcium ATPase 2 0.00566552 1.245952066 
Q9Y277 VDAC3 
Voltage-dependent anion-selective 
channel protein 3 0.045992892 1.236705167 
Q15293 RCN1 Reticulocalbin-1 0.028667905 1.235797623 
P07237 P4HB Protein disulfide-isomerase 0.011549926 1.219981871 
Q658Y4 FAM91A1 Protein FAM91A1 0.015879417 1.215013125 
P11021 HSPA5 78 kDa glucose-regulated protein 0.024740822 1.211591938 
Q15041 ARL6IP1 
ADP-ribosylation factor-like protein 6-
interacting protein 1 0.043679625 1.200338639 
Q9HA65 TBC1D17 TBC1 domain family member 17 0.027312508 1.199378372 
P30040 ERP29 
Endoplasmic reticulum resident protein 
29 0.015926314 1.196722969 
P07197 NEFM Neurofilament medium polypeptide 0.00185507 1.183152983 
Q9BSB4 ATG101 Autophagy-related protein 101 0.002352739 1.181346413 
O60313 OPA1 
Dynamin-like 120 kDa protein, 
mitochondrial 0.038133005 1.169224916 
P07199 CENPB Major centromere autoantigen B 0.023473555 1.163129628 
Q9BWD3 FAM127B Protein FAM127B 0.000847684 1.161839136 
Q9UPN4 CEP131 Centrosomal protein of 131 kDa 0.014742813 1.159572115 
Q9UHD2 TBK1 Serine/threonine-protein kinase TBK1 0.003450459 1.151030935 
Q9UMX0 UBQLN1 Ubiquilin-1 0.039992662 1.136614529 
Q9UM82 SPATA2 Spermatogenesis-associated protein 2 0.021618881 1.132401505 
Q8TD19 NEK9 Serine/threonine-protein kinase Nek9 0.013203895 1.131817607 
P46060 RANGAP1 Ran GTPase-activating protein 1 0.000670819 1.12326431 
Q9NP72 RAB18 Ras-related protein Rab-18 0.02527698 1.118135089 
Q8NC44 FAM134A Protein FAM134A 0.003871366 1.116394943 
Q96HR8 NAF1 
H/ACA ribonucleoprotein complex 
non-core subunit NAF1 0.033317026 1.101697773 
Q6PIU2 NCEH1 Neutral cholesterol ester hydrolase 1 0.002808146 1.101250499 
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Uniprot 
ID 
Gene Protein P-value Log2(Fold-
Change) 
P36941 LTBR 
Tumor necrosis factor receptor 
superfamily member 3 0.015596447 1.097394965 
Q12981 BNIP1 Vesicle transport protein SEC20 0.007531027 1.077471196 
P36551 CPOX 
Oxygen-dependent 
coproporphyrinogen-III oxidase, 
mitochondrial 0.039310893 1.067473976 
P04792 HSPB1 Heat shock protein beta-1 0.000108323 1.055509541 
Q99442 SEC62 Translocation protein SEC62 0.013447552 1.037230192 
Q8WXW3 PIBF1 Progesterone-induced-blocking factor 1 0.03881136 1.017493942 
O75143 ATG13 Autophagy-related protein 13 0.000594066 1.008862267 
P24534 EEF1B2 Elongation factor 1-beta 0.022696291 1.003779209 
P26374 CHML 
Rab proteins geranylgeranyltransferase 
component A 2 0.042508733 1.000946567 
Q9H4A6 GOLPH3 Golgi phosphoprotein 3 0.010979159 0.999828084 
Q9Y371 SH3GLB1 Endophilin-B1 0.009168595 0.99964662 
P30101 PDIA3 Protein disulfide-isomerase A3 0.048394592 0.995289323 
P23284 PPIB Peptidyl-prolyl cis-trans isomerase B 0.030006021 0.993730016 
Q8NI08 NCOA7 Nuclear receptor coactivator 7 0.004309707 0.989894255 
Q14974 KPNB1 Importin subunit beta-1 0.001631935 0.985065425 
Q96KG9 SCYL1 N-terminal kinase-like protein 0.029720666 0.959263434 
Q12834 CDC20 Cell division cycle protein 20 homolog 0.003944309 0.948474758 
Q96AG4 LRRC59 
Leucine-rich repeat-containing protein 
59 0.021875965 0.948253255 
Q9NWV8 BABAM1 
BRISC and BRCA1-A complex 
member 1 0.002351318 0.940832491 
Q8WUX9 CHMP7 Charged multivesicular body protein 7 0.014088699 0.931640388 
P14625 HSP90B1 Endoplasmin 0.028082372 0.926122083 
P52292 KPNA2 Importin subunit alpha-1 0.003828987 0.92133271 
Q9BSJ8 ESYT1 Extended synaptotagmin-1 0.013173842 0.916474677 
P51572 BCAP31 B-cell receptor-associated protein 31 0.001218218 0.916256205 
Q8NEB9 PIK3C3 
Phosphatidylinositol 3-kinase catalytic 
subunit type 3 0.002286463 0.909534456 
O75396 SEC22B Vesicle-trafficking protein SEC22b 0.012754017 0.907802777 
P21964 COMT Catechol O-methyltransferase 0.000735966 0.906661806 
O14974 PPP1R12A 
Protein phosphatase 1 regulatory 
subunit 12A 0.028961844 0.905878125 
P13667 PDIA4 Protein disulfide-isomerase A4 0.033287674 0.903517401 
Q13162 PRDX4 Peroxiredoxin-4 0.016548828 0.90209015 
P62820 RAB1A Ras-related protein Rab-1A 0.019201511 0.901523988 
P63167 DYNLL1 Dynein light chain 1, cytoplasmic 0.026808344 0.900657309 
 25 
Uniprot 
ID 
Gene Protein P-value Log2(Fold-
Change) 
Q9Y394 DHRS7 
Dehydrogenase/reductase SDR family 
member 7 0.014051672 0.889227176 
Q96CS3 FAF2 FAS-associated factor 2 0.000510662 0.880638354 
Q9Y5B9 SUPT16H FACT complex subunit SPT16 0.012218089 0.875222857 
Q96JJ7 TMX3 Protein disulfide-isomerase TMX3 0.005515443 0.87463842 
P12004 PCNA Proliferating cell nuclear antigen 0.038236395 0.871450352 
O15155 BET1 BET1 homolog 0.014423959 0.870285501 
Q9Y2D8 SSX2IP 
Afadin- and alpha-actinin-binding 
protein 0.036294793 0.867961676 
Q9P0L0 VAPA 
Vesicle-associated membrane protein-
associated protein A 0.024891607 0.864878055 
Q99614 TTC1 Tetratricopeptide repeat protein 1 0.030151961 0.863586029 
Q6DD88 ATL3 Atlastin-3 0.011689448 0.84357797 
P24386 CHM 
Rab proteins geranylgeranyltransferase 
component A 1 0.004451191 0.839465232 
P20645 M6PR 
Cation-dependent mannose-6-
phosphate receptor 0.03188103 0.837820011 
Q96A49 SYAP1 Synapse-associated protein 1 0.004461263 0.835579961 
Q9H078 CLPB 
Caseinolytic peptidase B protein 
homolog 0.004675601 0.825270203 
Q99942 RNF5 E3 ubiquitin-protein ligase RNF5 0.019653094 0.822913947 
O00505 KPNA3 Importin subunit alpha-4 0.011545542 0.817782718 
P18031 PTPN1 
Tyrosine-protein phosphatase non-
receptor type 1 0.013801499 0.814080304 
P61026 RAB10 Ras-related protein Rab-10 0.014587058 0.811941407 
Q8WZA9 IRGQ 
Immunity-related GTPase family Q 
protein 0.025882851 0.803612394 
Q8IZ07 ANKRD13A 
Ankyrin repeat domain-containing 
protein 13A 0.003767815 0.801459178 
Q96HY6 DDRGK1 DDRGK domain-containing protein 1 0.028608054 0.794603776 
P53396 ACLY ATP-citrate synthase 0.042171192 0.787022678 
Q01469 FABP5 Fatty acid-binding protein, epidermal 0.001461956 0.771785806 
O75694 NUP155 Nuclear pore complex protein Nup155 0.005740588 0.769866377 
P12814 ACTN1 Alpha-actinin-1 0.03338147 0.76371946 
Q7Z3C6 ATG9A Autophagy-related protein 9A 0.021141022 0.759308247 
P19367 HK1 Hexokinase-1 0.016133949 0.752556221 
Q9H0U4 RAB1B Ras-related protein Rab-1B 0.003011718 0.749935306 
O95292 VAPB 
Vesicle-associated membrane protein-
associated protein B/C 0.006776302 0.747893511 
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Uniprot 
ID 
Gene Protein P-value Log2(Fold-
Change) 
P42566 EPS15 
Epidermal growth factor receptor 
substrate 15 0.003265947 0.74633098 
P29373 CRABP2 Cellular retinoic acid-binding protein 2 0.006146825 0.736959574 
P13861 PRKAR2A 
cAMP-dependent protein kinase type 
II-alpha regulatory subunit 0.007279451 0.729136385 
Q14457 BECN1 Beclin-1 0.042119462 0.724493333 
Q8WVD5 RNF141 RING finger protein 141 0.012599962 0.721635005 
P61006 RAB8A Ras-related protein Rab-8A 0.026260301 0.715515926 
Q14677 CLINT1 Clathrin interactor 1 0.025464528 0.714451261 
O75410 TACC1 
Transforming acidic coiled-coil-
containing protein 1 0.017413251 0.712036216 
Q99729 HNRNPAB 
Heterogeneous nuclear 
ribonucleoprotein A/B 0.032713619 0.709610641 
P48066 SLC6A11 
Sodium- and chloride-dependent 
GABA transporter 3 0.007241431 0.700204296 
O14966 RAB29 Ras-related protein Rab-7L1 0.000354102 0.697312744 
Q96F24 NRBF2 Nuclear receptor-binding factor 2 0.007047901 0.690222804 
Q13185 CBX3 Chromobox protein homolog 3 0.037503479 0.689747053 
Q9NT62 ATG3 
Ubiquitin-like-conjugating enzyme 
ATG3 0.032227222 0.688439757 
Q96A57 TMEM230 Transmembrane protein 230 0.01569375 0.681524356 
P62745 RHOB Rho-related GTP-binding protein RhoB 0.012800724 0.674884907 
O95857 TSPAN13 Tetraspanin-13 0.011383802 0.664246561 
Q9NTJ5 SACM1L 
Phosphatidylinositide phosphatase 
SAC1 0.036551796 0.66241358 
O75368 SH3BGRL 
SH3 domain-binding glutamic acid-
rich-like protein 0.017853602 0.660693908 
Q8NBJ5 COLGALT1 Procollagen galactosyltransferase 1 0.028998303 0.660316737 
Q9NZ52 GGA3 
ADP-ribosylation factor-binding 
protein GGA3 0.021670631 0.659879048 
P54727 RAD23B 
UV excision repair protein RAD23 
homolog B 0.031857283 0.657514813 
Q6RW13 AGTRAP 
Type-1 angiotensin II receptor-
associated protein 0.015229189 0.653056178 
P43003 SLC1A3 Excitatory amino acid transporter 1 0.001748001 0.651693103 
Q13505 MTX1 Metaxin-1 0.020058118 0.651232821 
P08238 HSP90AB1 Heat shock protein HSP 90-beta 0.049509084 0.649860437 
O94826 TOMM70A 
Mitochondrial import receptor subunit 
TOM70 0.034088388 0.640038638 
P78318 IGBP1 Immunoglobulin-binding protein 1 0.009268242 0.635295593 
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Uniprot 
ID 
Gene Protein P-value Log2(Fold-
Change) 
Q12893 TMEM115 Transmembrane protein 115 0.024276707 0.629252594 
P08183 ABCB1 Multidrug resistance protein 1 0.002438499 0.626933227 
P30153 PPP2R1A 
Serine/threonine-protein phosphatase 
2A 65 kDa regulatory subunit A alpha 
isoform 0.002371456 0.620967167 
Q99570 PIK3R4 
Phosphoinositide 3-kinase regulatory 
subunit 4 0.012189339 0.606257539 
Q8TC12 RDH11 Retinol dehydrogenase 11 0.009278043 0.591211018 
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Figure 2.3. Overlap of autophagy-dependent secretome under inhibition of endolysosomal 
acidification with baseline autophagy-dependent secretome and autophagosome proteomes 
(a) Venn diagram showing the overlap of proteins enriched in 100k from wild-type (WT) cells 
treated with bafA1 relative to 100k from ATG7-/- cells treated with bafA1 with the LDELS 
secretome defined in Leidal et al. 2020. List of enriched proteins is provided in Table 1. (b) List 
of overlapping proteins in (a). (c) Venn diagram showing the overlap of proteins enriched in 
Gene Protein
SQSTM1 Sequestosome-1
MAP1LC3B
Microtubule-associated proteins 
1A/1B light chain 3B
RANBP2 E3 SUMO-protein ligase RanBP2
TPD52L2 Tumor protein D54
NEK9 Serine/threonine-protein kinase Nek9
RANGAP1 Ran GTPase-activating protein 1
EEF1B2 Elongation factor 1-beta
SCYL1 N-terminal kinase-like protein
TTC1 Tetratricopeptide repeat protein 1
SYAP1 Synapse-associated protein 1
IRGQ
Immunity-related GTPase family Q 
protein
ATG3
Ubiquitin-like-conjugating enzyme 
ATG3
Gene Protein
FTL Ferritin light chain
FTH1 Ferritin heavy chain
TAX1BP1 Tax1-binding protein 1
CALCOCO2
Calcium-binding and coiled-coil 
domain-containing protein 2
PRKACA
cAMP-dependent protein kinase 
catalytic subunit alpha
SQSTM1 Sequestosome-1
GABARAPL2
Gamma-aminobutyric acid receptor-
associated protein-like 2
NCOA4 Nuclear receptor coactivator 4
PRKAR1A
cAMP-dependent protein kinase type 
I-alpha regulatory subunit
CCPG1 Cell cycle progression protein 1
CALCOCO1
Calcium-binding and coiled-coil 
domain-containing protein 1
PRKAR1B
cAMP-dependent protein kinase type 
I-beta regulatory subunit
NBR1 Next to BRCA1 gene 1 protein
MAP1LC3B
Microtubule-associated proteins 
1A/1B light chain 3B
KEAP1 Kelch-like ECH-associated protein 1
TPRG1L
Tumor protein p63-regulated gene 1-
like protein
RB1CC1 RB1-inducible coiled-coil protein 1
TNIP1 TNFAIP3-interacting protein 1
TBC1D15 TBC1 domain family member 15
VAMP8
Vesicle-associated membrane 
protein 8
PRKACB
cAMP-dependent protein kinase 
catalytic subunit beta
OPTN Optineurin
TBK1
Serine/threonine-protein kinase 
TBK1
SCYL1 N-terminal kinase-like protein
CHM
Rab proteins 
geranylgeranyltransferase
component A 1
ATG9A Autophagy-related protein 9A
RHOB
Rho-related GTP-binding protein 
RhoB
Gene Protein
FTH1 Ferritin heavy chain
TAX1BP1 Tax1-binding protein 1
CALCOCO2
Calcium-binding and coiled-coil 
domain-containing protein 2
SQSTM1 Sequestosome-1
NCOA4 Nuclear receptor coactivator 4
CCPG1 Cell cycle progression protein 1
NBR1 Next to BRCA1 gene 1 protein
VDAC2
Voltage-dependent anion-selective 
channel protein 2
PCM1 Pericentriolar material 1 protein
TOMM22
Mitochondrial import receptor subunit 
TOM22 homolog
RAB18 Ras-related protein Rab-18
HSPB1 Heat shock protein beta-1
BCAP31 B-cell receptor-associated protein 31
CLPB
Caseinolytic peptidase B protein 
homolog
ACLY ATP-citrate synthase
ACTN1 Alpha-actinin-1
MTX1 Metaxin-1
HSP90AB1 Heat shock protein HSP 90-beta
a c
b
e
fd
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100k from WT cells treated with bafA1 relative to 100k from ATG7-/- cells treated with bafA1 
with the autophagosome proteome under chloroquine (CQ) treatment defined in Mancias et al. 
2014. List of enriched proteins is provided in Table 1. (d) List of overlapping proteins in (c). (e) 
Venn diagram showing the overlap of proteins enriched in 100k from WT cells treated with 
bafA1 relative to 100k from ATG7-/- cells treated with bafA1 with the autophagosome proteome 
under bafA1 treatment defined in Le Gerroue et al. 2017. List of enriched proteins is provided in 
Table 1. (f) List of overlapping proteins in (e). 
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Figure 2.4. Inhibition of endolysosomal acidification promotes secretion of autophagy cargo 
receptors 
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(a) Whole cell lysate (WCL) and 100,000 g EV (100k) fractions harvested from wild-type (WT) 
cells treated with vehicle or 20 nM bafA1 in serum-free media for 16 h were collected, 
normalized for cell number, and immunoblotted to detect LC3 and indicated autophagy cargo 
receptors and EV markers. (b) Quantification of autophagy cargo receptor protein levels in 100k 
from WT bafA1 treated cells relative to vehicle treated (mean ± s.e.; n=3). Statistical 
significance calculated by unpaired two-tailed t-test (* = p-value < 0.05, ** = p-value < 0.01, 
*** = p-value < 0.001). (c) WCL and 100k fractions harvested from WT cells treated with 
vehicle or 20 nM bafA1 in serum-free media for indicated time were collected, normalized for 
cell number, and immunoblotted to detect LC3 and indicated autophagy cargo receptors. (d) Cell 
death in WT cells treated with 48 µM digitonin in full media (Positive Control), treated with 
vehicle in serum-free media (Vehicle), or treated with 25 µM chloroquine (CQ) in serum-free 
media (25 µM CQ) for indicated time periods quantified using trypan blue staining (mean ± s.e.; 
n=3). Statistical significance calculated by ordinary one-way analysis of variance followed by 
Sidak multiple comparisons test for comparison between pairs (n.s. = not significant, * = p-value 
< 0.05, ** = p-value < 0.01, **** = p-value < 0.0001). (e) WCL and 100k fractions harvested 
from WT cells treated with vehicle or 25 µM CQ in serum-free media for 24 h were collected, 
normalized for cell number, and immunoblotted to detect LC3 and indicated autophagy cargo 
receptors and EV markers. (f) Quantification of LC3 and autophagy cargo receptor protein levels 
in 100k from WT CQ treated cells relative to vehicle treated (mean ± s.e.; n=3). Statistical 
significance calculated by unpaired two-tailed t-test (* = p-value < 0.05, ** = p-value < 0.01, 
**** = p-value < 0.0001). (g) 100k fractions harvested from equivalent volumes of plasma from 
GFP-LC3 transgenic mice injected with either 60 mg/kg CQ or vehicle for 3 consecutive days 
were collected and immunoblotted to detect GFP-LC3 and indicated autophagy cargo receptors. 
(h) Quantification of GFP-LC3 and autophagy cargo receptor protein levels in plasma 100k from 
CQ treated mice relative to vehicle treated (mean ± s.e.; n=3). Statistical significance calculated 
by unpaired two-tailed t-test (n.s. = not significant, * = p-value < 0.05, ** = p-value < 0.01). 
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Figure 2.5. Secreted autophagy cargo receptors are EV-associated but not membrane-
protected  
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e
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(a) Whole cell lysate (WCL), 10,000 g EV (10k), 100,000 g EV (100k), and TCA-precipitated 
soluble protein (TCA) fractions harvested from wild-type (WT) cells treated with vehicle or 20 
nM bafA1 in serum-free media for 16 h were collected, normalized for protein concentration, 
and immunoblotted to detect LC3 and indicated autophagy cargo receptors and EV markers. (b) 
Quantification of autophagy cargo receptor protein levels in 100k relative to 10k and TCA (mean 
± s.e.; n=3). Statistical significance calculated by one-way analysis of variance followed by 
Sidak multiple comparisons test for comparison between pairs (* = p-value < 0.05, ** = p-value 
< 0.01, *** = p-value < 0.001, **** = p-value < 0.0001). (c) 100k fractions harvested from WT 
cells treated with 20 nM bafA1 in serum-free media for 16 h were collected, incubated with 100 
ug/mL trypsin (protease) and/or 1% NP-40 (detergent) for 30 min on ice, and immunoblotted to 
detect TSG101 and indicated autophagy cargo receptors.  (d) Quantification of protease 
protection of TSG101 and autophagy cargo receptors in trypsin and/or protease-treated 100k 
from WT bafA1 treated cells (mean ± s.e.; n=3). Statistical significance calculated by one-way 
analysis of variance followed by Dunnett multiple comparisons test for comparison to a control 
(n.s. = not significant, * = p-value < 0.05, ** = p-value < 0.01, **** = p-value < 0.0001). (e) 
100k fractions from WT cells treated with 20 nM bafA1 in serum-free media for 16 h were 
collected, separated via linear sucrose density gradient ultracentrifugation, fractionated, and 
immunoblotted to detect LC3, indicated autophagy cargo receptors, and CD9. (f) Quantification 
of LC3, autophagy cargo receptors, and CD9 protein levels in 100k sucrose density fractions 
from WT bafA1 treated cells (mean ± s.e.; n=3). 
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Figure 2.6. ATGs encompassing autophagosome initiation, elongation, and closure and 
Rab27a are required for secretion of autophagy cargo receptors  
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(a) Whole cell lysate (WCL) and 100,000 g EV (100k) fractions harvested from wild-type (WT) 
or indicated ATG -/- cells treated with vehicle or 20 nM bafA1 in serum-free media for 16 h 
were collected, normalized for protein concentration, and immunoblotted to detect LC3 and 
indicated autophagy cargo receptors and EV markers. (b) Quantification of autophagy cargo 
receptor protein levels in 100k from indicated ATG -/- bafA1 treated cells relative to WT bafA1 
treated (mean ± s.e.; n=3). Statistical significance calculated by unpaired two-tailed t-test (n.s. = 
not significant, * = p-value < 0.05, ** = p-value < 0.01, *** = p-value < 0.001, **** = p-value < 
0.0001). (c) WCL and 100k fractions harvested from cells stably expressing non-targeting (NT) 
or Rab27a shRNAs treated with vehicle or 20 nM bafA1 in serum-free media for 16 h were 
collected, normalized for cell number, and immunoblotted to detect LC3, indicated autophagy 
cargo receptors, and CD9. (d) Quantification of autophagy cargo receptor protein levels in 100k 
from Rab27a knockdown cells relative to NT (mean ± s.e.; n=3). Statistical significance 
calculated by one-way analysis of variance followed by Dunnett multiple comparisons test for 
comparison to control (n.s. = not significant, * = p-value < 0.05, ** = p-value < 0.01). 
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Figure 2.7. Genetic inhibition of autophagosome-lysosome fusion promotes secretion of 
autophagy cargo receptors 
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(a) Cells stably expressing non-targeting (NT), SNAP29, or VAMP8 shRNAs transfected with 
mCherry-GFP-LC3 were grown in full media (FM), treated with vehicle in serum-free media 
(SS), or treated with 20 nM bafilomycin A1 (bafA1) in serum-free media (BafA1) for 16 h. Scale 
bar, 5 µm. (b) WCL and 100k fractions harvested from cells stably expressing non-targeting 
(NT) or SNAP29 shRNAs grown in serum-free media for 24 h were collected, normalized for 
cell number, and immunoblotted to detect LC3, indicated autophagy cargo receptors, and CD9. 
(c) Quantification of autophagy cargo receptor protein levels in 100k from SNAP29 knockdown 
cells relative to NT (mean ± s.e.; n=3). Statistical significance calculated by one-way analysis of 
variance followed by Dunnett multiple comparisons test for comparison to control (n.s. = not 
significant, * = p-value < 0.05, ** = p-value < 0.01). (d) WCL and 100k fractions harvested from 
cells stably expressing non-targeting (NT) or VAMP8 shRNAs grown in serum-free media for 
24 h were collected, normalized for cell number, and immunoblotted to detect LC3, indicated 
autophagy cargo receptors, and CD9. (e) Quantification of autophagy cargo receptor protein 
levels in 100k from VAMP8 knockdown cells relative to NT (mean ± s.e.; n=3). Statistical 
significance calculated by one-way analysis of variance followed by Dunnett multiple 
comparisons test for comparison to control (n.s. = not significant, * = p-value < 0.05, ** = p-
value < 0.01). 
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Figure 2.8. Model of secretion  
Proposed model for autophagosome formation-dependent and Rab27a-dependent secretion of 
LC3, autophagy cargo receptors, and autophagic cargo.   
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METHODS 
Cell culture 
HEK-293T cells (ATCC, CRL-3216) were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM), high glucose, pyruvate (Gibco 11995040) supplemented with 10% fetal bovine serum 
(FBS) (Atlas Biologicals F-0500-D), 25 mM HEPES (Teknova H1030), 100 units/mL penicillin 
and 100 µL/mL streptomycin (Gibco 14140163). All cell lines were tested for mycoplasma 
contamination (Sigma-Aldrich MP0035). 
 
CRISPR/Cas9 gene-deletion 
HEK-293T knockout cell lines were generated by transient transfection of pSpCas9(BB)-2A-
Puro (Addgene 48139) encoding U6 driven expression of sgRNAs (Scramble Guide: 
GCACTACCAGAGCTAACTCA; ATG7 Guide: ACACACTCGAGTCTTTCAAG; ATG12 
Guide: CCGTCTTCCGCTGCAGTTTC; ATG14 Guide: CTACTTCGACGGCCGCGACC; 
FIP200 Guide: AGAGTGTGTACCTACAGTGC). Cells were selected 48-72 hours post-
transfection with 1  g/ml puromycin for 48 h. Polyclonal populations were collected for 
Surveyor analysis (IDT, 706020) and were sorted into single-cell populations by limiting dilution 
at 1.5 cells/well per 96-well plate. For DNA analysis, genomic DNA samples were prepared 
using QuickExtract (Epicentre). The PCR products were column purified and analyzed with 
Surveyor Mutation Detection Kit (IDT). For genotyping of single-sorted cells, PCR amplified 
products encompassing the edited region (ATG7 Fwd: TGGGGGACAGTAGAACAGCA, 
ATG7 Rev: CCTGGATGTCCTCTCCCTGA; ATG12 Fwd: AGCCGGGAACACCAAGTTT, 
ATG12 Rev: GTGGCAGCCAAGTATCAGGC; ATG14 Fwd: 
AAAATCCCACGTGACTGGCT, ATG14 Rev: AATGGCAGCAACGGGAAAAC; FIP200 
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Fwd: ATTCTCTGGCTTGACAGGACAG, FIP200 Rev: AAATACTGAGCGTGCACATTGC) 
were cloned into pCR™4-TOPO® TA vector using the TOPO-TA cloning kit (Thermo Fisher 
450030) and sequence verified. Sequencing is available upon request. 
 
RNA interference 
To generate stable knockdowns, cells were transduced with pLKO.1 lentiviral vectors (Sigma-
Aldrich) expressing shRNAs targeting SNAP29 (#1 TRCN0000083650; #2 TRCN0000231850), 
VAMP8 (#1 TRCN0000219911; #2 TRCN0000181123), Rab27a (#1 TRCN0000005296; #2 
TRCN0000005297), and non-targeting control (SHC002). 
 
Lentiviral packaging, infection, and selection 
Individual lentiviral pLKO.1 expression vectors were packaged by co-transfecting HEK-293T 
cells with packaging vectors pMDLg/pRRE (Addgene 12251), pMD2.G (Addgene 12259), and 
pRSV/pRev (Addgene 12253). Virus-containing conditioned media was collected 3 days after 
transfection and filtered through 0.45 µm. Virus-containing media was then diluted 1:4 in 
DMEM media supplemented with 8 µg/mL polybrene. The viral transduction mix was incubated 
with HEK-293T cells for 72 h, then cells were selected with 1 µg/mL puromycin (Sigma-Aldrich 
P7255) for 2 days. 
 
Antibodies 
The following antibodies were used for immunoblotting: rabbit anti-ATG14 (MBL, PD026; 
1:1,000), rabbit anti-LAMP1 (Cell Signaling, 9091; 1:1,000), rabbit anti-Rab7a (Cell Signaling, 
9367; 1:1,000), rabbit anti-Rab5a (Cell Signaling, 3547; 1:1,000), mouse anti-GM130 (BD 
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Biosciences, 610823; 1:1,000), rabbit anti-CYC1 (Novus Biologicals, NBP1-86872; 1:1,000), 
mouse anti-NUP62 (BD Biosciences, 610497; 1:1,000), mouse anti-GAPDH (Millipore, 
MAB374; 1:10,000), rabbit anti-LC3 (Millipore, ABC232; 1:1,000), guinea pig anti-
p62/SQSTM1 (Progen, GP62-C; 1:1,000), rabbit anti-p62/SQSTM1 (Cell Signaling, 5114; 
1:1,000), mouse anti-NBR1 (Santa Cruz Biotechnology, sc-130380; 1:500), rabbit anti-OPTN 
(Abcam, ab23666; 1:1,000), mouse anti-NDP52/CALCOCO2 (Abnova, H00010241-B01P; 
1:1,000), mouse anti-TSG101 (BD Biosciences, 612696; 1:1,000), mouse anti-ALIX (Cell 
Signaling, 2171; 1:1,000), mouse anti-CD9 (Sigma-Aldrich, CBL162; 1:1,000), mouse anti-GFP 
(Santa Cruz sc-9996), rabbit anti-Rab27a (Cell Signaling, 69295; 1:1,000), rabbit anti-SNAP29 
(Abcam, ab138500; 1:1,000), rabbit anti-VAMP8 (Abcam, ab76021; 1:1,000), Peroxidase-
AffiniPure Donkey Anti-Rabbit IgG (H+L) (Jackson, 711-035-152; 1:5,000), Peroxidase-
AffiniPure Donkey Anti-Guinea Pig IgG (H+L) (Jackson, 706-035-148; 1:5,000), Peroxidase-
AffiniPure Donkey Anti-Goat IgG (H+L) (Jackson, 705-035-147; 1:5,000), and Peroxidase-
AffiniPure Donkey Anti-Mouse IgG (H+L) (Jackson, 715-035-150; 1:5,000). 
 
Immunoblotting 
For whole cell lysate (WCL), cells were lysed in RIPA buffer (25 mM Tris-HCl pH 8.0, 150 mM 
NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) supplemented with 10 mM NaF, 10 mM 
b-glycerophosphate, 1 mM Na3VO4, 10 nM calcyulin A, 0.5 mM phenylmethyl sulphonyl 
fluoride, 0.1 mM E-64-D, 10 µg/mL pepstatin A, and protease inhibitor cocktail. Lysates were 
cleared by centrifugation at 15,000 g for 10 min at 4oC. For EV lysate, pelleted EVs were 
resuspended in urea buffer (50 mM Tris-HCl, pH 8.0, 8 M urea, 2% SDS, 10 mM NaF, 5 mM 
EDTA). WCL and EV lysates were quantified by BCA assay (Thermo Fisher 23225), mixed 
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with sample buffer, resolved by SDS-PAGE, and transferred to polyvinylidene fluoride 
membrane. Membranes were then blocked in 5% milk in PBS with 0.1% Tween 20 (PBST), 
incubated in primary antibody overnight at 4oC in blocking buffer, washed with PBST, incubated 
in HRP-conjugated secondary antibodies for 1 h at room temperature in blocking buffer, washed 
with PBST, and visualized by enhanced chemiluminescence (Thermo Fisher 32106) on film. 
Immunoblots were quantified by densitometry using Fiji (ImageJ v.2.0.0-rc-69/1.52p). 
 
Fluorescence microscopy 
For fluorescence of mCherry-GFP-LC3, cells were transiently transfected with mCherry-GFP-
LC3 at 70% confluency using Lipofectamine 2000 (Thermo Fisher 11668019). After 6h, 
transfected cells were seeded onto coverslips coated with 10 µg/mL fibronectin and incubated for 
24 h before treatment with vehicle or 20 nM bafA1 in serum-free DMEM for 16 h. Cells were 
then fixed with 4% PFA in PBS for 15 min at room temperature, washed with PBS, and mounted 
onto slides with Prolong Gold Antifade with DAPI (Thermo Fisher P36935). Cells were 
visualized using a DeltaVision microscope (Applied Precision Ltd.) fitted with a 60Å~, 1.4-NA 
objective and CoolSnap HQ camera (Photometrics). Images were acquired using softWoRx 
software (Applied Precision Ltd.) and prepared in Fiji and Adobe Photoshop. 
 
Cell viability assay 
To quantify cell viability, cells were seeded in 12-well plates and after 24 h, were treated with 48 
µM digitonin (positive control for cell death) in complete DMEM, vehicle (negative control) in 
serum-free DMEM, or 20 nM bafA1 or 25 µM CQ in serum-free DMEM. Cells were collected at 
the indicated timepoints and stained with 0.4% trypan blue (Thermo Scientific T10282). Live 
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and dead cells were then enumerated using the Countess II Automated Cell Counter (Thermo 
Scientific AMQAX1000). 
 
Extracellular vesicle preparation and characterization 
EVs were isolated according to standard differential centrifugation protocol as described 
previously68. Briefly, HEK-239T cells were seeded in 15 cm tissue culture dishes and, when 
confluent, incubated with serum-free DMEM +/- treatment (20 nM bafA1, 25 µM CQ) for 16 or 
24h. Conditioned media was then collected and serially centrifuged: 200 g for 10 min at 4oC to 
pellet cells, 2,000 g for 10 min at 4oC to pellet cellular debris and apoptotic bodies, 10,000 g for 
30 min at 4oC in an ultracentrifuge to pellet large EVs, and 110,000 g for 70 min or 3h at 4oC in 
an ultracentrifuge to pellet small EVs. The 110,000 g pellet was then gently resuspended in 1 mL 
PBS by pipetting, diluted in 12 mL PBS, and ultracentrifuged at 110,000 g for 70 min at 4oC. 
The final EV pellets were resuspended in urea lysis buffer for immunoblotting analysis, 10% 
sucrose for sucrose density gradient analysis, or PBS for protease protection analysis. For 
analysis of secreted soluble protein, the supernatant from the first 110,000 g spin was collected 
and precipitated by addition of 15% trichloroacetic acid (TCA), then incubated for 1 h on ice 
before centrifugation at 180,000 g for 2h at 4oC. The 180,000 g pellet was then resuspended in 
10 mL ice-cold 100% acetone, centrifuged at 180,000 g for 1 h at 4oC, and finally resuspended in 
urea lysis buffer. For comparison of EVs between experimental conditions in vitro, EV 
quantification or EV protein quantification were corrected as indicated in figure legends based 
on total cell number or WCL protein quantification to correct for cell seeding differences 
between conditions. 
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 Sucrose density gradient separation was used to analyze co-fractionation between LC3, 
ATG cargo receptors, and canonical EV markers. 10% and 60% sucrose solutions in PBS were 
used to prepare continuous 10-60% sucrose gradients on a gradient station (Biocomp Instruments 
153). EV pellets were generated by differential centrifugation as described previously, then 
resuspended in 100 µL 10% sucrose solution, gently layered on top of the 10-60% gradient, and 
ultracentrifuged at 210,000 g for 18 h at 4oC. After ultracentrifugation, 1 mL fractions of the 
gradient were carefully top-unloaded, weighed, and diluted in 12 mL PBS. The diluted sucrose 
gradient fractions were ultracentrifuged at 110,000 g for 70 min at 4oC and pellets were 
resuspended in urea lysis buffer for immunoblotting analysis. 
 Protease protection analysis was used to determine membrane protection of secreted LC3 
and ATG cargo receptors. EV pellets were generated by differential centrifugation as described 
previously, resuspended in 60 µL PBS, and divided equally into 3 fractions for resuspension in 
PBS, 100 µg/mL trypsin in PBS, or 1% NP-40 and 100 µg/mL trypsin in PBS. After incubation 
and occasional mixing for 30 min at 4oC, protease reactions were stopped with the addition of 10 
µL protease inhibitor cocktail and 2x sample buffer before immunoblotting analysis. 
Nanoparticle tracking analysis (NTA) technology was used to determine EV 
concentration and size. Conditioned media clarified of cell debris and large EVs by 0.22 µm 
filter were normalized by cell number, then loaded on a nanoparticle analyzer (Malvern 
Panalytical NanoSight NS300) and analyzed using NTA software (NTA 3.3 Dev Build 3.3.104). 
Camera level was set at 15 for all recordings. Camera focus was adjusted to make the particles 
appear as individual dots with surrounding refractory rings. Three 30 s videos were recorded for 
each sample with a delay of 5 s between each recording. 
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Mass spectrometry of extracellular vesicle proteins 
WT and ATG7-/- HEK293T cells were treated with 20nM BafA1 or vehicle in serum-free media 
for 16 h. After 16 h, conditioned media was collected and EVs were isolated using the 
differential centrifugation protocol outlined previously. Pelleted EVs were lysed in 800 µL RIPA 
buffer (25 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% 
SDS) supplemented with 2% SDS, then sonicated with a probe sonicator at amplitude 8 for 10 
pulses of 10 s each. Samples were then diluted in 4 mL ice-cold 100% acetone and incubated at -
20oC overnight. Samples were spun in an ultracentrifuge at 200,000 g for 18 h at 4oC, the 
acetone was decanted, and the samples air dried for 1 h at 25oC before being stored at -80oC until 
further processing. 
Three biological replicates of precipitated EVs from WT and ATG7-/- bafA1-treated cells 
were resuspended in 30 µL 6 M guanidinium-chloride, 100 mM Tris pH 8.0, 10 mM TCEP, 40 
mM 2-chloroacetamide. EV proteins were denatured for 1 h at 37oC, then quantified with 660nm 
Protein Assay Reagent (Thermo Scientific 22660). Samples were then diluted six-fold in 150 µL 
100 mM Tris pH 8.0. 125-150 µg of protein for each sample was trypsinized with 15 µg trypsin 
(Thermo Scientific 90057) in an orbital shaker at 250 rpm, 37oC for 20 h. Trypsin digestion was 
then stopped by adding 10% trifluoracetic acid (TFA) to a final concentration of 0.5% TFA. 
Samples were desalted with SOLA solid phase extraction cartridges (Thermo Scientific 60109). 
Briefly, columns were washed with 500 µL 100% acetonitrile (ACN), then equilibrated with 500 
µL 0.1% TFA twice before adding sample. Samples were washed with 500 µL 0.1% TFA three 
times, then 500 µL 0.1% formic acid (FA), 2% ACN, and eluted with 450 µL 0.1% FA, 50% 
ACN. Samples were dried by speed-vac, then resuspended in 10 µL 50 mM HEPES pH 8.5 and 
quantified by Pierce Quantitative Colorimetric Peptide Assay (Thermo Scientific 23275).  
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For Tandem Mass Tag (TMT) labeling, 800 µg of TMT10-126, 127N, 128C, 129N, 130C, 
and 131 (Thermo Scientific 90110) was reconstituted with 41 µL 100% anhydrous ACN. 15 µg 
of peptides from each replicate were individually combined with 7.69 µL (150 µg) of the TMT 
isobaric tags. Samples were incubated at 25oC for 1 h before quenching the reaction with 8 µL 
5% hydroxylamine for 15 min. After labeling, the six individually labeled samples were pooled, 
dried by speed-vac, and then resuspended in 300 µL 0.1% TFA. The pooled samples were then 
fractionated into 8 fractions using Pierce High pH Reversed-Phase Peptide Fractionation Kit 
(Thermo Scientific 84868), then dried by speed-vac. The fractions were then resuspended in 
0.1% FA, 2% ACN before LC-MS/MS analysis. 
For LC-MS/MS analysis, 1 µg TMT-labeled peptide per fraction was analyzed on a 15 
cm C18 analytical column, in-line with a Q-Exactive Plus mass spectrometer. The peptides were 
separated on a multi-slope, 100 min gradient (6.4% - 27.2% ACN with 0.1% FA for 80 min at 
0.2 µL/min, then 27.2% - 40% ACN with 0.09% FA for 15 min at 0.3 µL/min, then 40% - 56% 
ACN with 0.09% FA for 5 min at 0.3 µL/min, and then washed for 3 min). Data dependent 
acquisition with MS1 resolution of 70,000, top15 method, and HCD normalized collision energy 
of 32 was used, with MS2 resolution of 35,000 and an isolation window of 0.7 m/z. Dynamic 
exclusion was activated for 30 s after initial parent ion selection.  
Eight injections of the different fractions of TMT-labeled EV peptides were analyzed 
together via MaxQuant (v1.6.0.16). Search parameters for peptide search tolerance was 4.5 ppm, 
centroid match tolerance was 8 ppm, and 2 missed tryptic cleavages were permitted. Constant 
modification of carbamidomethylation of cysteines and variable modifications of N-terminal 
acetylation, methionine oxidation, and Ser/Thr/Tyr phosphorylation were allowed. Peptide 
spectrum match FDR and protein FDR were set at 1%. “Match between runs” was enabled to 
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increase peptide identification. Type was set to “Reporter ion MS2,” and the six labels used in 
sample preparation were selected. The resulting quantifications were then median normalized for 
each channel, and statistical analysis (two-sample t-test) was applied in R with a statistical 
significance threshold of p < 0.05. 
 
Bioinformatic analyses 
For mass spectrometry, the top eight proteins with the highest connectivity to candidates 
statistically enriched in EVs from wild-type cells treated with bafA1 versus EVs from ATG7-/- 
cells treated with bafA1 (p-value < 0.05; log2 WT/ATG7-/- > 0.585; n=3) were identified using 
the protein-protein interaction (PPI) hub protein tool in the Enrichr gene set enrichment analysis 
web server69,70 and plotted according to their -log10 adjusted p-values. GO analysis (database 
released 2019-12-09) of the secretome was performed with PANTHER Overrepresentation Test 
(released 2019-07-11)71 and the top ten terms for biological process and cellular component were 
plotted according to their -log10 false discovery rate. The overlaps between the defined secretome 
and the ATG8 interactome28, ATG7-dependent secretome29, LDELS secretome29, CQ 
autophagosome proteome56, and BafA1 autophagosome proteome57 were performed using 
Biovenn72. 
 
In vivo extracellular vesicle isolation from mice 
All experimental procedures and treatments were conducted in compliance with UCSF 
Institutional Animal Care and Use Committee (IACUC) guidelines under an approved animal 
protocol (#AN170608). C57BL/6JJc1 homozygous transgenic mice expressing GFP-LC3B73,74 
(Riken Bioresource Center No. 00806) received either 60 mg/kg CQ or vehicle via 
 48 
intraperitoneal injection for 3 consecutive days. 6 h after final CQ injection, whole blood was 
collected in heparin-coated capillary tubes (Sarstedt CB 300 Lithium Heparin) and centrifuged at 
2,000 g for 5 min at room temperature. The plasma phase was collected and 1 mL was pooled 
(from 3-4 mice per condition), diluted in 10 mL PBS, clarified by 0.22 µm filter, and 
ultracentrifuged at 110,000 g for 3 h at 4oC. The pellet was resuspended in 10 mL PBS, 
ultracentrifuged at 110,000 g for 70 min at 4oC, and resuspended in urea buffer for 
immunoblotting analysis. For comparison of EVs between experimental groups in vivo, samples 
were normalized by collection from equivalent volumes of plasma from experimental groups.  
 
Statistical analyses 
Statistical analysis was performed using GraphPad Prism 8 (v.8.3.0). Experimental groups were 
compared using unpaired Student’s t-test for pairwise comparison, one-way analysis of variance 
followed by Dunnett multiple comparisons test for comparison to a control column, or one-way 
analysis of variance followed by Sidak multiple comparisons test for comparison between pairs 
of columns. 
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CHAPTER 3: Implications of autophagy and secretion in neurodegenerative disease  
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DISCUSSION 
In this study, we identify a new relationship between degradative autophagy and secretory 
autophagy, in which failure of lysosomal fusion and degradation promotes secretion of 
autophagic material. Utilizing a proteomic approach, we determined that impaired 
endolysosomal acidification results in ATG7-dependent secretion of LC3 and autophagy cargo 
receptors, normally subject to degradation. We characterized the secreted material as EV-
associated but not membrane-protected, distinct from the LDELS secreted material. Further 
analysis revealed this secretory event requires complete autophagosome formation and Rab27a, 
implicated in MVB fusion with the plasma membrane, suggesting the autophagosome-MVB 
hybrid organelle, the amphisome, is secreted when intracellular degradation is impaired.  
 While previous studies have demonstrated the connection between the autophagy and 
secretory pathways, there has been a lack of convincing evidence that the autophagosome 
structure itself, rather than just single ATG proteins, can interchange between degradative and 
secretory pathways. This study demonstrates that in the absence of fusion with the lysosome for 
degradation, the autophagosome can be redirected for secretion. As autophagosomes mediate the 
specific degradation of pathogenic or damaged cytoplasmic material, their secretion may both 
improve cell autonomous homeostasis by removing such material and impair non-cell 
autonomous homeostasis by spreading it to healthy neighboring cells. This occurrence would be 
most relevant in the context of neurodegenerative diseases, in which cells exhibit endo-
lysosomal dysfunction, failure of autophagosome degradation, and secretion of pathogenic 
protein aggregates. 
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AUTOPHAGY AND NEURODEGENERATIVE DISEASE 
Many neurodegenerative diseases are defined by the accumulation of misfolded proteins, 
including Alzheimer’s and Parkinson’s diseases. Given the role of autophagy in maintain cellular 
homeostasis by degrading cellular components like protein aggregates, it is logical that 
autophagy may play a role in maintaining viability and health of neurons. This is even more 
critical considering that neurons are post-mitotic and cannot reduce their intracellular load of 
misfolded proteins via cell division75. Neural deletion of Atg5 and Atg7 results in motor function 
defects and presence of ubiquitinated protein aggregates in neurons, evidence that loss of 
autophagy leads to neurodegenerative disease76,77. There are likely two causes of autophagy-
related neurodegenerative disease: aging and inherited mutations that impact the autophagy-
endolysosome pathway. Overexpression of Atg5 in mice not only activates autophagy, but 
improves lifespan and promotes anti-aging phenotypes78. Meanwhile, mutations that impair 
various steps of the autophagic pathway result in neurodegenerative disease51. The two most 
common neurodegenerative diseases, Alzheimer’s and Parkinson’s, both feature impairments in 
the final step of autophagy: fusion with the lysosome and degradation of autophagic cargo. 
 
Alzheimer’s Disease 
Alzheimer’s is the most common neurodegenerative disease and is characterized by intracellular 
accumulation of hyperphosphorylated tau in neurofibrillary tangles and extracellular 
accumulation of beta-amyloid (Ab) plaques associated with dystrophic neurites79. Ab is 
generated by cleavage of amyloid protein precrusors (APP) though cleavage by b and g-
secretase. Cleavage can result in multiple peptide products including Ab-40 and Ab-42, but Ab-
42 is the most pathogenic, as it is more hydrophobic and forms insoluble aggregates (plaques)80. 
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The ratio of Ab-42/40 is critical for pathogenesis, as it affects the morphology and stability of 
extracellular plaques81. Autophagosomes are enriched in APP and Ab and induction of 
autophagy by starvation or rapamycin induces Ab production, suggesting Ab is generated inside 
of autophagosomes82,83. These Ab peptides can be routed to MVBs and subsequently secreted in 
association with exosomes, and exosomal proteins like Alix have been identified in plaques in 
Alzheimer’s patient brains84. In addition, the exogenous addition of Ab aggregates can induce 
further Ab aggregation, suggesting a self-perpetuating prion-like spread of pathological protein 
that may underlie the pathogenesis of this disease85. Alzheimer’s patient brains reveal an 
accumulation of autophagosomes, MVBs, and autolysosomes in dystrophic neurites86. 
Furthermore, inhibition of lysosomal acidification phenocopies Alzheimer’s, suggesting a failure 
of autophagosome-lysosome fusion leads to the disease87. Mutations in presenilin-1 (PS1) are the 
most common cause of early-onset familial Alzheimer’s disease; PS1 knockout cells exhibit 
increased lysosomal pH and accumulated autophagosomes. PS1 is required for delivery of v-
ATPase subunit V0a1 from the endoplasmic reticulum to lysosomes, and thereby sufficient v-
ATPase activity88,89.  PS1 mutations that cause early-onset FAD result in reduced protein 
turnover, high LC3-II/LC3-I ratios, a block in autophagic flux, and impaired acidification of 
lysosomes88. Furthermore, pharmacological inhibition of v-ATPase function induces a similar 
autophagy phenotype to loss of PS189. In addition to their role in lysosomal function, PS1 
mutations augment extracellular secretion of Ab-42 in vitro and in vivo90.  
  
Parkinson’s Disease 
The second most common neurodegenerative disease, Parkinson’s, is caused by the degeneration 
of dopaminergic neurons in the substantia nigra. Both sporadic and familial cases of the disease 
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are pathologically characterized by large protein aggregates or inclusions (referred to as Lewy 
bodies) in neurons. a-synuclein (a-syn) is the predominant protein in Lewy bodies, and two 
missense mutations (A53T and A30P) result in early-onset Parkinson’s disease91. Furthermore, 
overexpression of wild-type a-syn results in Lewy body pathology, suggesting the accumulation 
of a-syn aggregates causes Parkinson’s92. Similar to Ab in Alzheimer’s disease, exogenous 
addition of mutant a-syn can speed endogenous a-syn aggregation in recipient brains93–95. 
Intriguingly, a-syn is secreted in association with exosomes, and treatment of neuronal cells with 
the conditioned media results in cell death, indicating that extracellular release and non-cell 
autonomous uptake of a-syn would further amplify disease96. While soluble a-syn is degraded 
by autophagy97, aggregates are not effectively degraded. a-syn aggregates co-localize with 
autophagosomes, yet those structures fail to fuse with lysosomes98. In addition, cells treated with 
bafA1 to block autophagosome degradation display accumulation of a-syn aggregates97. 
Although whether a-syn affects v-ATPase activity is unclear, its overexpression results in 
lysosomal de-acidification99. Several other mutations are linked to familial Parkinson’s disease, 
including mutations of ATP13A2 and LRRK2, which both cause accumulation of a-syn. While 
the function of ATP13A2, a lysosomal P-type ATPase, is still unknown, it has been suggested  to 
protect against alpha-synuclein misfolding100. Furthermore, mutations in ATP13A2 lead to 
lysosomal deficiency, including impaired acidification, decreased proteolysis by lysosomal 
enzymes, reduced degradation of substrates, and clearance of autophagosomes101. Mutations in 
LRRK2 are the most frequent cause of familial Parkinson’s disease, and two unique mutations 
affecting kinase activity, G2019S and R1441C, both result in impaired lysosomal function by 
reduced pH and impaired autophagosome degradation. While the direct effect of the G2019S 
mutation is unknown102, R1441C blocks LRRK2 interaction with v-ATPase subunit a1, resulting 
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in its mislocalization and the deacidification of the lysosome103. Ultimately, these studies 
indicate that both sporadic and inherited Parkinson’s disease feature impaired lysosomal 
acidification, thereby blocking degradation of autophagosomes and their cargo. 
 Therefore, two distinct neurodegenerative diseases exhibit several shared features 
regarding autophagy and pathological protein aggregates. Alzheimer’s and Parkinson’s diseases 
are driven by protein aggregates (Ab and a-syn, respectively), which are subject to both 
autophagic degradation and extracellular secretion. Intriguingly, Ab and a-syn are secreted in 
association with exosomes, but have not been demonstrated to be localized within the exosomal 
lumen84,96. Finally, familial mutations that drive the diseases feature impaired lysosomal 
acidification and autophagosome-lysosome fusion, resulting in an accumulation of 
autophagosomes inside of the cell. These cellular events are strikingly similar to the extracellular 
release of autophagy cargo receptors, and should be further examined to determine if secretory 
autophagy may be involved. 
 
IMPLICATIONS FOR SECRETORY AUTOPHAGY IN NEURODEGENERATIVE 
DISEASE 
While autophagy has been implicated in many neurodegenerative diseases as a means of 
degradation of pathogenic protein aggregates, few studies have explored the role of secretory 
autophagy in these diseases. Since protein aggregates have been demonstrated to transfer from 
one neuron to another, could there be a mechanism by which neurons overwhelmed with 
material to be degraded can instead shunt it toward secretion? For example, C. elegans neurons 
can dispose of protein aggregates via large extracellular vesicles (4 µm in diameter) called 
exophers in response to proteotoxic stress, such as the inhibition of autophagy or the 
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overexpression of Ab-42104.  Secretory autophagy could enable neurons to selectively discard 
protein aggregates destined for degradation when canonical autophagy is impaired. Several 
studies have begun to explore the role of ATGs in secretion of Ab and a-syn. 
 While autophagy has been implicated in the degradation of APP and Ab, it is unclear if 
autophagy is required for routing of Ab to MVBs prior to its secretion in association with 
exosomes. APP transgenic mice with conditional neural knockout of Atg7 have both increased 
intracellular accumulation of Ab and decreased extracellular Ab plaque burden. In Atg7 
knockout neurons, Ab accumulates in the Golgi, but is not present in MVBs105. Furthermore, loss 
of ATG or pharmacological inhibition of autophagosome formation reduces Ab extracellular 
release and impairs memory in mice106. Together, this data indicates that ATG7 is critical for Ab 
secretion, potentially by incorporation of Ab into an autophagosome that fuses with the MVB 
prior to extracellular release. Further research into Ab secretion is necessary to determine if this 
event is dependent on other ATGs, indicating a role for the autophagosome itself.  
 In addition, three studies have investigated the role of autophagy in exosome-associated 
secretion of a-syn. Overexpression of a-syn in neuroblastoma or neuroglioma cell lines 
increases the release of a-syn, which co-fractionate with exosomal markers. Secreted a-syn is 
not protected from protease treatment, indicating it does not reside within the lumen of 
EVs107,108. Furthermore autophagic activity impacts the secretion of a-syn, as secretion is 
amplified by bafA1 or CQ treatment and reduced by rapamycin treatment107–109. Ultrastructural 
analysis of bafA1-treated cells reveals amphisome-like compartments with nondegraded 
cytoplasmic cargo as well as small ILVs, suggesting the pathway by which a-syn can be 
exosome-associated yet not internalized. Intriguingly, cerebral spinal fluid (CSF) from 
Parkinson’s patients contains LC3 and p62 in fractions positive for exosomal markers. Finally, 
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human a-syn from CSF exosome fractions can be internalized by mouse neurons, as it 
colocalizes with mouse endosomal markers in the brain and induces endogenous a-syn 
aggregation109. In summary, inhibition of autophagy-lysosome fusion leads to the presence of 
amphisome structures as well as increased secretion of exosome-associated a-syn, which can be 
internalized by neighboring cells. Additional questions to address include if a-syn secretion is 
dependent upon interaction with autophagy cargo receptors, and if these proteins can also be 
transmitted between cells. 
In this work, we identify a novel form of secretory autophagy by which autophagosomes 
and their protein cargo are redirected to secretion when lysosomal fusion and degradation is 
blocked. Questions prompted by this finding include what is the fate of this secreted material and 
how this event impacts non-cell autonomous homeostasis. Is this pathway a mechanism by which 
diseased cells incapable of autophagic degradation can release harmful material for degradation 
by competent cells, spread pathogenic protein aggregates to neighboring cells, or both? 
Furthermore, could medicine utilize this secretory event as a blood biomarker for early diagnosis 
of diseases in which lysosomal degradation is impaired? Future studies should address these 
questions in the context of neurodegenerative disease. 
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the proteins have an indirect effect on viral replication. RNA 
sequencing analysis demonstrates that ATG13 and FIP200 af-
fect genes predominantly involved in transcriptional regulation 
during CV infection. Future studies expanding on these results 
are needed to dissect the exact mechanism by which ATG13 and 
FIP200 reduce picornaviral replication.
Autophagy has inexorably been linked to the host cellular 
response to diverse intracellular pathogens. Indeed, autophagy 
frequently serves as an innate mechanism that sequesters or 
clears offending pathogens from the host cell, termed xenoph-
agy. In response to infection, pathogen- and damage-associated 
molecular patterns stimulate pattern recognition receptors, 
which then activate ATG proteins to induce autophagy or pro-
mote recognition of the microbe by the LC3-positive autopha-
gosome (Deretic et al., 2015). Nevertheless, the autophagy 
trafficking process can be subverted by pathogens that have 
adapted to avoid or use autophagy to their own benefit (Deretic 
and Levine, 2009). One example is poliovirus, which utilizes 
LC3 to promote its nonlytic viral release, potentially by the 
fusion of LC3-positive vesicles containing poliovirus with the 
plasma membrane (Bird et al., 2014).
Interestingly, this last example broaches how ATG pro-
teins, either as individual proteins or in groups, may enable un-
conventional functions distinct from the canonical process of 
autophagy. This can include entirely novel functions or ATG 
processes that use only a subset of the core components (Beste-
broer et al., 2013). Before Mauthe et al. (2016), a comprehen-
sive, unbiased analysis of the entire ATG proteome to uncover 
the autophagy-independent functions of ATG proteins during 
infection had not been undertaken. Nevertheless, other studies 
have highlighted some of the emerging noncanonical roles of 
ATG proteins during microbial pathogenesis. A well character-
ized example is LC3-associated phagocytosis (LAP), in which 
a select group of ATG proteins promotes maturation and deg-
radation of the phagosome. Upon toll-like receptor-triggered 
phagocytosis, Beclin 1 is recruited to the phagosome, where it 
induces production of phosphatidylinositol triphosphate and lo-
calization of LC3, causing fusion with the lysosome (Sanjuan 
et al., 2007). Although LAP requires several ATG proteins—
Beclin 1, LC3, ATG5, and ATG7, among others—it is mech-
anistically distinct from autophagy as it does not use the ULK 
complex that initiates canonical autophagy. In addition, LAP 
utilizes proteins such as Rubicon, which is inhibitory to auto-
phagy, further demonstrating deviation from the conventional 
functions of ATG proteins (Martinez et al., 2015). LAP serves 
as a host defense system that targets several pathogens, includ-
ing Salmonella typhimurium and Aspergillus fumigatus (Huang 
et al., 2009; Martinez et al., 2015).
In other cases, the growing list of noncanonical func-
tions of ATG proteins has led the field to reevaluate a general 
role of the autophagy pathway in certain aspects of microbial 
pathogenesis. First, the autophagy pathway was proposed to 
defend against Mycobacterium tuberculosis infection because 
induction of autophagy by starvation or treatment with rapa-
mycin reduces M. tuberculosis viability and because myeloid- 
specific deletion of ATG5 results in increased inflammation 
and bacterial load in the lungs (Castillo et al., 2012; Watson et 
al., 2012). Although this result originally assumed a protective 
function of autophagy, recent work demonstrates that ATG5 
is unique in its ability to restrict M.  tuberculosis infection. In 
stark contrast to ATG5, the genetic deletion of other essential 
ATG genes (ATG3, ATG7, ATG12, ATG14L, and ATG16L) has 
no effect on M.  tuberculosis infection in vivo. Instead, ATG5 
prevents accumulation of polymorphonuclear cells in the lungs, 
thereby controlling inflammation and M.  tuberculosis replica-
tion (Kimmey et al., 2015).
During Brucella abortus infection, multiple ATG proteins 
implicated in the early steps of autophagosome initiation, such as 
ULK1 and Beclin 1, are involved in the formation of a B. abor-
tus–containing vacuole (BCV) with autophagic features (aBCV), 
which promotes bacterial proliferation. Double-membrane cres-
cents reminiscent of the autophagosome engulf BCVs late in 
infection but do not degrade or clear the bacteria. Instead, ULK1, 
Beclin 1, and class III phosphatidylinositol 3-kinase activity are 
all required for the conversion of BCVs into aBCVs. However, 
the ATG conjugation pathways involved in autophagosome 
elongation play no role in aBCV formation. Furthermore, these 
aBCVs facilitate bacterial release and infection of neighboring 
cells, demonstrating that very specific components of autophago-
some initiation promote B. abortus infection (Starr et al., 2012).
Moreover, the lipidated form of LC3 (LC3-II) is essen-
tial for autophagosome formation and crucially interacts with 
cytoplasmic cargo to be degraded. However, during MHV 
infection, unlipidated LC3 (LC3-I) promotes viral replica-
tion in double-membrane vesicles (DMVs). The similarity of 
DMVs to autophagosomes prompted speculation that classical 
autophagy controlled MHV infection. However, ATG5 does 
not affect infection, and only LC3-I colocalizes with MHV 
DMVs, suggesting that canonical autophagy is not involved 
(Zhao et al., 2007). Further investigation revealed that two 
proteins in the ER-associated degradation pathway interact 
with LC3-I and MHV replication translation complexes, that 
MHV DMVs are of ER origin, and that LC3-I, but not LC3-II, 
is required for MHV replication (Reggiori et al., 2010). Re-
markably, these LC3-I–positive DMVs represent another 
LC3-presenting membrane distinct from the canonical dou-
ble-membrane autophagosome as well as the LC3-II–positive 
single-membrane phagosome in LAP.
Lastly, during mouse norovirus (MNV) infection, IFN-γ–
activated phagocytes use ATG5-ATG12/ATG16L1 to inhibit 
formation of the viral replication complex, thus restricting in-
fection. This ATG complex typically promotes LC3 lipidation, 
resulting in expansion of the autophagosome. Based on the re-
quirement for ATG5 in IFN-γ–mediated inhibition of MNV rep-
lication, autophagy was initially suggested as the mechanism 
of host defense. However, IFN-γ has no effect on autophagy in 
phagocytes, and inducing or inhibiting autophagy does not alter 
MNV replication. Instead, only ATG5-ATG12/ATG16L1 is re-
quired for MNV replication inhibition, and ATG16L1 localizes 
to the MNV replication complex. ATG5-ATG12/ATG16L1 is 
required for IFN-γ–mediated suppression of MNV polymerase 
expression and, therefore, replication as a whole, an example 
of multiple ATG proteins functioning to inhibit viral infec-
tion (Hwang et al., 2012).
Ultimately, the discovery of widespread autophagy-inde-
pendent functions of ATG proteins marks a significant turning 
point as well as reinforces an important caveat for the field. 
Going forward, researchers must use caution when attributing 
a phenotype to canonical autophagy based on the genetic anal-
ysis of a single ATG protein. The experiments in Mauthe et al. 
(2016) poignantly illustrate the need to functionally test multi-
ple ATG proteins when characterizing a phenotype to ascertain 
a general role for autophagy as opposed to a distinct function 
mediated by individual ATG proteins.
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Although autophagy is classically viewed as a lysosomal deg-radation process1, genetic evidence implicates autophagy pathway components (ATGs) in secretion, including the 
conventional secretion of inflammatory cytokines2, extracellu-
lar release of lysozyme3, efficient egress of secretory lysosomes4, 
EV production5,6 and unconventional secretion of proteins lack-
ing amino-terminal leader peptides or signal sequences7–10. These 
processes, collectively termed secretory autophagy, implicate the 
autophagy pathway in non-cell autonomous control of cell fate 
decisions and tissue microenvironments, both normally and during 
disease11–13. Nevertheless, our understanding of secretory autophagy 
remains rudimentary. First, apart from a limited number of pro-
tein targets, the autophagy-dependent secretome remains unchar-
acterized. Furthermore, studies to date largely rely on phenotypic 
analysis following ATG genetic loss-of-function, which fail to dis-
cern whether secretory defects represent a direct versus indirect 
consequence of impaired autophagy. Here, we describe a secretory 
autophagy pathway in which LC3 mediates the loading of protein 
and RNA cargoes into EVs for secretion outside cells.
Results
LC3 proximity-dependent biotinylation identifies proteins 
secreted via autophagy-dependent pathways. We developed a 
proximity-dependent biotinylation (BioID)14 strategy to label pro-
teins within autophagic intermediates that are subsequently secreted 
outside cells (Fig. 1a). Hypothesizing that such secreted proteins 
interact with or reside near MAP1LC3B (LC3), an ATG8 ortho-
logue that captures substrates for autophagy, we fused the mutant 
Escherichia coli biotin ligase (BirA*) to the LC3 N terminus. BirA*–
LC3 (myc epitope-tagged) was lipidated with phosphatidylethanol-
amine, localized at autophagosomes and degraded within lysosomes 
(Extended Data Fig. 1a–c). Biotin incubation triggered robust label-
ling of intracellular targets in BirA*–LC3 cells (Fig. 1b and Extended 
Data Fig. 1d) including multiple well-known LC3-interacting intra-
cellular proteins (Fig. 1c). However, these molecules were not detect-
ably secreted into conditioned medium (CM). Instead, numerous 
unique biotin-labelled proteins were detected in CM of BirA*–LC3 
cells compared to BirA* controls (Fig. 1b). Importantly, the BirA*–
LC3-labelled secretome represented secretion of proteins that were 
biotin-labelled inside cells, not promiscuous biotinylation following 
extracellular release (Extended Data Fig. 1e,f).
Combining this strategy with stable isotope labelling with amino 
acids in cell culture (SILAC) as a quantitative proteomics approach 
to detect differences in secreted protein abundance between BirA*–
LC3 and BirA* via mass spectrometry (MS; Fig. 1d), we identified 
>350 secreted proteins in three independent biological replicates 
(Supplementary Table 1). Candidates were selected on the basis of 
significantly increased log2(BirA*–LC3/BirA*) ratios and the pres-
ence of two or more peptides. A total of 31 proteins exhibited statis-
tically significant enrichment (log2(BirA*–LC3/BirA*) > 1; P < 0.05) 
in all 3 replicates and an additional 170 proteins were enriched in 2 
of 3 replicates (Fig. 1e–g and Extended Data Fig. 2a). We refer to hits 
enriched in all replicates as class I proteins and those in two of three 
as class II proteins (Supplementary Table 1).
In the class I dataset, we identified two autophagy proteins, 
MAP1LC3B and ATG3, along with multiple RBPs previously shown 
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Traditionally viewed as an autodigestive pathway, autophagy also facilitates cellular secretion; however, the mechanisms 
underlying these processes remain unclear. Here, we demonstrate that components of the autophagy machinery specify secre-
tion within extracellular vesicles (EVs). Using a proximity-dependent biotinylation proteomics strategy, we identify 200 puta-
tive targets of LC3-dependent secretion. This secretome consists of a highly interconnected network enriched in RNA-binding 
proteins (RBPs) and EV cargoes. Proteomic and RNA profiling of EVs identifies diverse RBPs and small non-coding RNAs requir-
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protein K (HNRNPK) and scaffold-attachment factor B (SAFB), we demonstrate that these proteins interact with LC3 and are 
secreted within EVs enriched with lipidated LC3. Furthermore, their secretion requires the LC3-conjugation machinery, neutral 
sphingomyelinase 2 (nSMase2) and LC3-dependent recruitment of factor associated with nSMase2 activity (FAN). Hence, the 
LC3-conjugation pathway controls EV cargo loading and secretion.
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to interact with LC3 or other ATG8 family proteins15 (Fig. 1g and 
Extended Data Fig. 2a–c). Together, the class I + II datasets con-
tained 42 and 76 proteins in common with the LC3 interactome and 
the entire ATG8 interactome, respectively15. Notably, five LC3 fam-
ily members ranked among the top proteins connected to the iden-
tified secreted targets (Extended Data Fig. 2d). Eighty-three percent 
of the proteins enriched in the BirA*–LC3-labelled secretome were 
previously identified in proteomics of human plasma, consistent 
with a role for autophagy in controlling secretion in vivo16 (Fig. 1h). 
Importantly, an interaction map of the class I + II datasets revealed 
a highly interconnected network enriched in protein–protein inter-
actions17 (Extended Data Fig. 2e). Gene Ontology (GO) analyses 
demonstrated that the BirA*–LC-labelled secretome was highly 
enriched in RBPs and proteins released within EVs (Fig. 1i and 
Extended Data Fig. 2e); 33% of the candidates identified in our 
proteomic screen were previously detected in EVs and 113 out of 
200 proteins have functions in messenger RNA binding18 (Extended 
Data Fig. 2e–g and Supplementary Table 1). Collectively, these 
results suggested that LC3 and the autophagy machinery control the 
loading and secretion of specific proteins such as RBPs within EVs.
LC3-II and BirA*–LC3 biotinylated targets are secreted within 
small EVs. CM from biotin-pulsed BirA*–LC3 cells was subjected 
to serial differential ultracentrifugation to recover large EVs (at 
10,000g), small EVs (at 100,000g)19 and soluble proteins precipi-
tated from the remaining sample. BirA*–LC3-labelled secreted pro-
teins were enriched in the 100,000g pellet along with multiple EV 
markers (Fig. 2a,b). Remarkably, these 100,000g fractions were also 
enriched in the lipidated, membrane-bound form of endogenous 
LC3 (LC3-II), suggesting that LC3-II itself was secreted via EVs. 
On further purifying EVs via a linear sucrose density gradient, we 
found that endogenous LC3-II co-fractionated with well-defined EV 
markers at characteristic buoyant densities, with a slightly broader 
distribution into less dense fractions19 (Fig. 2c). Transmission elec-
tron microscopy (TEM) further corroborated that samples isolated 
by ultracentrifugation were enriched in EVs. Importantly, endog-
enous LC3-II resided inside the lumen of EVs, evidenced by its 
protease protection in the absence of detergent, and co-purified 
with EVs immuno-isolated from concentrated preparations using 
antibodies against EV-associated tetraspanins (Fig. 2d–f). Finally, 
LC3-II was secreted within EVs from multiple cell types comprising 
diverse lineages, including primary astrocytes, and detected in vivo 
within EVs isolated from mouse plasma (Extended Data Fig. 3a–g).
A subset of EVs are produced by intraluminal budding from the 
limiting membrane of multivesicular bodies (MVBs)20–23. To deter-
mine whether intracellular LC3 localized to MVBs, we employed 
an APEX–LC3 recombinant probe24 to visualize LC3 via TEM, 
which revealed numerous MVBs containing subpopulations of 
LC3-positive intraluminal vesicles (ILVs) (Fig. 2g). To determine 
whether endogenous LC3 is delivered into the lumen to MVBs, 
we immunostained for LC3 in cells expressing constitutively active 
mutant mCherry–Rab5Q79L, which impairs endosomal trafficking 
and promotes the formation of enlarged terminal early endosomes 
exhibiting intraluminal budding25,26. We detected endogenous LC3 
at the limiting membrane and in ILVs within mCherry–Rab5Q79L 
endosomes of wild-type (WT) cells, but not in cells lacking ATG7, 
an autophagy regulator essential for LC3 lipidation27 (Fig. 3a). 
Furthermore, LC3 co-localized with CD63 in these enlarged vesicu-
lar intermediates (Extended data 3h). In contrast, ATG14, an ATG 
needed for classical degradative autophagy28,29, did not reduce the 
formation of LC3-positive ILVs in mCherry–Rab5Q79L endosomes 
(Fig. 3a), suggesting a specific requirement for the LC3-conjugation 
pathway in incorporating LC3 into ILVs. Finally, in the absence 
of Rab5Q79L expression, we observed significant co-localization of 
endogenous LC3 and CD63, further suggesting that LC3 is pack-
aged and released within EVs by an ATG7-dependent, but not 
ATG14-dependent, pathway (Fig. 3b–d).
LC3-conjugation pathway is required for EV loading and secre-
tion of RBPs. These phenotypic differences between ATG7 versus 
ATG14 deletion suggested that LC3-conjugation pathways specifi-
cally packaged proteins into EVs for secretion outside the cell1. To 
further elucidate the LC3-dependent EV proteome, we performed 
Tandem Mass Tag (TMT)-based quantitative proteomics compar-
ing EVs purified from WT versus cells lacking ATG7 or ATG12, 
two essential components of the LC3-conjugation machinery27 
(Fig. 4a,b and Supplementary Table 2). Overall, 81% of targets 
enriched in the BirA*–LC3B-labelled secretome were detected in 
the global EV proteome, further suggesting EVs as a principal route 
for autophagy-dependent unconventional secretion (Fig. 2a,b and 
Extended Data Fig. 4a). A total of 815 proteins were enriched in 
EVs from WT relative to ATG7- and ATG12-deficient cells (Fig. 4c  
and Supplementary Table 2), including 55 proteins overlapping 
with the BirA*–LC3B-labelled secretome, such as the RBPs SAFB, 
HNRNPK, LARP1, SF3A1 and G3BP1. Although we were unable to 
detect LC3B, probably due to its small size and lipid modification, 
five LC3 family members ranked among the top proteins connected 
to the 815 proteins enriched in the LC3-dependent EV proteome 
(Fig. 4c). Moreover, as for the BirA*–LC3 secretome, GO analyses 
highlighted a profound enrichment in RBPs and proteins that func-
tion in RNA metabolism (Figs. 1i and 4e). Among the 815 EV pro-
teins requiring the LC3-conjugation machinery for secretion, 112 
have been identified in stress granules and 206 in processing bod-
ies (P-bodies), two ribonucleoprotein assemblies that functionally 
sequester RNAs to control gene expression in response to diverse 
cellular stresses30 (Extended Data Fig. 4b,c and Supplementary Table 
2). Finally, among the proteins enriched within the BirA*–LC3 sec-
retome, but not the LC3-dependent EV proteome, histones made up 
Fig. 1 | Identification of proteins secreted via autophagy-dependent pathways using LC3 proximity-dependent biotinylation and quantitative 
secretomics. a, The proximity-dependent biotinylation strategy to label secretory autophagy targets. b, Protein biotinylation in whole-cell lysate (WCL, 
intracellular) and CM (secreted) collected from HEK293T cells stably expressing myc–BirA*–LC3, myc–BirA* or empty vector (control) following 24!h 
incubation with (+) or without (−) 50!µM biotin. Equal amounts of protein from TCA-precipitated CM or WCL were probed with Streptavidin–HRP 
(Strep–HRP) to detect biotinylated proteins, myc or GAPDH (n!=!3 biologically independent experiments). c, Streptavidin affinity purification (Strep AP) 
and immunoblotting to detect known LC3-interacting proteins within WCL and CM of cells expressing myc–BirA*–LC3 (n!=!2 biologically independent 
experiments). d, Autophagy-dependent secretion substrate enrichment and the quantitative secretomics workflow. e, A log2(H/L) histogram for the CM 
proteins identified in bioreplicate no. 2 and the scheme for identification of autophagy-dependent secretion candidates. f, Putative secretory autophagy 
candidates identified in n!=!3 independent experiments (Exp.). Among the 40 hits enriched in all 3 experiments, 31 were statistically significant overall 
(see Extended Data Fig. 2) and classified as class I candidates. The remaining proteins along with hits enriched in 2 out of n!=!3 experiments (170 proteins 
total) were designated as class II candidates. A full list of the candidates is provided in Supplementary Table 1. g, A log2(BirA*–LC3/BirA*) heat map of 
the class I candidates. h, The proportion of the secreted candidates (classes I and II) detected in human plasma. i, GO enrichment analysis of secreted 
candidates (classes I and II) with the top terms for molecular function and cellular component plotted according to −log10 FDR. The statistical significance 
was calculated by a one-way Fisher’s exact test. Sample size, n!=!3 independent biological replicates, yielding 200 enriched proteins in the class I!+!class II 
datasets. Data and unprocessed blots are available as source data.
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a significant proportion, consistent with reports that autophagy may 
facilitate the secretion of histones and DNA via EV-independent 
mechanisms31 (Supplementary Table 2).
Little is known regarding the pathways specifying cargo load-
ing into EVs20–23. Analogous to its role in sequestering cargo dur-
ing degradative autophagy32, we hypothesized that lipidated LC3-II 
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captures proteins at the MVB limiting membrane, incorporating 
them into ILVs for subsequent release as EVs. To test this prediction, 
we focused on SAFB and HNRNPK, two RBPs enriched in both 
the BirA*–LC3B secretome and the LC3-dependent EV proteome 
(Figs. 1g and 4a–c and Extended Data Fig. 4a). Endogenous SAFB 
and HNRNPK co-fractionated with membrane-bound LC3-II in 
purified EVs (Fig. 5a), interacted with LC3 (Fig. 5b), co-localized 
with LC3 in the lumen of a subset of mCherry–Rab5Q79L endosomes 
(Extended Data Fig. 4d) and were detected in EVs purified from 
multiple cell types (Extended Data Fig. 3a). In contrast to p62 (also 
known as SQSTM1), these LC3-binding RBPs were not degraded 
during starvation-induced autophagy (Fig. 5c).
We next assessed whether various autophagy pathway compo-
nents were required for SAFB and HNRNPK secretion. Deletion 
of the LC3-conjugation pathway components, ATG7 and ATG12, 
reduced overall EV production and protein content relative to con-
trols (Fig. 5d), but did not impact the size of EVs (Fig. 5e). To con-
trol for these differences in EV production among ATG null cells, 
we normalized EV lysates on the basis of protein concentration 
and assayed for LC3-binding RBPs. EVs from ATG7 and ATG12-
deleted cells were devoid of LC3-II, HNRNPK and SAFB, but still 
contained EV marker proteins (Fig. 5f,g). Similarly, reduced EV 
secretion of these targets was observed in cells deficient for ATG3, 
another essential component of the LC3-conjugation machinery27  
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Fig. 2 | LC3-II and BirA*–LC3 biotinylated targets are secreted within EVs. a, Protein biotinylation in WCLs (intracellular) and fractionated CM collected 
from BirA*–LC3 HEK293T cells incubated with 50!µM biotin for 24!h. The CM was subjected to differential ultracentrifugation to recover large EVs 
(10,000g; 10K), small EVs (100,000g; 100K) and precipitated free soluble protein (TCA). Equal amounts of protein from WCL and fractionated CM were 
probed with Streptavidin–HRP (Strep–HRP) or antibodies against the indicated EV marker proteins, LC3 and myc-tagged BirA*–LC3 (n!=!3 biologically 
independent replicates). b, Quantification of global protein biotinylation in the indicated fractions of CM relative to WCL (mean!±!s.e.m.; n!=!3 biologically 
independent experiments). The statistical significance between the CM fractions was calculated by one-way analysis of variance (ANOVA) coupled with 
Tukey’s post hoc test. c, EVs from CM separated via linear sucrose density gradient ultracentrifugation, fractionated and immunoblotted to detect the 
endogenous levels of the indicated markers and LC3 (n!=!3 biologically independent experiments). d, A representative transmission electron micrograph 
of EVs isolated via differential ultracentrifugation (n!=!3 biologically independent samples). Scale bar, 200!nm. e, Representative immunoblots of the 
indicated proteins from untreated EVs or EVs incubated with 100!µg!ml−1 trypsin and/or 1% Triton X-100 (TX-100) for 30!min at 4!°C (n!=!3 biologically 
independent experiments). f, Representative immunoblots of EVs immunopurified from concentrated CM fractions using antibodies targeting the 
tetraspanins CD9, CD63 and CD81 or a normal mouse IgG isotype control and immunoblotted to detect the endogenous levels of the indicated markers 
and LC3 (n!=!3 biologically independent experiments). g, Representative transmission electron micrographs of normal rat kidney epithelial cells expressing 
an APEX–LC3 recombinant fusion protein or APEX–GFP control and stained with 3,3-diaminobenzidine (DAB) and hydrogen peroxide (H2O2) (n!=!3 
biologically independent samples). Scale bars, 500!nm. Data and unprocessed blots are available as source data.
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Numerical data are available as source data.
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(Extended Data Fig. 4e,f). Impaired secretion was not due to 
changes in intracellular HNRNPK and SAFB protein levels or cell 
death (Fig. 5f,g and Extended Data Fig. 4e–h). In contrast, loss of 
ATG14 and RB1CC1 (also known as FIP200), two ATGs required 
for the early initiation steps of classical autophagy, but dispens-
able for LC3-conjugation28,29,33, did not attenuate EV production 
(Fig. 5d) or EV release of LC3-II and LC3-binding RBPs (Fig. 5f,g). 
Taken together with the results above that ATG14 deletion does not 
impair LC3-positive ILV formation or LC3 co-localization with tet-
raspanins (Fig. 3a–d and Extended Data Fig. 3a), our results sub-
stantiate a specific requirement for the LC3-conjugation machinery 
in loading LC3-II and LC3-binding RBPs into EVs. In further 
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support of this, LC3-II is not secreted within plasma EVs in vivo in 
mice systemically deleted for Atg12 (Extended Data Fig. 3b–d). As 
proteins that bind LC3 frequently contain a motif called an LC3-
interaction region (LIR), we investigated whether the loading of 
LC3-binding RBPs into EVs involved LIR-dependent interactions. 
Primary sequence analyses revealed a putative LIR consensus motif 
within SAFB (Extended Data Fig. 5d), whereas HNRNPK contained 
only regions with minimal overlap. Mutation of the core hydropho-
bic amino acid within this motif to alanine (F199A) was sufficient 
to disrupt LC3 binding (Fig. 4h,i), which potently suppressed EV 
secretion of SAFB (Fig. 4j,k).
Overall, this secretory autophagy pathway, which we term LC3-
dependent EV loading and secretion (LDELS), is distinct from clas-
sical autophagy. In support of this, treating cells with rapamycin 
stimulates classical autophagy, but conversely reduces EV secretion 
of LC3-II and LC3-binding RBPs (Extended Data Fig. 4i,j). In addi-
tion, other LC3 family members are released in EVs via mechanisms 
requiring the LC3-conjugation machinery (Extended Data Fig. 5a) 
and recent unbiased proteomic analyses have detected multiple LC3 
family members in EVs from diverse cell lines34. Notably, we cor-
roborated several additional RBPs identified from our proteomic 
screens, including G3BP1, LARP1 and SF3A1, to be secreted 
in EVs in an ATG7-dependent manner; similar to SAFB and 
HNRNPK, these targets interacted with diverse LC3 family mem-
bers (Extended Data Fig. 5b,c). Together, these data suggest that the 
LC3-conjugation machinery and LC3 family proteins mediate the 
cargo loading and secretion of RBPs via EVs.
LDELS regulates extracellular RNA secretion via EVs. We fur-
ther reasoned that LDELS influences extracellular RNA secretion 
via EVs. EVs contain diverse nucleic acids including mRNA, non-
coding RNAs and DNA, but the mechanisms incorporating genetic 
material into EVs remain poorly defined23,35. To scrutinize how 
LDELS impacted extracellular RNA secretion, we performed quan-
titative RNA sequencing (RNA-seq) of samples from EVs isolated 
from WT, ATG7- and ATG12-deficient cells; in parallel, RNA-seq 
of corresponding cell samples was performed to assess intracellu-
lar gene expression differences. We observed profound differences 
in the small RNA bio-types isolated from EVs from WT versus 
LDELS-deficient cells, with minimal differences in the intracel-
lular small RNA species (Fig. 6a,b and Supplementary Table 3). 
EVs derived from ATG7- and ATG12-deficient cells had relatively 
fewer RNA-seq reads mapping to small nucleolar RNAs (snoRNAs) 
and microRNAs (miRNAs), particularly in ATG7 knockout condi-
tions. Whereas 23% and 15% of the small RNA sequences in EVs 
from WT cells were snoRNAs and miRNAs, respectively, snoRNAs 
and miRNAs constituted 6% and 5% of EV small RNA sequences 
from ATG7-deficient cells and 18% and 5% from ATG12-deficient 
cells. Reduced levels of snoRNA and miRNA sequences in EVs 
from LDELS-deficient cells correlated with a relatively increased 
proportion of reads mapping to transfer RNA species. In contrast, 
ATG7/12 deletion minimally impacted extracellular release of large 
RNAs within EVs (Extended Data Fig. 5e–g and Supplementary 
Table 3). More detailed analysis revealed 252 and 105 small non-
coding RNAs to be significantly enriched in EVs from WT relative 
to ATG7- and ATG12-deficient cells, respectively (Fig. 6c,d); overlap 
between these two datasets highlighted 88 distinct RNAs requiring 
the LC3-conjugation machinery for efficient EV secretion (Fig. 6e 
and Supplementary Table 3). Most significantly, 76% of EV small 
non-coding RNAs regulated by LDELS were snoRNAs (or frag-
ments thereof), a class of small RNAs canonically involved in ribo-
somal RNA modification36 (Fig. 6f). Furthermore, 30% of snoRNAs 
secreted in an ATG7/12-dependent manner were enriched within 
EVs relative to total cellular RNA, consistent with their incorpo-
ration into EVs through an active packaging mechanism (Fig. 6g). 
Hence, LDELS influences the spectrum of extracellular small non-
coding RNA species secreted within EVs.
LDELS requires nSMase2. We next scrutinized whether path-
ways promoting inward budding and ILV formation from the 
MVB limiting membrane contribute to LDELS. Although the best-
characterized process involves the endosomal sorting complexes 
required for transport (ESCRT) machinery20–23, short interfering 
RNA (siRNA) against most ESCRT components, except CHMP4b, 
failed to abrogate incorporation of endogenous LC3 into mCherry–
Rab5Q79L endosomes (Extended Data Fig. 6a–c). In parallel, we 
evaluated an alternative pathway in which ceramide produced by 
SMPD3 (also known as nSMase2) induces vesicle curvature and 
inward budding from the MVB26. Indeed, siRNA-mediated deple-
tion of nSMase2 functionally impaired the incorporation of endog-
enous LC3 into mCherry–Rab5Q79L endosomes (Extended Data Fig. 
6a,d). Furthermore, treatment with the nSMase2 catalytic inhibi-
tor GW4869 or short hairpin RNA (shRNA) depletion targeting 
nSMase2 potently suppressed secretion of LC3-II and LC3-binding 
RBPs (Fig. 7a–d and Extended Data Fig. 7a,b). Although nSMase2 
ceramide production has been implicated in ILV formation, the 
mechanisms regulating nSMase2 activity and cargo selection remain 
obscure32. Bioinformatic analyses of the intracellular LC3 and ATG8 
family interactomes15 identified neutral sphingomyelinase activa-
tion associated factor (NSMAF; also known as FAN)37 as a potential 
Fig. 5 | LC3-conjugation machinery is required for EV loading and secretion of SAFB and HNRNPK. a, EVs from HEK293T CM separated via linear sucrose 
density gradient fractionation were immunoblotted to detect the endogenous levels of the indicated markers (n!=!2 biologically independent experiments). 
b, HEK293T cells transfected with myc-tagged LC3B or myc–BirA* were lysed, immunoprecipitated (IP) with anti-myc antibody, and immunoblotted with 
the indicated antibodies (n!=!3 biologically independent experiments). c, Cells were EBSS starved for the indicated times, lysed and immunoblotted for 
the indicated proteins. Baf A1!=!50!nM bafilomycin A1 for 1!h before lysis (n!=!2 biologically independent experiments). d, CM from equal numbers of the 
indicated cell types subjected to nanoparticle tracking analysis (open circles, left axis) to determine the EV number or the relative protein content measured 
using BCA from 100,000g EV fractions (black triangles, right axis) (mean!±!s.e.m.; n!=!3 biologically independent experiments). The statistical significance 
was calculated by one-way ANOVA coupled with Dunnett’s test. e, EV size distribution from a representative experiment for the indicated cell types in  
d (n!=!3 biologically independent experiments). f, WCL (left) and 100,000g EV fractions (right) from the indicated cell types were collected, normalized  
for protein concentration and immunoblotted to detect the endogenous levels of the indicated proteins (n!=!4 biologically independent experiments).  
g, Quantification of LC3 (red circles), SAFB (blue squares) and HNRNPK (green triangles) levels in EVs from the indicated ATG−/− cell lines relative to WT 
(mean!±!s.e.m.; n!=!4 biologically independent experiments). The statistical significance was calculated by one-way ANOVA coupled with Tukey’s post hoc 
test. h, HEK293T cells co-transfected with FLAG-tagged SAFB and myc-tagged LC3A, LC3B, LC3C, GABARAP (GR), GABARAPL1 (GRL1), GABARAPL2 
(GRL2) or myc–BirA* were lysed, immunoprecipitated with anti-myc antibody and immunoblotted with the indicated antibodies (n!=!2 biologically 
independent experiments). i, Cells co-transfected with FLAG-tagged WT SAFB or mutant SAFB (F199A) and myc-tagged LC3A, LC3B or myc–BirA* were 
lysed, immunoprecipitated with anti-myc antibody and immunoblotted with the indicated antibodies (n!=!2 biologically independent experiments). j, WCL 
and EVs collected from cells expressing WT or LIR mutant SAFB (F199A) were collected and immunoblotted for FLAG–SAFB and LC3 (n!=!3 biologically 
independent experiments). k, Quantification of WT and LIR mutant SAFB (F199A) secretion in EVs from cells (mean!±!s.e.m.; n!=!3 biologically independent 
experiments). The statistical significance was calculated by a paired two-tailed t-test. Data and unprocessed blots are available as source data.
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LC3-associated regulator of nSMase2. Indeed, FAN robustly inter-
acted with multiple LC3 isoforms, including LC3B, but itself was 
not degraded via autophagy (Fig. 7e and Extended Data Fig. 7d). 
Moreover, FAN knockdown suppressed EV secretion of LC3-II, 
SAFB and HNRNPK, whereas classical autophagy was unaltered 
(Fig. 7f,g and Extended Data Fig. 7e); siRNA-mediated depletion 
of FAN also impeded the incorporation of endogenous LC3 into 
mCherry–Rab5Q79L endosomes (Extended Data Fig. 7f–h). Finally, 
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we identified a putative LIR motif within FAN, whose mutation 
(F602A) impaired binding to LC3 isoforms (Fig. 7h,i). Re-expression 
of FANF602A in FAN-deficient cells failed to rescue LDELS (Fig. 7j,k 
and Extended Data Fig. 7i), whereas WT FAN fully restored EV 
secretion of LC3 and LC3-binding RBPs (Fig. 7j,k and Extended 
Data Fig. 7i). Thus, FAN interaction with LC3 is crucial for an LC3-
dependent circuit that coordinates cargo loading and biogenesis for 
nSMase pathway-derived EVs (Extended Data Fig. 7j).
Discussion
Here we demonstrate that LC3 and the LC3-conjugation machinery 
specify cargo loading into EVs. Previous work has intimated inter-
connections between autophagy and EV production. For example, 
we previously demonstrated a complex between ATG12 and ATG3 
that interacts with the ESCRT accessory protein ALIX (PDCDIP6) 
and regulates small EV release6. In addition, the autophagy proteins 
ATG5 and LC3 were found to coordinately regulate MVB acidifica-
tion and exosome production via control of ATP6V1E1 interactions 
with the V1V0-ATPase complex5. Moreover, because late endosomes 
can fuse to immature autophagosomes, EV biogenesis and autoph-
agy are proposed to be functionally connected38,39. In this study, we 
delineate a process called LDELS, highlighting a unique and pre-
viously unappreciated role for the LC3-conjugation machinery in 
specifying the cargo packaged into EVs.
Importantly, these functions for LC3 and the conjugation 
machinery in LDELS are distinct from their established roles in 
classical autophagy. We propose that instead of using LC3 located 
at early autophagic intermediates, LDELS employs a pool of LC3-II 
located at the MVB limiting membrane to directly capture RBPs and 
package them into ILVs; these are subsequently released as EVs via 
MVB fusion with the plasma membrane (Extended Data Fig. 7j). 
Hence, LDELS bears similarity to a growing list of autophagy-
related pathways, in which LC3-II is delivered to single membranes 
in the endolysosomal system, including LC3-associated endocy-
tosis, LC3-associated phagocytosis, entosis and macroendocytic 
processing40–43. LDELS also requires nSMase2 and LC3-dependent 
recruitment of FAN. Indeed, ceramides produced by nSMase2 can 
drive the formation of membrane microdomains that impose nega-
tive membrane curvature and facilitate ESCRT-independent intra-
luminal budding at the MVB limiting membrane26. In contrast to 
the case for many ESCRT components, we have not detected FAN 
within EVs, suggesting that FAN can interact only transiently with 
LC3 at the limiting membrane of MVBs or may act remotely to 
facilitate LDELS from other compartments such as the endoplasmic 
reticulum or Golgi apparatus, consistent with emerging roles for 
inter-organelle communication in MVB cargo sorting44,45.
Our studies also suggest that LDELS is largely independent of 
the ESCRT machinery; only genetic depletion of CHMP4b leads 
to reduced LC3 incorporation into Rab5Q79L endosomes. CHMP4b 
has recently been implicated in endosomal microautophagy42, sug-
gesting that these two pathways may be interconnected. However, 
in contrast to endosomal microautophagy, LDELS does not appear 
to require VPS4a/b. Further scrutinizing whether LDELS requires 
additional components of the ESCRT machinery and its relation-
ship to degradative pathways such as endosomal microautophagy 
and LC3-associated endocytosis remains an important topic for 
future study41,42.
Among the array of identified LDELS cargoes, RBPs represent 
the most prominent functional class of proteins. Although EVs are 
known to contain diverse RBPs, the mechanisms specifying their 
loading and secretion remain largely unclear23,35. We demonstrate 
here that LC3 and ATG8 family members interact with multiple 
secreted RBPs, many of which contain LIR consensus motifs, and 
show that mutation of the LIR within SAFB (SAFBF199A) is suf-
ficient to impair its secretion via EVs. Interestingly, many LDELS 
targets are detected in RNA granules, including stress granules 
and P-bodies46,47. Autophagy is proposed to regulate stress granule 
clearance48, but its role in RNA granule homeostasis appears more 
complex and nuanced beyond simple turnover of stress granule 
components49–52. We are actively investigating how LDELS interacts 
with classical autophagy to regulate the dynamic remodelling of 
RNA granules.
Consistent with its role in RBP secretion, the loss of LDELS via 
genetic ablation of ATG7 and ATG12 leads to profound changes in 
the extracellular small non-coding RNA profiles present in EVs. 
EVs contain diverse small RNA bio-types and the mechanisms that 
contribute to the packaging and secretion of small RNAs are only 
beginning to be unravelled35,53–56. Although LDELS affects secretion 
of multiple small RNA bio-types, its greatest impact is on snoRNAs, 
a class of nuclear small non-coding RNAs involved in ribosomal 
RNA modification36. Indeed, snoRNAs (or fragments thereof) are 
readily detected in EVs purified from human plasma and cell cul-
ture CM57–63. However, the mechanisms specifying snoRNA secre-
tion and the functions of extracellular snoRNAs remain largely 
unclear. Interestingly, a number of RBPs secreted via LDELS can 
preferentially bind snoRNAs, including SAFB64. Furthermore, pro-
cessed forms of snoRNAs interact with hnRNPs and cellular stresses 
such as starvation and oxidative damage promote the accumulation 
of snoRNAs in the cytoplasm65–67. Deciphering whether LDELS 
directs the EV secretion of snoRNAs as a means of regulating pro-
tein homeostasis during cell stress remains an intriguing question 
for future investigation.
Originally described as a mechanism to selectively eliminate 
proteins, lipids and nucleic acids from cells, EVs are emerging as an 
important mode of intercellular communication in diverse physi-
ological and pathological processes20–23. Elaborating how LDELS 
Fig. 6 | LDELS regulates the small non-coding RNA composition of EVs. a, The proportion of RNA-seq reads in total cellular RNA from WT, ATG7−/− and 
ATG12−/− HEK293T cells from the different classes of small non-coding RNA (n!=!3 biologically independent samples). b, The proportion of RNA-seq 
reads in total EV RNA from WT, ATG7−/− and ATG12−/− HEK293T cells from the different classes of small non-coding RNA (n!=!3 biologically independent 
samples). c, A volcano plot of the small non-coding RNAs detected in EVs from WT and ATG7−/− cells quantified by RNA-seq. The results are plotted 
according to −log10 P values as determined by DESeq2 and log2 fold enrichment (n!=!3 biologically independent samples; WT/ATG7−/−). Grey dots: RNAs 
identified with P!>!0.05 and/or log2 fold change between −0.5 and 0.5, and thus not relatively enriched in EVs from WT or ATG7−/− cells. The log2 fold 
change reflects the WT EV RNA/WT cell RNA to ATG7−/− EV RNA/ATG7−/− cell RNA ratio. Black dots: small non-coding RNAs significantly enriched 
in EVs from WT or ATG7−/− cells. Red dots: snoRNAs significantly enriched in EVs from WT or ATG7−/− cells. d, A volcano plot of the small non-coding 
RNAs detected in EVs from WT and ATG12−/− cells quantified by RNA-seq. The results are plotted according to −log10 P values as determined by DESeq2 
and log2 fold enrichment (n!=!3 biologically independent samples; WT/ATG12−/−). Grey dots: RNAs with a P!>!0.05 and/or log2 fold change between −0.5 
and 0.5, and thus not relatively enriched in EVs from WT or ATG12−/− cells. The log2 fold change reflects the WT EV RNA/WT cell RNA to ATG12−/− EV 
RNA/ATG12−/− cell RNA ratio. Black dots: small non-coding RNAs significantly enriched in EVs from WT or ATG12−/− cells. Red dots: snoRNAs significantly 
enriched in EVs from WT or ATG12−/− cells. e, A Venn diagram showing the overlap of the small non-coding RNAs enriched in EVs from WT cells relative 
to ATG7−/− or ATG12−/− cells. f, The proportion of different classes of small RNAs enriched in EVs from WT versus ATG-deficient cells. g, A heatmap of the 
67 snoRNAs enriched in EVs from WT cells across all genetic conditions and sample types. The scale indicates intensity, defined as Δ(read counts!−!mean 
read count)/s.d. Data are available as source data.
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impacts intercellular communication and non-cell autonomous 
functions in  vivo remains an important topic for future study. 
Overall, our studies expand the repertoire of putative targets of 
secretory autophagy and define a previously unrecognized mech-
anism by which the LC3-conjugation machinery specifies cargo 
loading into a subpopulation of EVs.
Enriched in 
WT versus ATG12 –/– EVs
Enriched in 
WT versus ATG7 –/– EVs
88
17
164
c
e f
–
lo
g 1
0[P
 
va
lu
e]
log 2[WT/ATG7 –/–]Cells
0 6–2–4 42
a
db
g
100
10
1
0.1
0.01
0.001
0.0001
–6
–
lo
g 1
0[P
 
va
lu
e]
0 6–2–4 42
100
10
1
0.1
0.01
0.001
0.0001
–6
log2[WT/ATG12–/–]
snoRNA
miRNA
tRNA
snRNA
Vault RNA
Y-RNA
hT RNA
ATG7 –/–WT ATG12 –/–
EVs
snoRNA
miRNA
tRNA
snRNA
Vault RNA
Y-RNA
hT RNA
50
100
0
50
100
0
Pe
rc
en
ta
ge
Pe
rc
en
ta
ge
snoRNA
miRNA
tRNA
snRNA
AT
G7
–
/–
WT AT
G1
2
–
/–
AT
G7
–
/–
WT AT
G1
2
–
/–
CellsEVs
U94
U87
ACA23
ACA62
HBII-142
U70B
ACA18
ACA38
ACA16
U100
U72
ACA28
ACA36B
U15A
ACA67B
U8
ACA37
HBI-43
ACA48
U38B
ACA22
ACA25
U62B
U62A
ACA27
U74
ACA6
U71a
U48
ACA31
ACA5c
U29
ACA51
ACA36
U71c
U37
mgh18S121
ACA5
ACA50
ACA64
ACA30
U101
U32A
ACA41
ACA46
U38A
ACA33
U68
ACA44
ACA67
U25
ACA34
U53
HBII-55
U73a
mgh28S2411
ACA1
U45C
U14
ACA32
snR38B
U15B
U51
U35A
U18A
HBII-239
U78
–2 –1 0 1 2
ATG7 –/–WT ATG12 –/–
NATURE CELL BIOLOGY | VOL 22 | FEBRUARY 2020 | 187–199 | www.nature.com/naturecellbiology196
 85 
 
ARTICLESNATURE CELL BIOLOGY
c
WCL EVs
LC3
I
II
TSG101
CD9
HNRNPK
ALIX
shRNA NT NT
d
nS
M2
 no
. 1
nS
M2
 no
. 2
AT
G7
CD9
ALIX
TSG101
HNRNPK
LC3
I
II
WCL EVs
NT NTshRNA AT
G7
FA
N n
o. 
1
FA
N n
o. 
2myc
IP: myc
FLAG
myc
GAPDH
WB: FLAG
FLAG–FAN
myc
IP: myc
FLAG
myc
GAPDH
WB: FLAG
FLAG–FAN
LC
3B
LC
3B
LC
3C
GR GR
L1
GR
L2
WT
LC
3A
F602A
WT F602Amyc–FAN:
f g
Bir
A*
LC
3B
LC
3C
GR GR
L1
GR
L2
LC
3A
e
WT F6
02
A
FAN
WCL
NT
EVs
NT
shRNA: FAN
 no. 1
FAN
 no. 1
19
64
97
16
R
el
at
iv
e 
se
cr
et
io
n
SAFB
SAFB
51
16
39
39
16
97
97
97
97
Mr (K)
19
64
97
16
39
97
Mr (K)
28
51
97
16
39
97
Mr (K)
97
P = 0.005
P = 0.027
P = 0.013
LC3
SAFB
HNRNPK
k
0
1.0
nS
M2
 no
. 1
nS
M2
 no
. 2
AT
G7
R
el
at
iv
e 
se
cr
et
io
n
shRNA
NT
FA
N n
o. 
1
FA
N n
o. 
2
AT
G7shRNA NT
R
el
at
iv
e 
se
cr
et
io
n
TSG101
LC3
SAFB
HNRNPK
TSG101
LC3
SAFB
HNRNPK
1.5
i
WCL EVs
– – +
LC3
I
II
TSG101
CD9
HNRNPK
SAFB
GW4869
Ve
hic
le
GW
48
69
0
1
2
3
4
5
b
Pa
rti
cl
es
 m
l–1
 
pe
r 2
4 
h 
(×1
09
)
a
j
917 aaFAN
GRAM
domain
BEACH
domain
599 609
WD40
repeats
h
LC3
I
II
TSG101
CD9
HNRNPK
SAFB
myc–FAN
shRNA
LIR
P 
=
 
0.
00
4
P 
<
 
0.
00
1
P 
=
 
0.
04
0
P 
=
 
0.
09
2
P 
=
 
0.
12
8
P 
<
 
0.
00
1
P 
<
 0
.0
01
P 
<
 
0.
00
1
P 
=
 
0.
23
0
P 
<
 
0.
00
1
P 
<
 
0.
00
1
P 
=
 
0.
00
1
P 
= 
0.
01
4
P 
=
 
0.
04
0
P 
=
 
0.
02
4
P 
=
 
0.
77
6
P 
=
 
0.
95
2
P 
=
 
0.
99
8
0
P 
<
 0
.0
01
P 
<
 0
.0
01
P 
<
 0
.0
01
P 
=
 
0.
00
8
P 
=
 
0.
02
5
P 
=
 
0.
01
2
ALIX
97
64
16
Mr (K)
39
19
Mr (K)Mr (K)
Fig. 7 | LDELS requires nSMase2 and FAN. a, WCL and EV lysates from cells treated in the absence or presence of 5!µM GW4869 for 24!h and 
immunoblotted for the indicated marker proteins (n!=!2 biologically independent experiments). b, Nanoparticle counting for a representative experiment  
in a (line, mean; n!=!1; 3 technical replicates). c, WCL and EV lysates collected from equal numbers of HEK293T cells stably expressing non-targeting (NT) 
shRNA or shRNAs that deplete ATG7 or nSMase2 (nSM2) were immunoblotted for the indicated proteins (n!=!3 biologically independent experiments).  
d, Quantification of the indicated protein levels in the EVs from equal numbers of stable knockdown cells in c relative to non-targeting shRNA (mean!±!s.e.m.; 
n!=!3 biologically independent experiments). The statistical significance was calculated by one-way ANOVA coupled with Tukey’s post hoc test. e, HEK293T 
cells co-transfected with FLAG-tagged FAN and myc-tagged LC3A, LC3B, LC3C, GABARAP (GR), GABARAPL1 (GRL1), GABARAPL2 (GRL2) or myc–
BirA* were lysed, immunoprecipitated with anti-myc antibody and immunoblotted (WB) with the indicated antibodies (n!=!2 biologically independent 
experiments). f, WCL and EV lysates collected from equal numbers of HEK293T cells stably expressing non-targeting shRNA or shRNAs that deplete  
ATG7 or FAN were immunoblotted for the indicated proteins (n!=!3 biologically independent experiments). g, Quantification of the indicated protein levels  
in the EVs from equal numbers of stable knockdown cells in c relative to non-targeting shRNA (mean!±!s.e.m.; n!=!3 biologically independent experiments). 
The statistical significance was calculated by one-way ANOVA coupled with Tukey’s post hoc test. h, A domain map and the primary LIR in FAN. i, Cells  
co-transfected with FLAG-tagged FAN and myc-tagged LC3A, LC3B, LC3C, GABARAP (GR), GABARAPL1 (GRL1), GABARAPL2 (GRL2) or myc–BirA* were 
lysed, immunoprecipitated with anti-myc antibody and immunoblotted (WB) with the indicated antibodies (n!=!2 biologically independent experiments).  
j, WCL and EV fractions from cells stably co-expressing non-targeting or shRNA that depletes endogenous FAN along with FLAG-tagged WT FAN or mutant 
FAN (F602A) were immunoblotted for the indicated markers (n!=!2 biologically independent experiments). k, Quantification of the indicated proteins in EVs 
from equal numbers of FAN knockdown HEK293T cells expressing FLAG-tagged WT FAN versus mutant FAN (F602A) (mean!±!s.e.m.; n!=!3 biologically 
independent experiments). The statistical significance was calculated by a paired two-tailed t-test. Data and unprocessed blots are available as source data.
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Methods
Cell culture. HEK293T cells (ATCC, CRL-3216), including all cell derivatives 
generated in this study, were cultured in DMEM (Thermo Fisher, 11995065) 
supplemented with 10% fetal bovine serum (FBS), 25 mM HEPES, 100 U ml−1 
penicillin and 100 µg ml−1 streptomycin (Thermo Fisher, 15140163). Murine RAW 
264.7 macrophages and murine B16F10 were gifts from M. Krummel (UCSF) and 
were cultured in DMEM (Thermo Fisher, 11995065) supplemented with 10% FBS, 
25 mM HEPES, penicillin and streptomycin. Murine LLC1 cells were purchased 
from ATCC (CRL-1642) and were cultured in DMEM (Thermo Fisher, 11995065) 
supplemented with 10% FBS, 25 mM HEPES, penicillin and streptomycin. All cell 
lines were authenticated using STR profiling (IDEXX BioResearch) and routinely 
tested for mycoplasma contamination (Sigma, MP0025).
To induce biotin-labelling, HEK293T cells expressing myc–BirA* or myc–
BirA*–LC3B were incubated with 50 µM biotin in DMEM with all supplements 
except FBS for 24 h. Unless indicated, CM and EV preparations were collected 
following 24 h incubation in DMEM containing all supplements except FBS. 
For autophagy flux assays, cells were incubated with 50 µM chloroquine (Sigma, 
C6628) or 50 µM bafilomycin A1 (Sigma, B1793) as indicated for 1 h before lysis. 
Treatment with 5 µM GW4869 (Cayman, 13127) or vehicle (dimethylsulfoxide, 
Sigma) in serum-free DMEM for 24 h was used to inhibit nSMase activity.
Plasmid constructs. The following plasmids were obtained or are available 
from Addgene: pcDNA3.1-myc-BirA* (mycBioID; Addgene no. 35700), 
pBABE-GFP-LC3B (Addgene no. 22405), pBABE-HRasV12 (Addgene no. 9051), 
mCherry-Rab5Q79L (Addgene no. 35138). Human LC3B (NM_022818.4), SAFB 
(NM_001201338.1), HNRNPK (NM_002140.4), LC3A (NM_032514.3), LC3C 
(NM_001004343.2), GABARAP (NM_007278.1), GABARAPL1 (NM_031412.2), 
GABARAPL2 (NM_007285.6), SF3A1 (NM_005877.5), LARP1 (NM_015315.4), 
G3BP1 (NM_005754) and FAN (NM_003580.3) were subcloned from mRNA 
isolated from human cell lines that was reverse transcribed using AccuScript High 
Fidelity Reverse Transcriptase (Agilent) and complementary DNA amplified using 
PfuUltra II Hot Start DNA polymerase and gene-specific primers (LC3B Fwd: 
agtcggatccatgccgtcggagaagacct; LC3B Rev: gactctcgagttacactgacaatttcatcccg; SAFB 
Fwd: agctggatccatggcggagactctgtcag; SAFB Rev: agctgtcgactcagtagcggcgagtgaag; 
HNRNPK Fwd: agtcggaattcgcatggaaactgaacagccagaag; HNRNPK Rev: 
agtcctcgagttagaatccttcaacatctgcata; LC3A Fwd: agtcggatccatgccctcagaccggcct; LC3A 
Rev: gactctcgagtcagaagccgaaggtttcct; LC3C Fwd: agtcggatccatgccgcctccacagaaaat; 
LC3C Rev: gactctcgagctagagaggattgcagggtc; GABARAP Fwd: 
agtcggatccatgaagttcgtgtacaaagaaga; GABARAP Rev: gactctcgagtt 
aaagaccgtagacactttc; GABARAPL1 Fwd: agtcggatccatgaagttccagtacaaggac; 
GABARAPL1 Rev: gactctcgagtcatttcccatagacactctc; GABARAPL2 Fwd: 
agtcagatctatgaagtggatgttcaaggag; GABARAPL2 Rev: gactctcgagtcagaagcc 
aaaagtgttctc; SF3A1 Fwd: agtctgatcaatgccggccggacccgtg; SF3A1 Rev: 
gatcctcgagctacttcttcctcccgcctc; LARP1 Fwd: agctagatctatgctttggagggtgcttttg; LARP1 
Rev: agctctcgagtcactttcccaaagtctgtgt; G3BP1 Fwd: agctggatccatggtgatggagaagcctagt; 
G3BP1 Rev: agctgtcgactcactgccgtggcgcaagc; FAN Fwd: agcttgatcaatggcgtttatccg 
gaagaag; FAN Rev: agctctcgagttaatactgcaatttccagaatata). Subsequently, the cDNAs 
were subcloned into pcDNA3 between the BamHI and XhoI or EcoRI and 
XhoI restriction sites downstream of an N-terminal myc-tag or 3 × Flag-tag. All 
constructs were verified by sequencing.
To generate pBABE-myc-BirA*, myc–BirA* was amplified with 
flanking primers (Fwd: agctaagcttaccggtgccaccatggaacaaaaactc; Rev: 
gactctcgagttacttctctgcgcttctcagg) from pcDNA3.1-myc-BirA* and sub-cloned 
into pBABE-GFP-LC3 between AgeI and SalI, entirely replacing the GFP–LC3 
open reading frame. To generate pBABE-myc-BirA*-LC3, myc–BirA* was 
amplified with flanking primers (Fwd: agctaagcttaccggtgccaccatggaacaaaaactc; 
Rev: gactggatcccttctctgcgcttctcagg) from pcDNA3.1-myc-BirA* and sub-cloned 
into the HindIII and BamHI sites in front of pcDNA3-FLAG-LC3, replacing the 
FLAG sequence. Subsequently, the myc–BirA*–LC3 fragment was sub-cloned 
from pcDNA3-myc-BirA*–LC3 using AgeI (introduced 3ʹ to the HindIII site) and 
XhoI into pBABE-GFP-LC3 between AgeI and SalI, replacing the GFP–LC3 open 
reading frame. All constructs were verified by sequencing.
Site-directed mutagenesis of FLAG-tagged SAFB and FAN was 
performed via QuikChange PCR. Overlapping primers carrying the desired 
mutation (SAFB Fwd: ttagatacttca tcatctgacgccactatattacaggaaattgaa; 
SAFB Rev: ttagatacttcatcatctgacgccactatattacaggaaattgaa; FAN 
Fwd: gattccccaggtgaagagtctgccgaagacctgaccgaagaaagc; FAN Rev: 
gctttcttcggtcaggtcttcggcagactcttcacctggggaatc) were used to amplify 
pcDNA3 FLAG–SAFB and FLAG–FAN, respectively, and template plasmid 
was eliminated via DpnI digestion. Subsequently, individual clones were 
sequenced to verify mutagenesis of the desired sites. Finally, for FAN 
rescue experiments, WT FAN and FAN F602A were amplified with 
primers incorporating an N-terminal myc-tag (myc–FAN/F602A Fwd: 
agcttgatcaaccatggaacaaaaacttatttctgaagaggatctgggctccatggcgttt atccggaagaag; Rev: 
agctctcgagttaatactgcaatttccagaatata) and cloned between the BamHI and XhoI of 
pLenti-CMV-blast (Addgene: no. 17486).
Retroviral and lentiviral packaging, infection and selection. Retroviral pBABE 
expression vectors were packaged and target cells were transduced according to 
established protocols68. Briefly, Phoenix-AMPHO cells (gift from C. McCormick, 
Dalhousie University) were seeded and transfected with retroviral vectors using 
polyethylenimine. Virus-containing CM was collected 2 d after transfection 
and clarified using a 0.45-µM filter. Before infection, virus-containing medium 
was diluted 1:4 in DMEM growth medium and the mix was supplemented with 
Polybrene to a final concentration of 8 µg ml−1. Subsequently, the viral transduction 
mix (5 ml total volume/10 cm culture dish) was incubated with HEK293T cells for 
24 h. Cells were selected 24 h post-transduction with 1 μg ml−1 puromycin for 2 d. 
To package lentivirus, HEK293T cells were seeded and co-transfected with the 
packaging vectors psPAX2 and pMD2.G, and individual pLKO.1 transfer vectors. 
Virus collection, infection and puromycin selection of stable cell pools were carried 
out as above.
SILAC, proximity-dependent biotinylation and affinity purification of biotin-
labelled secretome. For experimental replicates no. 1 and no. 2, HEK293T 
cells stably expressing myc–BirA* were grown in Lys- and Arg-free DMEM 
supplemented with 10% dialysed FBS (Thermo Fisher), 25 mM HEPES, penicillin/
streptomycin, and light (K0) lysine (50 μg ml−1) and light (R0) arginine (50 μg ml−1), 
whereas HEK293T cells stably expressing myc–BirA*–LC3 were grown in lysine- 
and arginine-free DMEM medium with supplements and the heavy isotopes 
K8 lysine (Cambridge Isotopes) and R10 arginine (Cambridge Isotopes). For 
experimental replicate no. 3, a label swap was performed to rule out potential 
labelling artefacts; the heavy and light labelling was reversed between myc–BirA* 
and myc–BirA*–LC3 cells. Cells were labelled in SILAC medium and expanded 
into 18 × 15 cm culture dishes of equal cell density (80% confluent).
Cells were gently washed twice in 20 ml EBSS and incubated with 15 ml serum-
free SILAC medium supplemented with 50 µM biotin to trigger biotin labelling 
according to standard protocols14. CM was collected 24 h later and centrifuged 
serially at 200g for 10 min to pellet cells, followed by 2,000g for 20 min to pellet 
cellular debris and apoptotic bodies. CM was routinely stored at −80 °C before 
analysis. CM was precipitated by adding trichloroacetic acid (TCA) to a final 
concentration of 15% and incubating on ice for 1 h. Subsequently, precipitated 
protein was pelleted by ultracentrifugation at 200,000g for 18 h. Pellets were washed 
with 10 ml of ice-cold acetone, re-centrifuged at 200,000g for 1 h and air-dried. 
To solubilize protein, pellets were resuspended in 8 M guanidine hydrochloride 
(Sigma G3272), 100 mM Tris hydrochloride pH 8.0 for 1 h with manual trituration 
every 15 min. Re-solubilized protein from myc–BirA* or myc–BirA*–LC3 was 
pooled separately and protein concentrations were quantified via BCA protein 
assays (Thermo Fisher, 23225), diluting samples below BCA threshold limits for 
chaotropic agents. Subsequently, samples from light myc–BirA* and heavy myc–
BirA*–LC3 were mixed in equal protein proportions and the combined sample 
was diluted to 2.5 mM guanidine hydrochloride with 50 mM Tris pH 8.0. Biotin-
labelled proteins were captured on 120 µl of packed high-capacity neutravidin 
Sepharose (Thermo Fisher, 29204) overnight at 4 °C, followed by 3 washes with 
5 ml 2.5 mM guanidine hydrochloride, 50 mM Tris HCl pH 8.0 before analysis by 
immunoblotting or MS.
Sample preparation, LC–MS/MS, peptide identification and protein 
quantification for MS of affinity-purified proteins. Neutravidin Sepharose- 
and affinity-purified proteins were resuspended and mildly denatured in 1 M 
guanidine hydrochloride, 1 mM calcium chloride and 100 mM Tris buffer pH 8.0. 
Disulfide bonds were reduced with 4 mM tris(2-carboxyethyl)phosphine (Sigma, 
C4706), and free thiols were alkylated with 10 mM iodoacetamide (Sigma, I1149). 
Subsequently, 10 μg of MS-grade trypsin (Thermo Fisher) dissolved in 10 μl 50 mM 
acetic acid was added to proteins on beads, and incubated at 37 °C for at least 18 h. 
The eluate was transferred to a new tube, acidified to a final concentration of 0.3% 
trifluoroacetic acid (TFA; pH < 3) and desalted by a reversed-phase C18 solid-
phase extraction (SPE) cartridge, using either a Sep-pak (Waters Corp.) or SOLA 
SPE (Thermo Fisher), and then dried down in a speed-vac. Dried peptides were 
stored at −20 °C, and resuspended in 2% acetonitrile (ACN), 0.1% formic acid (FA) 
in a bath sonicator for 5 min to a concentration of 2 μg μl−1 before MS analysis.
Peptides (0.5–1 µg) were submitted for nano-LC–electrospray ionization–MS/
MS, using a 195-min reversed-phase (2.4–32% ACN, 0.1–0.08% FA) buffer 
gradient with a 15-cm Acclaim PepMap 100 C18 analytical column (2-μm beads, 
75 μm i.d.), running at 200 nl min−1 on a Dionex Ultimate 3000 RSLCnano pump, 
in-line with a hybrid quadrupole–Orbitrap Q-Exactive Plus mass spectrometer 
(Thermo Fisher). A data-dependent method with a parent ion scan at a resolving 
power of 70,000 was run on each sample and a top 12 method for replicates 1 and 
2 and a top 15 method for replicate 3 were selected for the 12 and 15 most intense 
peaks for MS/MS using HCD fragmentation (normalized collision energy 27), 
respectively. Dynamic exclusion was activated such that parent ions were excluded 
from MS/MS fragmentation for 20 s after initial selection.
For protein identification and quantification, Thermo.RAW files were 
analysed by Maxquant69. The recorded spectra from three independent biological 
replicates were searched against the human reference proteome from UniProt 
(2014-11-16 release, with 20,193 unique proteins, including isoforms, on SwissProt 
and 47,673 entries in TrEMBL) using MaxQuant, version 1.5.1.2. Maxquant 
uses the Andromeda search engine to identify peptides. The search parameters 
allowed for a 4.5-ppm peptide ion search tolerance, a 7.5-ppm centroided 
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fragment ion tolerance and 2 missed tryptic cleavages. Oxidation of methionine, 
phosphorylation of serine/threonine/tyrosine and N-terminal acetylation were 
allowed as variable modifications, while carbamidomethylation of cysteines was 
selected as a constant modification and a threshold peptide spectrum match false 
discovery rate (FDR) and protein FDR of 1% was allowed. Quantification of SILAC 
ratios was performed by Maxquant on the MS1 level and the resulting ratios for all 
replicates were compared using statistical tools found in the Perseus bioinformatics 
analysis package70. Proteins with ratio quantification in only one replicate were 
filtered out. The statistical significance was determined by applying a one-sample 
Student t-test to the replicates with a P-value cutoff of P = 0.05. Protein group 
ratios and P values are included in Supplementary Table 1.
EV preparation and characterization. EVs were purified according to standard 
differential centrifugation protocols19. Briefly, cells seeded in 15-cm culture dishes 
at approximately 70% confluence were incubated with serum-free DMEM for 24 h. 
CM was collected and centrifuged serially at 200g for 10 min to pellet cells, 2,000g for 
20 min to pellet cellular debris and apoptotic bodies, 10,000g for 30 min to pellet large 
EVs, and 100,000g in an ultracentrifuge for 2 h to pellet EVs. Crude EVs pellets were 
then gently triturated in PBS using a P1000 pipette, diluted further in PBS (12 ml), 
and ultracentrifuged for an additional 70 min at 100,000g to generate EV preparations 
for further analysis as described below. Importantly, for all comparisons of EVs 
between experimental conditions, results from individual cohorts were corrected as 
indicated on the basis of total cell number or WCL protein concentration to ensure 
that EV or EV protein quantification was not confounded by seeding differences.
Sucrose density gradient separation was utilized to generate highly purified 
EV preparations and to analyse the co-fractionation of LC3-II and LC3-binding 
proteins with EV marker proteins on linear sucrose gradients. Briefly, the 100,000g 
EV pellets generated via differential centrifugation as described above were 
thoroughly resuspended in 100 µl 10% sucrose solution and gently layered onto 
a continuous 10–60% sucrose gradient formed on a gradient station (BioComp 
Instruments) and then ultracentrifuged at 210,000g for 18 h. Subsequently, 1 ml 
fractions from the gradient were top unloaded, weighed and diluted in 10 ml of 
PBS. The diluted fractions were spun at 100,000g for 70 min and the pellets were 
resuspended in urea lysis buffer for analysis by immunoblotting.
For protease protection assays, equal amounts of EVs were resuspended in 
PBS or PBS containing 1% Triton X-100 in the absence or presence of 100 µg ml−1 
trypsin for 30 min at 4 °C. Subsequently, the reactions were stopped by the addition 
of 2× protein sample buffer and the lysates were subjected to immunoblotting. 
Established protocols were used to perform TEM of HEK293T EVs prepared by 
differential centrifugation5.
Nanoparticle tracking analysis for EV preparations was performed with 
an LM10 nanoparticle analyser (NanoSight). The camera level was set at 9 for 
all recordings. The camera focus was adjusted to make the particles appear as 
individual dots with surrounding refractory rings. Five 60-s videos were recorded 
for each sample with a delay of 10 s between each recording. All post-acquisition 
functions were set at automatic, with the exception of the detection threshold, 
which was set to 2. The protein content in EV pellets was quantified via BCA assay 
(Thermo Fisher, 23225), diluting samples below the threshold limits for interfering 
detergents and chaotropic agents.
Sample preparation, TMT labelling, LC–MS/MS, peptide identification and 
protein quantification for MS of EV proteins. Serum-free medium conditioned 
for 24 h from four bioreplicates of approximately 5 × 109 WT, ATG7−/− and 
ATG12−/− HEK293T cells was collected and EVs were isolated using the standard 
differential centrifugation protocols described above. On purification, EVs from 
each condition were lysed in 800 μl of radioimmunoprecipitation buffer (25 mM 
Tris HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% 
SDS), supplemented with 2% SDS and sonicated with a probe sonicator set to an 
amplitude of 8 for 10 bursts of 10 s. Each 800 μl sample was then diluted in 3.5 ml 
ice-cold 100% acetone and incubated at −20 °C for 12 h. Subsequently, the samples 
were spun in an ultracentrifuge at 200,000g for 18 h, the acetone was decanted and 
the pelleted protein was left to air dry. Dried pellets were stored at −80 °C before 
solubilization and TMT labelling.
Biological replicates of HEK293T WT, ATG7−/− and ATG12−/− precipitated 
EV proteins were resuspended in 30 μl 6 M guanidine chloride, 100 mM Tris 
pH 8.0, 10 mM TCEP, 40 mM 2-chloroacetamide (CAA). Proteins were denatured 
for 1 h at 37 °C and quantified with 660 nm Protein Assay Reagent (Thermo). 
The 4 bioreplicates from each condition were pooled into 2 separate samples 
and subsequently diluted sixfold with 150 μl 100 mM Tris pH 8.0. Two hundred 
micrograms of protein for each sample was trypsinized with 4 μg trypsin (Thermo) 
in an orbital shaker at 250 r.p.m., 37 °C for ~20 h. After 20 h, trypsin digestion was 
stopped by acidifying samples with 10% TFA to a final concentration of 0.5% TFA, 
and then desalting with SOLA C18 reverse-phase SPE columns (Thermo), where 
the samples were washed with 1.5 ml 0.1% TFA, then 0.5 ml 0.1% FA, 2% ACN, 
and eluted with 450 μl 0.1% FA, 50% ACN. These samples were dried by speed-vac, 
then resuspended in 10 μl 50 mM HEPES (pH 8.5) and quantified by a peptide 
quantification kit (Thermo).
For TMT labelling, 800 μg of each TMT six-plex (Thermo no. 90061) isobaric 
compound was resuspended with 41 μl 100% anhydrous ACN (Sigma). A 15 μg 
quantity of peptides for each replicate was individually combined with 7.69 μl (or 
150 μg) of the TMT isobaric tags. Samples were incubated at 25 °C for 1 h, and then 
the reaction was quenched with 8 μl 5% hydroxylamine for 15 min. After labelling, 
the six individually labelled samples were pooled and 1/3 of the pooled sample 
(30 μg) was fractionated by high-pH reverse-phase fractionation into 8 fractions 
and dried down by speed-vac. The fractions were then resuspended in 0.1% FA, 2% 
ACN before LC–MS/MS analysis.
For LC–MS/MS analysis, 1 μg TMT-labelled peptides were analysed on a 15-cm 
C18 analytical column, in-line with a Q-Exactive Plus mass spectrometer. The 
peptides were separated on a multi-slope, 100 min gradient (6.4%–27.2% ACN 
with 0.1% FA for 80 min at 0.2 μl min−1, then 27.2%–40% ACN with 0.09% FA for 
15 min at 0.3 μl min−1, then 40%–56% ACN with 0.09% FA for 5 min at 0.3 μl min−1, 
and then washed for 3 min). Data-dependent acquisition with MS1 resolution of 
70,000, top15 method, and HCD normalized collision energy of 32 was used, with 
MS2 resolution of 35,000 and an isolation window of 0.7 m/z. Dynamic exclusion 
was activated for 30 s after initial parent ion selection.
Eight injections of the different fractions of TMT-labelled exosome peptides 
were analysed together via Maxquant (v1.6.0.16). The search parameters 
included a peptide search tolerance of 4.5 ppm, a centroided MS2 tolerance of 
7.5 ppm, and allowed for two missed tryptic cleavages. Constant modification 
of carbamidomethylation of cysteines and variable modifications of N-terminal 
acetylation, methionine oxidation and serine/threonine/tyrosine phosphorylation 
were allowed. Peptide spectrum match FDR and protein FDR was set at 1%. 
Match between runs was enabled to increase peptide identifications. Type is set to 
‘Reporter ion MS2’, and TMT6plex-Nter126 to 131, TMT6plex-Lys126 to 131 labels 
are selected. The resulting quantifications are then median normalized for each 
protein group and statistical analysis (two-sample two-sided t-test) was applied in 
Perseus, with a statistical significance threshold of P < 0.05.
Isolation and sequencing of small and large RNA species in EVs. Serum-free 
medium conditioned for 24 h from 4.5 × 108 WT, ATG7−/− and ATG12−/− HEK293T 
cells was collected and EVs were isolated according to the standard differential 
centrifugation protocols described above. Small and large RNA was isolated from 
EVs and cells using the Macherey-Nagel NucleoSpin kit (no. 740971) according to 
the manufacturer’s protocol.
Short RNA libraries were prepared using the SMARTer smRNA-Seq Kit for 
Illumina (Takara no. 635030). Briefly, input RNA from three bio-replicates of WT, 
ATG7−/− and ATG12−/− cells and EV RNA samples was first polyadenylated and 
then reverse transcribed using Primescript Reverse Transcriptase and oligo(dT) 
and SMART smRNA oligonucleotides. Subsequently, primers with unique Illumina 
i5 and i7 adapter sequences were used to PCR amplify the cDNA from the different 
samples for 12 cycles. Libraries were then subjected to size selection to enrich for 
small RNA species using SPRI AMPure Beads (Beckman Coulter, no. A63880) 
and the yield and concentration were assessed using a Qubit 2.0 Fluorometer 
(Invitrogen) and DNA 1000 chips on an Agilent 2100 Bioanalyzer (Applied 
Biosystems), respectively. Libraries were then diluted to 8 nM and pooled together.
Large RNA libraries were prepared using the SMARTer Stranded Total RNA 
Sample Prep Kit - HI (Takara no. 634875). Input RNA from three bio-replicates of 
WT, ATG7−/− and ATG12−/− cells and EV RNA samples was depleted of ribosomal 
RNA, chemically fragmented and then reverse transcribed using Primescript 
Reverse Transcriptase, random primers and SMART stranded oligonucleotides. 
The cDNA was then purified using SPRI AMPure Beads (Beckman Coulter, no. 
A63880). Subsequently, primers with unique Illumina i5 and i7 adapter sequences 
were used to PCR amplify the cDNA from the different samples for 22 cycles. 
Libraries were then purified using SPRI AMPure Beads (Beckman Coulter, 
no. A63880) and the yield and concentration were assessed using a Qubit 2.0 
Fluorometer (Invitrogen) and DNA 1000 chips on an Agilent 2100 Bioanalyzer 
(Applied Biosystems), respectively.
Each library was diluted to a final concentration of 4.2 nM and pooled before 
single-end, 50-base-pair sequencing on two separate lanes of a HiSeq 4000 
sequencer (UCSF Center for Advanced Technology, San Francisco, CA). For small 
RNAs, raw reads were first trimmed using cutadapt (v2.3) by removing the polyA 
tail and the tri-nucleotide template switch. Trimmed reads were then mapped 
to the human reference genome (GRCh38/hg38) using bowtie2 (v2.3). Bedtools 
(intersectBed) was used to count the number of reads that overlap annotated 
small RNA species (DASHRv2.071). Differential expression analysis was performed 
using DESeq2. For RNA-seq, salmon (v0.14) was used to map reads to the human 
transcriptome (Gencode v28). Tximport was used to import the data into R and 
DESeq2 was then used to perform differential gene expression analysis.
Bioinformatic analyses. Candidate proteins identified by MS of the BirA*–LC3-
labelled secretome were subdivided into class I proteins, which were significantly 
enriched (log2(BirA*–LC3/BirA*) > 1) in the three quantitative MS bioreplicates, 
and class II proteins, which were enriched in two out of three biological 
replicates. Unless indicated, higher stringency class I and lower stringency class 
II datasets were combined to generate the BirA*–LC3-labelled secretome for all 
bioinformatic analyses. The proportion of candidates detected in human plasma 
was established by searching the BirA*–LC3-labelled secretome against the Plasma 
Proteome Database16. GO analysis was performed using protein analysis through 
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evolutionary relationships (PANTHER) and the top 10 terms for molecular 
function and cellular component were plotted according to their −log10 FDR72. The 
network map of the BirA*–LC3-labelled secretome was plotted with Search Tool 
for the Retrieval of Interacting Genes/Proteins (STRING) using experiments and 
databases for interaction sources with a minimum interaction confidence score of 
0.400 (ref. 73). Extracellular exosome and RBPs within the network were identified 
using PANTHER GO analyses for individual candidates. The number of candidate 
proteins associated with the GO term extracellular exosome was obtained using 
PANTHER. The top ten proteins with the greatest connectivity to the combined 
class I and class II data were identified using the protein–protein interaction 
tool in the Enrichr gene set enrichment analysis suite and plotted according to 
their adjusted P values74. Overlap between datasets, including individual Q-MS 
bioreplicates, LC3 and the broader ATG8 interactome15 and mRNA-binding 
proteome18, was visualized using Biovenn75.
For TMT Q-MS, the overlap between candidates significantly enriched in EVs 
from WT versus EVs from ATG7−/− and ATG12−/− (P < 0.05; log2(WT/ATG7−/−) 
or (WT/ATG12−/−) > 0.5; n = 2) and the BirA*–LC3-labelled secretome (classes I 
and II), as well the ATG7- and ATG12-dependent EV proteome versus the stress 
granule47 and P-body46 proteomes was visualized using Biovenn13. The top ten 
proteins with the greatest connectivity to the ATG7- and ATG12-dependent 
EV proteome were identified using the protein–protein interaction tool in the 
Enrichr gene set enrichment analysis suite and plotted according to their adjusted 
P values10. GO analysis of the ATG7- and ATG12-dependent EV proteome was 
performed with PANTHER and the top 10 non-redundant terms for molecular 
function were plotted according to their −log10 FDR8.
For RNA-seq data, the overlap between RNA candidates significantly enriched 
in EVs from WT versus EVs from ATG7−/− and ATG12−/− (P < 0.05; log2 WT EV 
RNA/WT cell RNA versus ATG7−/− EV RNA/ATG7−/− cell RNA or WT EV RNA/
WT cell RNA versus ATG12−/− EV RNA/ ATG12−/− cell RNA > 0.5) was visualized 
using Biovenn13. The classes of different RNA species identified were annotated 
using metascape76 and the heatmap of snoRNA species enriched in WT EVs 
relative to ATG7−/− and ATG12−/− EVs was plotted using Prism statistical analysis 
software.
Antibodies. Immunoblotting: Streptavidin–HRP (Thermo Fisher, cat. no. 21130, 
lot no. TA263511, SB241752A; 1:40,000), rabbit anti-MAP1LC3 (Millipore, cat. 
no. ABC232; 1:1,000), rabbit anti-myc (Cell Signaling Technology, cat. no. 2278S, 
clone no. 71D10, lot no. 5; 1:1,000), mouse anti-myc (Sigma, cat. no. M5546, 
clone no. 9E10, lot no. 128M4898V; 1:1,000), mouse anti-GAPDH (Millipore, 
cat. no. MAB374, lot no. 3075597; 1:1,000), guinea pig anti-SQSTM1 (also 
known as p62) (Progen/Cedarlane, cat. no. GP62-C, lot no. 703241-1; 1:1,000), 
rabbit anti-OPTN (Abcam, cat. no. ab23666, lot no. GR3270251; 1:1,000), goat 
anti-ATG7 (Santa Cruz Biotechnology, cat. no. sc-8668, clone no. N-20, lot 
no. B0316; 1:1,000), mouse anti-Nbr1 (Santa Cruz Biotechnology, cat. no. sc-
130380, clone no. 4BR, lot no. B2019; 1:1,000), mouse anti-ALIX (Cell Signaling 
Technology, cat. no. 2171S, clone no. 3A9, lot no. 5; 1:1,000), rabbit anti-Hsc70 
(Cell Signaling Technology, cat. no. 8444, clone no. D12F2, lot no. 1; 1:1,000), 
rabbit anti-TSG101 (BD Biosciences, cat. no. 612696, lot no. 8172853; 1:1,000), 
mouse anti-CD9 (Millipore, cat. no. CBL162, clone no. MM2-57, lot no. 2691299; 
1:1,000), mouse anti-FLAG-M2 (Sigma-Aldrich, cat no. F3165, clone no. M2, 
lot no. SLBN8915V, SLCC4005, SLBF1225; 1:5,000), rabbit anti-DYKDDDDK 
(Cell Signaling Technology, cat. no. 2368S, lot no. 12; 1:1,000), rabbit anti-SAFB 
(Abcam, cat. no. ab187650, clone no. EPR13588, lot no. GR167184-1, GR167184-4, 
GR167184-5; 1:500), mouse anti-HNRNPK (Abcam, cat. no. ab39975, clone no. 
3C2, lot no. GR275360-20, GR275360-6, GR275360-8, GR148352-24; 1:1,000), 
rabbit anti-ATG12 (Cell Signaling Technology, cat. no. 2010S, clone no. human 
specific, lot nos. 2, 5; 1:1,000), rabbit anti-ATG14 (MBL, cat. no. PD026, lot no. 
5; 1:1,000), rabbit anti-CHMP3 (Abcam, cat. no. ab175930, clone no. EPR12821, 
lot no. YK032912CS; 1:1,000), rabbit anti-VPS4a (Sigma, cat. no. SAB4200022, 
lot no. 119K4789; 1:1,000), rabbit anti-VPS4b (Abcam, cat. no. ab102687, lot 
no. GR60499-4; 1:1,000), rabbit anti-CHMP4b (Abcam, cat. no. ab76334, lot no. 
GR26679-7; 1:1,000), rabbit anti-FIP200/RB1CC1 (Proteintech, cat. no. 17250-
1-AP, lot no./barcode no. 00012978; 1:1,000), rabbit anti-phospho-S6 (Cell 
Signaling Technology, cat. no. 4858S, D57.2.2E, lot no. 3; 1:1,000), rabbit anti-S6 
(Cell Signaling Technology, cat. no. 2217L, clone no. 5G10, lot no. 3; 1:1,000), 
rabbit anti-nSMase2 (Santa Cruz Biotechnology, cat. no. sc-67305, clone no. 
H-195, lot no. E1116; 1:1,000), rabbit anti-CD9 (Abcam, cat. no. ab92726, clone 
no. EPR2949, lot no. GR260186-21, 1:1,000), rabbit anti-CD63 (Abcam, cat. no. 
ab134045, clone no. EPR5702, lot no. GR3212162-2; 1:1,000), rabbit anti-CD81 
(Abcam, cat. no. ab109201, clone no. EPR4244, lot no. GR181359; 1:1,000), rabbit 
anti-FAN (Abcam, cat. no. ab81260, lot no. GR32198-5; 1:1,000), rabbit anti-
ATG3 (Sigma-Aldrich, cat. no. A3231, lot no. NA; 1:500), rabbit anti-LC3A (Cell 
Signaling Technology, cat. no. 4599T, clone no. D50G8, lot no. 5; 1:1,000), rabbit 
anti-LC3B (Cell Signaling Technology, cat. no. 3868T, clone no. D11, lot no. 11; 
1:1,000), rabbit anti-LC3C (Cell Signaling Technology, cat. no. 14736T, lot no. 1; 
1:1,000), rabbit anti-GABARAP (Cell Signaling Technology, cat. no. 13733T, clone 
no. E1J4E, lot no. 3; 1:1,000), rabbit anti-GABARAPL1 (Cell Signaling Technology, 
cat. no. 26632T, clone no. D5R9Y, lot no. 1; 1:1,000), rabbit anti-GABARAPL2 
(Cell Signaling Technology, 14256T, clone no. D1W9T, lot no. 3; 1:1,000), rabbit 
anti-LARP1 (Cell Signaling Technology, cat. no. 14763S, lot no. 1; 1:500), mouse 
anti-G3BP1 (BD Biosciences, cat. no. 611126, clone no. 23/G3BP, lot no. 39834, 
1:500), mouse anti-SF3A1 (Abcam, cat. no. ab139271, clone no. OTI2C4, lot 
no. GR128640-10, 1:500), peroxidase-AffiniPure donkey anti-rabbit IgG (H+L) 
(Jackson, cat. no. 711-035-152, lot no. 143451; 1:5,000), peroxidase-AffiniPure 
donkey anti-guinea pig IgG (H+L) (Jackson, cat. no. 706-035-148, lot no. 108535; 
1:5,000), peroxidase-AffiniPure donkey anti-goat IgG (H+L) (Jackson, cat. no.  
705-035-147, lot no. 125729; 1:5,000), peroxidase-AffiniPure donkey anti-mouse 
IgG (H+L) (Jackson, cat. no. 715-035-150, lot no. 142341;1:5,000).
EV immuno-isolation: mouse anti-CD9 (Millipore, cat. no. CBL162, clone no. 
MM2-57, lot no. 2691299), mouse anti-CD63 (Abcam, cat. no. ab8219, clone no. 
MEM-259, lot no. GR3196070-12), mouse anti-CD81 (BD Biosciences, cat. no. 
555675, lot no. 7096566).
Immunofluorescence: rabbit anti-LC3B (1:500, MBL, cat. no. PM036, lot no. 
031), mouse anti-CD63 (1:200, Abcam, cat. no. ab8219, clone no. MEM-259, lot no. 
GR3196070-12), mouse anti-LC3 (1:200, Nanotools, cat. no. 0231-100/LC3-5F10, 
clone no. 5F10, lot no. 0231S), rabbit anti-CD9 (1:200, Abcam, cat. no. ab92726, 
clone no. EPR2949, lot no. GR260186-21), rabbit anti-LC3B (1:200, Cell Signaling 
Technology, cat. no. 3868T, clone no. D11, lot no. 11), AlexaFluor goat anti-rabbit 
488 (1:500, Thermo Fisher, cat. no. A-11034, lot no. 52700A), goat anti-mouse 647 
(1:500, Thermo Fisher, cat. no. A21235, lot no. 490187).
Immunoblotting. To generate WCL, cells were lysed in NP40 buffer (25 mM 
Tris, pH 8.0, 150 mM NaCl, 1% NP40, 5% glycerol) plus protease inhibitor 
cocktail (Sigma-Aldrich), 2 mM EDTA, 2 mM EGTA, 10 mM β-glycerophosphate, 
2.5 mM sodium pyrophosphate, 10 mM NaF, 1 mM Na3VO4. For EV lysate and 
re-solubilization of precipitated material for immunoblotting, samples were 
resuspended in urea buffer (50 mM Tris-HCl, pH 8.0, 8 M urea, 2% SDS, 10 mM 
sodium fluoride, 5 mM EDTA) plus protease inhibitor cocktail. Lysates were 
cleared by centrifugation, quantified by BCA assay (Thermo Fisher, 23225), 
mixed with sample buffer, resolved by SDS–polyacrylamide gel electrophoresis 
(PAGE) and transferred to polyvinylidene fluoride membrane. Membranes were 
blocked for 1 h in 5% milk in PBS with 0.1% Tween 20, incubated in primary 
antibody overnight at 4 °C, washed, incubated for 1 h at room temperature with 
HRP-conjugated secondary antibodies (1:5,000; Jackson), washed and visualized 
via enhanced chemiluminescence (Thermo Fisher) on film. Immunoblots were 
quantified by densitometry using Fiji.
Immunoprecipitation. For immunoprecipitation of endogenous SAFB and 
HNRNPK, cells transiently transfected with myc-tagged BirA*, LC3B were lysed 
24 h post-transfection in NP40 buffer (25 mM Tris, pH 8.0, 150 mM NaCl, 1% 
NP40, 5% glycerol) plus protease inhibitor cocktail (Sigma-Aldrich), 2 mM EDTA, 
2 mM EGTA, 10 mM β-glycerophosphate, 2.5 mM sodium pyrophosphate, 10 mM 
NaF, 1 mM Na3VO4. Lysates were pre-cleared with protein A/G beads (Santa Cruz, 
sc-2003) and normal mouse IgG (Santa Cruz, sc-2025) at 4 °C and incubated 
overnight with mouse anti-myc antibody (Sigma, M5546; 1 µg per 200 µg lysate) 
at 4 °C. Immune complexes were captured by incubation with protein A/G beads 
for 4 h at 4 °C and then washed five times with NP40 buffer plus inhibitors, eluted 
with sample buffer and analysed by immunoblotting. For immunoprecipitation of 
epitope-tagged prey, cells transiently transfected with myc-tagged BirA*, LC3B (or 
individual LC3 family members) and FLAG–SAFB, FLAG–G3BP1, FLAG–LARP1, 
FLAG–SF3A1, FLAG–FAN or mutants thereof were lysed 24 h post-transfection 
and captured using methods identical to those employed for endogenous protein 
immunoprecipitations.
Immuno-isolation of EVs. The following antibodies were employed for immune-
isolation of EVs: mouse anti-CD9 (Millipore, CBL162), mouse anti-CD63 (Abcam, 
ab8219), mouse anti-CD81 (BD, 555675). Briefly, EVs purified from approximately 
4.5 × 108 cells by differential centrifugation were resuspended in 100 μl of PBS, 
split equally between four Eppendorf tubes (25 μl each), and resuspended in 
500 μl PBS. Each sample was mixed with 2 μg of normal mouse IgG and 50 μl of 
MACs microbeads (Miltenyi Biotec) for 1 h and then pre-cleared through a MACs 
magnetic μ Column (Miltenyi Biotec). Flow-through from each of the samples 
was collected, mixed with 2 μg of antibody against 1 of 3 different EV-associated 
tetraspanins or normal mouse IgG, 50 μl of MACs microbeads (Miltenyi Biotec) 
and left to capture overnight at 4 °C. The following day, bound EVs were captured 
separately on MACs magnetic μ Columns, washed with 1,500 μl PBS and then 
eluted with 100 μl of hot 2× sample buffer. Samples were then resolved via SDS–
PAGE and immunoblotted for LC3 and EV marker proteins.
Immunofluorescence and fluorescence microscopy. For immunofluorescence 
of myc–BirA* and myc–BirA*–LC3, cells stably expressing GFP–LC3 and myc–
BirA* probes were seeded on coverslips coated with 10 µg ml−1 fibronectin (BD 
Biosciences, 356008) diluted in PBS. The next day, cells were briefly washed with 
PBS, fixed with 4% paraformaldehyde (PFA) for 20 min at room temperature, 
quenched with PBS/glycine and permeabilized with 0.2% Triton X-100 in PBS. Cells 
were blocked for 1 h in blocking buffer (5% goat serum in PBS), incubated with 
mouse anti-myc antibody (1:1,000) overnight at 4 °C, washed, incubated with Alexa 
Fluor 594 goat anti mouse-secondary antibodies (1:500; Life Technologies) for 1 h at 
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room temperature, washed and mounted using Prolong Gold Anti-Fade mounting 
medium (Thermo Fisher, P36934). For immunofluorescence of endogenous 
LC3, cells stably expressing myc–BirA* probes were processed as above with the 
exception that rabbit anti-LC3 antibody (1:500, MBL PM036) and Alexa Fluor 488 
goat anti rabbit-secondary antibody (1:500; Life Technologies) were incorporated 
into the primary and secondary staining steps, respectively. Confocal imaging 
was performed using a TI-inverted microscope stand (Nikon) equipped with a 
Borealis-modified Yokogawa CSU-X1 confocal head (Spectral Applied Research), 
solid-state 488-nm (for GFP) and 561-nm (for Alexa Fluor 594) lasers, and a Clara 
cooled scientific-grade interline CCD (charge-coupled device) camera (Andor) or a 
CoolSNAP MYO cooled scientific-grade CCD camera (Photometrics). Intracellular 
fluorescent-tagged protein and immunofluorescence images were acquired at 37 °C 
using a 100× (NA, 1.49; oil) objective (CFI Aprochromat; Nikon). Microscope 
hardware was controlled with Nikon Elements Advanced (version 4.5.1) and the 
images were prepared in Fiji and Adobe Photoshop.
For immunofluorescence detection of endogenous LC3, CD63, SAFB 
and HNRNPK in enlarged Rab5-positive endosomes, cells of the indicated 
genotypes were transiently transfected with mCherry–Rab5CA(Q79L) at 70% 
confluency with Lipofectamine 2000 (Thermo Fisher, 11668027) according to 
the manufacturer’s instructions; in RNA interference experiments, cells were 
first transfected with siRNA SMARTpools and 24 h later mCherry–Rab5Q79L was 
transfected using Lipofectamine 2000 (Thermo Fisher, 11668027). After 6 h, 
DNA-transfected cells were plated onto coverslips coated with fibronectin. Cells 
were incubated on coverslips for 72 h and then fixed with 4% PFA in PBS for 
15 min at room temperature, permeabilized with ice-cold methanol and incubated 
at −20 °C for 5 min before quenching with PBS/glycine. Cells were blocked in 
blocking buffer (PBS + 0.1% Tween + 10% goat serum) for 1 h at room temperature, 
incubated with rabbit anti-LC3B (1:200, MBL PM036), mouse anti-CD63 (1:200, 
Abcam ab8219) or mouse anti-LC3 (1:200, Axxora 5F10) and rabbit anti-SAFB 
(1:200, Abcam ab187650) or rabbit anti-LC3B (1:200, CST 3868) and mouse 
anti-HNRNPK (1:200, Abcam ab39975) antibodies diluted in blocking buffer 
overnight at 4 °C, washed with PBS, and then incubated with AlexaFluor goat 
anti-rabbit 488 (1:500, Thermo Fisher, A-11034) and goat anti-mouse 647 (1:500, 
Thermo Fisher, A21235) secondary antibodies in blocking buffer for 1 h at room 
temperature. Coverslips were washed with PBS and mounted using Prolong 
Gold (Thermo Fisher, P36934). For immunofluorescence of endogenous LC3 
and CD63 in the absence of Rab5CA(Q79L) perturbation, cells were processed 
as above using rabbit anti-LC3B (1:200, CST 3868) and mouse anti-CD63 (1:200, 
Abcam ab8219) antibodies for primary staining. Cells were visualized using a 
DeltaVision microscope (Applied Precision) fitted with a 60X, 1.4-NA objective 
and a CoolSnap HQ camera (Photometrics). Images were acquired using softWoRx 
software (Applied Precision) and prepared in Fiji and Adobe Photoshop. Costes 
significance tests for co-occurrence77 and the Mander’s overlap coefficient for LC3 
with CD63 were performed by drawing a region of interest around individual 
cells and then employing the Coloc 2 analysis function within Fiji (PSF: 20, 
Costes randomizations: 10). Furthermore, the proportion of mCherry–Rab5Q79L 
endosomal area that overlaps with endogenous LC3 in siRNA-treated cells was 
quantified using Fiji.
APEX staining and TEM. APEX staining and TEM was performed as previously 
described24. Briefly, cells transfected with APEX–LC3 or APEX–GFP were fixed 
using room-temperature 2.5% glutaraldehyde (Electron Microscopy Sciences) in 
buffer (100 mM sodium cacodylate with 2 mM CaCl2, pH 7.4), and then transferred 
to ice. All subsequent steps until resin infiltration were performed at 4 °C. After 
30 min, cells were rinsed 5 × 2 min in cold buffer (100 mM sodium cacodylate with 
2 mM CaCl2, pH 7.4), and then incubated for 5 min in buffer containing 20 mM 
glycine, followed by 5 × 2 min washes in cold buffer. Freshly prepared 1 mg ml−1 
DAB tetrahydrochloride (Sigma, 32750) dissolved in 0.1 M HCl was combined with 
0.03% (v/v) (10 mM) H2O2 in chilled buffer, and the solution was added to cells 
for 2 min. The reaction was terminated by removal of the DAB solution, and cells 
were rinsed 5 × 2 min with cold buffer. Post-fixation staining was performed with 
2% osmium tetroxide (Electron Microscopy Sciences, 19152) for 30 min in chilled 
buffer. Cells were washed 5 × 2 min in ice-cold distilled water, and then placed in 
2% aqueous uranyl acetate (Electron Microscopy Sciences, 22400) at 4 °C overnight. 
Samples were then incubated in a cold-graded ethanol series (20%, 50%, 70%, 90%, 
100%, 100%; 2 min in each), washed once in room-temperature anhydrous ethanol, 
and infiltrated in Durcupan ACM resin (Electron Microscopy Sciences, 14040) 
using 1:1 (v/v) anhydrous ethanol and resin for 30 min, then 100% resin 2 × 1 h, and 
finally into fresh resin and polymerized in a vacuum oven at 60 °C for 48 h.
For TEM, DAB-stained areas of resin-embedded cultured cells were identified 
by bright-field microscopy. Areas of interest were sawed out using a jeweller’s saw 
and mounted onto dummy blocks using cyanoacrylic glue, with the glass coverslip 
opposite the dummy block. The coverslip was carefully removed, the block was 
trimmed, and ultrathin (80 nm thick) sections were cut using an ultramicrotome 
(Leica Ultracut UTC6). Electron micrographs were recorded using a JEOL 1200 
TEM operating at 80 keV.
In vivo EV isolation from mice. All experimental procedures and treatments 
were conducted in compliance with UCSF Institutional Animal Care and 
Use Committee (IACUC) guidelines under an approved animal protocol (no. 
AN170608). Compound transgenic C57bl/6 male and female mice harbouring 
floxed alleles of Atg12 (Atg12f/f) or Atg5 (Atg5f/f) and Cre-recombinase under 
the ubiquitous CAG promoter (Cag-CreER) were generated by cross-breeding 
of Atg12f/f or Atg5f/f mice15 and CagCreER mice78. Offspring were genotyped 
with the following PCR primers: Atg12 WT and f/f: 5ʹ-atgtgaatcagtcctttgccc-
3ʹ, 5ʹ-actctgaaggcgttcacggc-3ʹ, 5ʹ-ctctgaaggcgttcacaaca-3ʹ; Atg5 WT and 
f/f: 5ʹ-gaatatgaaggcacacccctgaaatg-3ʹ, 5ʹ-acaacgtcgagcacagctgcgcaagg-3ʹ, 
5ʹ-gtactgcataatggtttaactcttgc-3ʹ; Cag-CreER: 5ʹ- gcctgcattaccggtcgatgc-3ʹ, 
5ʹ-cagggtgttataagcaatccc-3ʹ.
Primary astrocyte cultures were prepared as previously described79. Briefly, 
cerebral cortices were collected from P3–4 Atg5f/f and Cag-CreER;Atg5f/f pups 
(eight male and eight female across conditions). The meninges were removed 
and the cerebral cortices were dissected into smaller pieces with forceps and then 
triturated in DMEM, 20% FBS, penicillin/streptomycin and 20 ng ml−1 of GM-CSF 
(PeproTech). The cells were grown in poly-l-lysine-coated flasks. The medium 
was replenished 3 d after the initial collection. Microglia were removed from the 
astrocyte layer 6–10 d later by shaking flasks at 200 r.p.m. for 1–2 h at 37 °C. The 
remaining primary astrocytes were trypsinized and expanded in DMEM, 20% FBS, 
penicillin/streptomycin and 20 ng ml−1 of GM-CSF (PeproTech) for 11 d. Finally, 
astrocyte cultures were treated with medium containing 2 μM 4-hydroxytamoxifen 
(4-OHT) for 3 d, washed with PBS and replenished with Neurobasal medium 
supplemented with N2, l-glutamine and penicillin/streptomycin. After 5 d, the CM 
from primary astrocyte cultures was collected for EV purification by differential 
centrifugation (see the section on EV preparation above) and cells were lysed to 
assess genetic deletion.
For plasma and kidney analysis, 6-week-old Cag-CreER;Atg12f/f animals or 
controls received either tamoxifen (0.2 mg per gram of mouse) or vehicle (peanut 
oil) via oral gavage for five consecutive days (eight male and eight female across 
conditions). At 10 weeks after the first tamoxifen treatment, tissues were collected. 
Kidney was homogenized and lysed before immunoblotting. Whole blood was 
collected in heparin-coated tubes (Sarstedt, CB 300 LH), centrifuged at 2,000g for 
5 min at room temperature and the plasma phase was collected. For purification of 
plasma EVs, approximately 1 ml of platelet-free murine plasma (pooled from four 
mice per cohort) was diluted in 10 ml of PBS and clarified through a 0.22-μm filter. 
Subsequently, filtered samples were ultracentrifuged at 100,000g for 2 h at 4 °C and 
purified EV pellets were resuspended in lysis buffer for analysis.
Cell viability assays. To quantify EV-independent release of lactate dehydrogenase, 
cells were seeded in 6-well culture plates and serum starved for 24 h; cells treated 
with 100 μM etoposide for 24 h served as a positive control for cell death. After 
24 h, CM was collected and EVs were pelleted via differential centrifugation. The 
supernatant from these samples was then collected and soluble proteins were 
precipitated by adding TCA to a final concentration of 20% and incubating on ice 
for 1 h. Subsequently, precipitated protein was pelleted by ultracentrifugation at 
200,000g for 1 h. Pellets were washed with 5 ml of ice-cold acetone, re-centrifuged 
at 200,000g for 1 h and air-dried. Urea lysis buffer was added to re-solubilize the 
pellets and the levels of lactate dehydrogenase were quantified by western blot.
To quantify viability following serum starvation, cells were seeded on 
coverslips coated with fibronectin and subjected to serum starvation or control 
medium with full serum for 24 h. Cells were then stained for viability using 
Calcein AM and ethidium homodimer-1 (Thermo Fisher, MP 03224) according 
to the manufacturer’s instructions, visualized on an Axiovert 200 epifluorescent 
microscope, and dead cells (ethidium-positive, Calcein-negative) were enumerated.
CRISPR–Cas9 gene deletion. HEK293T knockout cell lines were generated by 
transient transfection of pSpCas9(BB)-2A-Puro (Addgene no. 48139) encoding U6-
driven expression of sgRNAs (Scramble guide: GCACTACCAGAGCTAACTCA; 
ATG7 guide: ACACACTCGAGTCTTTCAAG; ATG12 guide: 
CCGTCTTCCGCTGCAGTTTC; ATG14 guide: CTACTTCGACGGCCGCGACC; 
FIP200 guide: AGAGTGTGTACCTACAGTGC). Cells were selected 
48–72 h post-transfection with 1 μg ml−1 puromycin for 48 h. Polyclonal 
populations were collected for Surveyor analysis (IDT, 706020) and were 
sorted into single-cell populations by limiting dilution at 1.5 cells per 
well per 96-well plate. For DNA analysis, genomic DNA samples were 
prepared using QuickExtract (Epicentre). The PCR products were column 
purified and analysed with the Surveyor Mutation Detection Kit (IDT). For 
genotyping of single-sorted cells, PCR-amplified products encompassing the 
edited region (ATG7 Fwd: TGGGGGACAGTAGAACAGCA, ATG7 Rev: 
CCTGGATGTCCTCTCCCTGA; ATG12 Fwd: AGCCGGGAACACCAAGTTT, 
ATG12 Rev: GTGGCAGCCAAGTATCAGGC; ATG14 Fwd: 
AAAATCCCACGTGACTGGCT, ATG14 Rev: AATGGCAGCAACGGGAAAAC; 
FIP200 Fwd: ATTCTCTGGCTTGACAGGACAG, FIP200 Rev: 
AAATACTGAGCGTGCACATTGC) were cloned into the pCR4-TOPO TA vector 
using the TOPO-TA cloning kit (Thermo Fisher no. 450030) and sequence verified. 
Sequencing is available on request.
RNA interference. For transient siRNA-mediated knockdown, cells were first 
transfected with siRNA and using DharmaFECT no. 1 (Dharmacon T-2001-03) 
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according to the manufacturer’s instructions, and after 24 h were transfected with a 
plasmid encoding mCherry–Rab5Q79L. ON-TARGETplus smart pools against ATG7 
(10533; L-020112-00-0005), PDCD6IP (also known as ALIX) (10015; L-004233-
00-0005), TSG101 (7251; L-003549-00-0005), CHMP3 (51652; L-004696-00-0005), 
VPS4a (27183; L-013092-00-0005), VPS4b (9525; L-013119-00-0005), CHMP4b 
(128866; L-018075-01-0005), SMPD3 (also known as nSMase2) (55512, L-006678-
00-0005), NSMAF (also known as FAN) (8439; L-017920-00-0005) and non-
targeting siRNA (D-001810-01-20) were purchased from Dharmacon. To generate 
stable knockdowns, cells were transduced with pLKO.1 lentiviral vectors (Sigma-
Aldrich) expressing shRNAs targeting ATG7 (TRCN0000007584), ATG3 (no. 1, 
TRCN0000148120; no. 2, TRCN0000146846; no. 3, TRCN0000147381), SMPD3 
(nSMase2) (no. 1, TRCN0000048944; no. 2, TRCN0000048945), NSMAF (FAN) 
(no. 1, TRCN0000145430; no. 2, TRCN0000143925) and non-targeting shRNA 
(SHC002).
Quantitative PCR. For quantitative PCR analysis, total RNA from cells was 
isolated using QIAzol lysis reagent (Qiagen). RNA was reverse transcribed using 
MMLV reverse transcriptase (Roche) and the resulting cDNA was analysed via 
real-time quantitative PCR using QuantiTect SYBR Green PCR Master Mix and 
gene-specific primers (GAPDH Fwd: TGTCAAGCTCATTTCCTGGTATG, 
GAPDH Rev: CTCTCTTCCTCTTGTGCTCTTG; SMPD3 (nSMase2) 
Fwd: CAACAAGTGTAACGACGATGCC, SMPD3 (nSMase2) Rev: 
CGATTCTTTGGTCCTGAGGTGT) according to the manufacturer’s instructions. 
Ct values for intracellular transcripts were converted to fold expression changes 
(2−ΔΔCt values) following normalization to intracellular GAPDH. Quantitative 
real-time PCR was performed using an Applied Biosystems StepOneplus Real-
Time PCR System (Thermo Fisher).
Statistics and reproducibility. Statistical analyses were performed using Prism 
GraphPad 5 software. Groups were compared using unpaired or paired Student’s 
t-test where indicated for pairwise comparisons or one-way ANOVA followed 
by Tukey’s post-hoc test for multiple comparisons. The sample size was chosen 
on the basis of the size of the effect and variance for the different experimental 
approaches. Details regarding the statistical analysis of the proteomic data and the 
bioinformatics analysis of the BirA*–LC3-labelled secretome (both class I and class 
II datasets), the ATG7- and ATG12-dependent EV proteome and the RNA profiles 
are provided in the corresponding figure legends and/or the Methods sections 
above. P values of less than 0.05 are considered to be significant.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
The MS proteomics data associated with this study have been deposited to the 
ProteomeXchange Consortium via the PRIDE80 partner repository with the dataset 
identifier PXD015479. RNA-seq data have been deposited in GEO: GSE137618. 
Furthermore, the data and/or reagents that support the findings of this study are 
available from the corresponding author, J.D., upon reasonable request. Source data 
for Figs. 1–7 and Extended Data Figs. 1–7 are provided online.
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Extended Data Fig. 1 | See next page for caption.
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Extended Data Fig. 1 | Functional validation of the BirA*-LC3 recombinant probe. a, Cells stably expressing myc-BirA*-LC3, myc-BirA* or vector control 
were incubated in either full (F) or serum free media (S) for 4h in the absence or presence of 50 µM chloroquine (CQ) for the last 1h. Cells were lysed 
and subject to immunoblotting for indicated proteins (n=2 biologically independent experiments). b, Representative images of cells stably expressing 
GFP-LC3 and myc-BirA*-LC3 or myc-BirA* and immunostained with anti-myc antibody (n=3 biologically independent samples). c, Representative images 
of cells stably expressing myc-BirA*-LC3 or myc-BirA* and co-immunostained with anti-LC3 (green) and anti-myc (magenta) antibody (n=3 biologically 
independent samples). d, Biotinylation blots reproduced from Fig. 1b with accompanying Ponceau S stained membranes of whole cell lysate (WCL) and 
conditioned media (CM) (n=3 biologically independent experiments). e, Schematic of experiment to test for intracellular versus extracellular origin of 
BirA* and BirA*-LC3-mediated biotinylated targets isolated from CM. f, Representative Strep-HRP blot for biotinylated proteins in the precipitated CM 
from myc-BirA*-LC3 or myc-BirA* cells co-incubated (Co) or post-incubated (Post) with 50 µM biotin for 24h and negative control (Neg). CM was probed 
to validate expression and secretion of the myc-tagged recombinant proteins (n=2 biologically independent experiments). Unprocessed blots available in 
Source Data Extended Data Fig. 1.
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Extended Data Fig. 2 | See next page for caption.
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Extended Data Fig. 2 | BirA*-LC3B-labelled secretome is enriched in RBPs. a, Volcano plot of BirAf*-LC3-labeled secretome quantified by mass 
spectrometry. SILAC labelled biotin-tagged proteins plotted according to -log10 p-values as determined by two-tailed t-test and log2 fold enrichment 
(BirA*-LC3/BirA*) (n=3 biologically independent samples). Grey horizontal dotted line: significance cut-off with p-value of 0.05. Log2 fold change reflects 
LC3-BirA* to BirA* alone ratio. Grey vertical dotted line: 2-fold enriched and de-enriched cut-off. Pink: significantly enriched proteins relative to BirA* alone. 
Red: Class I enriched proteins represented in heat map in Fig. 1. Inset: Expanded view of significantly enriched proteins. b, Venn diagram showing overlap 
of secretory autophagy candidates (Class I and II hits) with the LC3B intracellular interactome defined in Behrends et al. 2010. c, Venn diagram showing 
the overlap of secretory autophagy candidates (Class I and II hits) with the entire ATG8 intracellular interactome defined in Behrends et al. 2010. d, Ranked 
list of proteins with greatest connectivity to secretory autophagy candidates as determined by the Enrichr gene enrichment analysis tool (n=3 biologically 
independent samples; 200 enriched proteins in Class I + II datasets). Statistical significance calculated by one-way Fisher’s exact test and adjusted using 
the Benjamini–Hochberg method. LC3 family members highlighted in red. e, Network map of autophagy-dependent secretion candidates. Class I and 
II secretory autophagy candidates mapped to zero-order protein interaction network using Search Tool for the Retrieval of Interacting Genes/Proteins 
(STRING) and proteins associated with extracellular exosomes or with RNA-binding functions coloured in red and blue, respectively. f, Pie chart plotting 
percentage of Class I and II secretory autophagy candidates assigned to Gene Ontology (GO) term extracellular exosome by PANTHER. g, Venn diagram 
showing overlap of class I and II secretory autophagy candidates with the mRNA binding proteins from Castello et al. 2012. Data available in Source Data 
Extended Data Fig. 2.
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Extended Data Fig. 3 | See next page for caption.
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Extended Data Fig. 3 | Endogenous LC3-II is secreted within EVs isolated from cultured cells and murine plasma. a, Whole cell lysate (WCL) and 
extracellular vesicle lysates (EVs) from murine RAW264.7 macrophages treated with 100 ng/ml LPS for 24h and 20 μM nigericin for 1 h, murine 
B16F10 melanoma cells, and murine LLC1 cells were immunoblotted for LC3, SAFB, HNRNPK and extracellular vesicle marker proteins (n=2 biologically 
independent experiments). b, Workflow employed to obtain plasma and tissue from CAG-CreER;Atg12flox/flox mice in which Atg12 was systemically deleted 
via tamoxifen treatment. c, Extracellular vesicles (EVs) isolated from the plasma of naïve wild-type mice (CAG-CreER or Atg12flox/flox) and mice in which 
Atg12 was systemically deleted by 4-OHT treatment (CAG-CreER; Atg12flox/flox) were lysed and immunoblotted for LC3 and the indicated extracellular 
vesicle marker proteins (n=2 biologically independent experiments). d, Whole cell lysates (WCL) derived from the renal tissue of mice in Panel c were 
immunoblotted for LC3 and the indicated marker proteins (n=2 biologically independent experiments). e, Workflow employed to obtain CM from murine 
astrocytes (CAG-CreER;Atg5flox/flox) in which Atg5 was deleted ex vivo via 4-OHT treatment. f, Extracellular vesicles (EVs) isolated from the conditioned 
media of naive wild-type (Atg5flox/flox) primary astrocytes and astrocyte cultures in which Atg5 was deleted ex vivo (CAG-CreER; Atg5flox/flox) by 4-OHT 
treatment were lysed and immunoblotted for LC3 and CD9 (n=2 biologically independent experiments). g, Whole cell lysates (WCL) primary astrocyte 
cultures in Panel d were immunoblotted for LC3 and CD9 (n=2 biologically independent experiments). h, Representative fluorescence micrographs from 
wild-type, ATG7-/- and ATG14-/- HEK293T cells transfected with mCherry-Rab5Q79L (yellow). Cells were immunostained for endogenous LC3 (green) and 
CD63 (magenta) (n=3 biologically independent samples). Scale bar=10μm. Unprocessed blots available in Source Data Extended Data Fig. 3.
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Extended Data Fig. 4 | See next page for caption.
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Extended Data Fig. 4 | Components of stress granules and P-bodies secreted in EVs through mechanisms requiring the LC3-conjugation machinery. a, 
Proportion of BirA*-LC3B- labelled secretome (Class I, II candidates) detected in the total extracellular vesicle (EV) proteome defined by TMT quantitative 
mass spectrometry. b, Venn diagram showing overlap of EV components requiring ATG7 and ATG12 for secretion with the fixed and unfixed stress granule 
proteome from Jain et al., 2016. c, Venn diagram showing the overlap of EV components requiring ATG7 and ATG12 for secretion with the P-body proteome 
from Hubstenberger et al., 2017. d, Representative fluorescence micrographs from wild-type HEK293T cells transfected with mCherry-Rab5Q79L (blue) 
and immunostained for endogenous LC3 (green) and SAFB or HNRNPK (magenta) (n=3 biologically independent samples). Scale bar=10μm. e, Whole 
cell (WCL) and EV lysates harvested from equal numbers of cells stably expressing non-targeting (NT) or ATG3 shRNA were immunoblotted for indicated 
proteins (n=3 biologically independent samples). f, Quantification of indicated protein levels in EVs from cells stably expressing shRNAs targeting 
ATG3 relative to non-targeting shRNA (mean ±s.e.m.; n=3 biologically independent samples). g, Quantification of Lactate Dehydrogenase (LDH) in EV-
depleted conditioned media from wild-type (WT) HEK293T cells treated 100 μM Etoposide (Etop) for 24h or WT and ATG knockout cells serum starved 
for 24h (mean ±s.e.m.; n=3 biologically independent experiments). h, Cell death in wild-type (WT) and ATG knockout cells (KO) after 24h in full serum 
media (FM) or serum starved media (SS) quantified using Calcein-AM and ethidium bromide staining (mean ±s.e.m.; n=3 biologically independent 
experiments). i, Whole cell and EV lysates from wild-type cells grown in EV-depleted full serum media (FM) or EV-depleted FM with 100 nM Rapamycin 
(Rap) for 24h. Immunoblots probed against the indicated proteins (n=2 biologically independent experiments). j, Quantification of the relative levels of 
indicated proteins in EVs from Rap-treated cells in Panel d (line=mean; n=2 biologically independent experiments). Data and unprocessed blots available 
in Source Data Extended Data Fig. 4.
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Extended Data Fig. 5 | LC3-conjugation machinery controls EV-mediated secretion of diverse RBPs. a, EVs from WT and ATG deficient cells normalized 
for protein concentration and immunoblotted to detect endogenous LC3A, LC3B, LC3C, GABARAP (GR), GABARAPL1 (GRL1), GABARAPL2 (GRL2), and 
indicated marker proteins (n=2 biologically independent experiments). b, Whole cell (WCL) and EV lysates from WT and ATG7-/- cells were normalized 
for protein concentration and immunoblotted for indicated proteins (n=3 biologically independent experiments). c, HEK293T cells co-transfected with 
FLAG-tagged G3BP1, LARP1 or SF3A1, and myc-tagged LC3B, GABARAP (GR), LC3C respectively, or myc-BirA* were lysed, immunoprecipitated (IP) 
with anti-myc antibody and immunoblotted (WB) with indicated antibodies (n=3 biologically independent experiments). d, Diagram mapping the 
domains and primary LC3-interaction region (LIR) in SAFB. e, Volcano plot of mRNA and long non-coding RNA (large RNA) detected in EVs from WT and 
ATG7-/- cells. Results plotted according to -log10 p-values as determined by DESeq2 and log2 fold enrichment (n=3 biologically independent samples; 
WT/ATG7-/-). Grey dots: RNAs not enriched in EVs from WT or ATG7-/- cells identified with a p-value >0.05 and/or log2 fold change between -0.5 and 
0.5 (-0.5<log2FC<0.5). Black dots: Large RNAs enriched in EVs from WT cells or ATG7-/- cells. f, Volcano plot of mRNA and long non-coding RNA (large 
RNA) detected in EVs from WT and ATG12-/- cells. Results plotted according to -log10 p-values as determined by DESeq2 and log2 fold enrichment (n=3 
biologically independent samples; WT/ATG12-/-). Grey dots: RNAs not enriched in EVs from WT or ATG12-/- cells identified with a p-value >0.05 and/or 
log2 fold change between -0.5 and 0.5 (-0.5<log2FC<0.5). Black dots: Large RNAs enriched in EVs from WT or ATG12-/- cells. g, Venn diagram showing 
the overlap of mRNA and long non-coding RNAs (large RNAs) enriched in EVs from WT relative to ATG7-/- cells and EVs from WT relative to ATG12-/- 
cells. Data and unprocessed blots available in Source Data Extended Data Fig. 5.
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Extended Data Fig. 6 | See next page for caption.
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Extended Data Fig. 6 | LC3 delivery into ILVs of Rab5Q79L endosomes requires CHMP4b and nSMase2, but is independent of other ESCRT machinery 
components. a, Representative fluorescence micrographs from wild-type HEK293T cells co-transfected with mCherry-Rab5Q79L (magenta) and non-
targeting (NT) control siRNA or siRNAs that deplete ATG7, ALIX, TSG101, VPS4a/b, CHMP3, CHMP4b and nSMase2. Cells were immunostained for 
endogenous LC3 (green) (n=2 biologically independent experiments). Scale bar=10μm. b, Scatter plot of the proportion of mCherry-Rab5Q79L endosomes 
that overlap with LC3 in immuno-stained cells in Panel a (mean ± s.e.m.; n=23 biologically independent samples). Statistical significance calculated by 
one-way ANOVA coupled with Fisher’s least significant difference test. c, Lysates from cells in Panel a were immunoblotted with antibodies the various 
siRNA targets and GAPDH as a loading control. Representative blots are shown (n=2 biologically independent experiments). Non-specific bands are 
indicated with an asterisk (*). d, Quantitative PCR (QPCR) measurement of nSMase2 mRNA in HEK293T cells transfected with siRNAs targeting nSMase2, 
nSMase2 (nSM2) relative to non-targeting siRNA (NT) control cells (line=mean; n=1, 2 technical replicates). Data and unprocessed blots available in 
Source Data Extended Data Fig. 6.
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Extended Data Fig. 7 | See next page for caption.
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Extended Data Fig. 7 | LC3-dependent EV loading and secretion (LDELS) requires FAN and nSMase2. a, Whole cell lysate harvested from equal numbers 
of HEK293Ts stably expressing non-targeting (NT) shRNA or shRNAs that deplete ATG7 or nSMase2(nSM2) immunoblotted for indicated proteins 
(n=2 biologically independent experiments). b, Quantitative PCR (QPCR) for nSMase2 mRNA in HEK293Ts stably expressing shRNAs targeting ATG7, 
nSMase2 (nSM2) relative to non-targeting shRNA (NT) control cells (line=mean; n=1, 2 technical replicates). c, Whole cell lysates from HEK293Ts 
stably expressing non-targeting shRNA (NT) or shRNAs that deplete ATG7 or FAN were immunoblotted with antibodies for the indicated proteins (n=2 
biologically independent experiments). d, HEK293Ts were EBSS starved for the indicated times, treated with DMSO or 50nM Bafilomycin A1 (Baf A1) 
for 1 h prior to lysis, lysed and immunoblotted for FAN and the indicated proteins (n=2 biologically independent experiments). e, HEK293Ts expressing 
non-targeting (NT) shRNA or shRNA that depletes FAN were starved in EBSS for 4h, treated with DMSO or 50nM Bafilomycin A1 (Baf A1) for 1h prior 
to lysis, lysed and immunoblotted for the indicated proteins (n=2 biologically independent experiments). f, Representative fluorescence micrographs 
from wild-type cells co-transfected with mCherry-Rab5Q79L (magenta) and non-targeting (NT) control siRNA or siRNAs that deplete FAN. Cells were 
immunostained for endogenous LC3 (green)(n=2 biologically experiments). Scale bar=10μm. g, Lysates from cells in Panel f were immunoblotted with 
antibodies against FAN and GAPDH as a loading control (n=2 biologically independent experiments). h, Scatter plot of the proportion of mCherry-
Rab5Q79L endosomes overlapping with LC3 in immuno-stained cells in Panel f (mean ±s.e.m.; n=22 biologically independent samples). Statistical 
significance calculated by unpaired two-tailed t-test. i, Whole cell lysate from HEK293Ts analysed in Fig. 7j that were co-expressing non-targeting (NT) 
shRNA or shRNA that depletes endogenous FAN along with FLAG-tagged wild-type FAN (WT) or mutant FAN (F199A) were immunoblotted for the 
indicated proteins (n=2 biologically independent experiments). j, Proposed model for LC3-dependent EV loading and secretion (LDELS) in comparison to 
classical autophagy. Data and unprocessed blots available in Source Data Extended Data Fig. 7.
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